Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission file number 000-55648

INNOVATIVE PAYMENT SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

Nevada		33-1230229
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

56B 5^th Avenue, Lot 1 #AT, Carmel By The Sea, CA 93921

(Address of Principal Executive Offices, including zip code)

(866) 477-4729

(Registrant’s telephone number, including area code)

n/a

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.) Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☐	Accelerated Filer	☐
Non-accelerated Filer	☒	Smaller Reporting Company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered

As of August 11, 2023, there were 379,075,592 shares of the Company’s common stock issued and outstanding.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Form 10-Q

For the Quarter Ended June 30, 2023

Index

		Page No.

Cautionary Note Regarding Forward-Looking Statements		ii

Part I. Financial Information		1

Item 1.	Financial Statements (Unaudited)	1

	Condensed Consolidated Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022	1

	Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022 (Unaudited)	2

	Condensed Consolidated Statements of Changes in Stockholders’ Equity for the six months ended June 30, 2023 and 2022 (Unaudited)	3

	Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022 (Unaudited)	4

	Notes to the Condensed Consolidated Financial Statements (Unaudited)	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	35

Item 4.	Controls and Procedures	35

Part II. Other Information		36

Item 1.	Legal Proceedings	36

Item 1A.	Risk Factors	37

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	37

Item 3.	Defaults Upon Senior Securities	38

Item 4.	Mine Safety Disclosures	38

Item 5.	Other Information	38

Item 6.	Exhibits	39

Signatures		40

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (this “report”) contains “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) that reflect our current expectations and views of future events. The forward-looking statements are contained principally in the section of this report entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Readers are cautioned that significant known and unknown risks, uncertainties and other important factors (including those over which we may have no control and others listed in report and in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”)) may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. You can identify some of these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements include statements relating to:

●

our ability to implement our business plan, including our ability to launch, achieve customer downloads of and generate revenue from our IPSIPay, IPSIPay Express or other digital payment solutions;

●

acceptance by the marketplace of our products and services, notably IPSIPay and IPSIPay Express;

●

our ability to formulate, implement and modify as necessary effective sales, marketing, and strategic initiatives to drive revenue growth;

●

the viability of our current intellectual property and intellectual property created in the future;

●

our ability to comply with currently applicable laws and government regulations and those that may be applicable in the future;

●

our ability to retain key employees and third-party service providers;

●

adverse changes in general market conditions for payment solutions such as IPSIPay, IPSIPay Express and other products and services we offer;

●

our ability to generate cash flow and profitability and continue as a going concern;

●

our future financing plans and ability to repay outstanding indebtedness; and

●

our ability to adapt to changes in market conditions which could impair our operations and financial performance.

These forward-looking statements involve numerous and significant risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are reasonable, our expectations may later be found to be incorrect. Our actual results of operations or the results of other matters that we anticipate herein could be materially different from our expectations. Important risks and factors that could cause our actual results to be materially different from our expectations are generally set forth in the “Management’s Discussion and Analysis of Financial Condition and Results of Operation,” section contain in this report and in the “Business,” “Risk Factors” and other sections of the 2022 Form 10-K. You should thoroughly read this report and the documents that we refer to with the understanding that our actual future results may be materially different from, and worse than, what we expect. We qualify all of our forward-looking statements by these cautionary statements.

The forward-looking statements made in this report relate only to events or information as of the date of this report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this report completely and with the understanding that our actual future results may be materially different from what we expect

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Balance Sheets

	June 30,			December 31,
	2023			2022
	(Unaudited)
Assets
Current Assets
Cash	$	46,788		$	373,822
Receivable from equity method investment		22,103			-
Receivable on sale of subsidiary		166,668			-
Other current assets		19,080			97,042
Assets held for sale		-			807,263
Total Current Assets		254,639			1,278,127

Non-current assets
Plant and equipment		14,861			40,362
Intangible assets		1,191,693			1,401,491
Receivable on sale of subsidiary		64,768			-
Security deposit		19,800			32,592
Equity method investment		306,839			-
Investment		-			-
Total Non-Current Assets		1,597,961			1,474,445
Total Assets	$	1,852,600		$	2,752,572

Liabilities and Equity (Deficit)

Current Liabilities
Accounts payable	$	1,387,412		$	727,922
Liabilities held for sale		-			33,810
Related party payables		50,000			-
Federal relief loans – current portion		3,275			-
Notes payable		1,012,736			964,268
Convertible debt, net of unamortized discount of $463,104 and $0, respectively		2,837,176			2,266,602
Derivative liability		3,012,574			2,550,642
Total Current Liabilities		8,303,173			6,543,244

Non-Current Liabilities
Federal relief loans		158,360			163,978
Total Non-Current Liabilities		158,360			163,978

Total Liabilities		8,461,533			6,707,222

Equity (Deficit)
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of June 30, 2023 and December 31, 2022.		-			-
Common stock, $0.0001 par value; 750,000,000 shares authorized, 379,075,592 and 376,901,679 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively.		37,908			37,690
Additional paid-in-capital		49,200,624			48,405,921
Accumulated deficit		(55,847,465	)		(52,399,858	)
Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders		(6,608,933	)		(3,956,247	)
Non-controlling interest		-			1,597
Total Equity (Deficit)		(6,608,933	)		(3,954,650	)
Total Liabilities and Equity (Deficit)	$	1,852,600		$	2,752,572

See accompanying notes to the unaudited condensed consolidated financial statements.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

	Three months ended			Three months ended			Six months ended			Six months ended
	June 30,			June 30,			June 30,			June 30,
	2023			2022			2023			2022

Net Revenue	$	5		$	-		$	438		$	-

Cost of Goods Sold		284			-			2,369			-

Gross loss		(279	)		-			(1,931	)		-

General and administrative		1,057,631			769,054			2,007,578			1,620,580
Depreciation and amortization		139,015			4,497			279,705			8,993
Total Expense		1,196,646			773,551			2,287,283			1,629,573

Loss from Operations		(1,196,925	)		(773,551	)		(2,289,214	)		(1,629,573	)

Loss on debt conversion		(18,478	)		-			(18,478	)		-
Penalty on convertible notes		-			-			-			(719,558	)
Interest expense		(95,079	)		(45,196	)		(180,300	)		(90,962	)
Amortization of debt discount		(88,687	)		-			(111,654	)		(263,200	)
Derivative liability movements		(1,252,682	)		(242,102	)		(311,932	)		(149,941	)
Loss before Income Taxes		(2,651,851	)		(1,060,849	)		(2,911,578	)		(2,853,234	)

Income Taxes		-			-			-			-
Net Loss after income taxes		(2,651,851	)		(1,060,849	)		(2,911,578	)		(2,853,234	)

Net loss from equity method investments		(1,381	)		-			(1,381	)		-
Net loss from continuing operations		(2,653,232	)		(1,060,849	)		(2,912,959	)		(2,853,234	)

Discontinued operations
Operating loss from discontinued operations		(25,561	)		(26,483	)		(40,821	)		(44,344	)
Loss on disposal of subsidiary and investment		(495,424	)		-			(495,424	)		-
		(520,985	)		(26,483	)		(536,245	)		(44,344	)
Net loss		(3,174,217	)		(1,087,332	)		(3,449,204	)		(2,897,578	)
Net loss attributable to non-controlling interest		-			12,977			1,597			21,729
Net loss attributable to Innovative Payment Solutions, Inc., stockholders	$	(3,174,217	)	$	(1,074,355	)	$	(3,447,607	)	$	(2,875,849	)

Basic and diluted loss per share
Continuing operations	$	(0.01	)	$	(0.00	)	$	(0.01	)	$	(0.01	)
Discontinued operations		(0.00	)		(0.00	)		(0.00	)		(0.00	)
	$	(0.01	)	$	(0.00	)	$	(0.01	)	$	(0.01	)
Weighted Average Number of Shares Outstanding – Basic and diluted		377,905,023			367,901,679			377,403,351			367,901,679

See accompanying notes to condensed consolidated financial statements.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

	Preferred Stock Shares		Amount		Common Stock Shares*		Amount		Additional Paid-in Capital		Accumulated Deficit			Non-controlling shareholders interest			Total Stockholders’ Equity (Deficit)

Balance at December 31, 2022		-	$	-		376,901,679	$	37,690	$	48,405,921	$	(52,399,858	)	$	1,597		$	(3,954,650	)
Fair value of warrants issued to convertible debt holders		-		-		-		-		251,856		-			-			251,856
Stock based compensation		-		-		-		-		130,671		-			-			130,671
Net loss		-		-		-		-		-		(273,390	)		(1,597	)		(274,987	)
Balance at March 31, 2023		-	$	-		376,901,679	$	37,690	$	48,788,448	$	(52,673,248	)	$	-		$	(3,847,110	)
Conversion of convertible debt		-		-		2,173,913		218		43,260		-			-			43,478
Fair value of warrants issued to convertible debt holders		-		-		-		-		130,025		-			-			130,025
Fair value of warrants issued for equity method investments		-		-		-		-		108,220		-			-			108,220
Stock based compensation		-		-		-		-		130,671		-			-			130,671
Net loss		-		-								(3,174,217	)		-			(3,174,217	)
Balance as of June 30, 2023		-	$	-		379,075,592	$	37,908	$	49,200,624	$	(55,847,465	)	$	-		$	(6,608,933	)

	Preferred Stock Shares		Amount		Common Stock Shares*		Amount		Additional Paid-in Capital		Accumulated Deficit			Non-controlling shareholders interest			Total Stockholders’ Equity (Deficit)

Balance at December 31, 2021		-		-		367,901,679	$	36,790	$	45,771,012	$	(42,111,701	)	$	35,211		$	3,731,312
Stock based option expense		-		-		-		-		94,466		-			-			94,466
Restricted stock awards		-		-		-		-		62,766		-			-			62,766
Net loss		-		-		-		-		-		(1,801,494	)		(8,752	)		(1,810,246	)
Balance at March 31, 2022		-	$	-		367,901,679	$	36,790	$	45,928,244	$	(43,913,195	)	$	26,459		$	2,078,298
Contribution by minority shareholders															9,653			9,653
Stock based option expense		-		-		-		-		94,462		-			-			94,462
Restricted stock awards		-		-		-		-		62,766		-			-			62,766
Net loss		-		-		-		-		-		(1,074,355	)		(12,977	)		(1,087,332	)
Balance at June 30, 2022		-	$	-		367,901,679	$	36,790	$	46,085,472	$	(44,987,550	)	$	23,135		$	1,157,847

See accompanying notes to condensed consolidated financial statements.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Six months ended			Six months ended
	June 30,			June 30,
	2023			2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(3,449,204	)	$	(2,897,578	)
Net loss from discontinued operations		536,245			44,344
Net loss from continuing operations		(2,912,959	)		(2,853,234	)
Adjustments to reconcile net loss to net cash used in operating activities:
Derivative liability movements		311,932			149,941
Depreciation		279,705			8,993
Amortization of debt discount		111,654			263,200
Loss on conversion of debt to equity		18,478			-
Penalty on convertible debt		-			719,558
Unrealized loss on equity method investments		1,381			-
Stock based compensation		261,342			314,460
Changes in Assets and Liabilities
Receivable from equity method investments		(22,103	)		-
Receivable from disposal of subsidiary		18,570			-
Other current assets		77,957			58,312
Accounts payable and accrued expenses		659,490			(63,881	)
Related party payables		50,000			-
Interest accruals		176,107			2,712
Cash used in operating activities – continuing operations		(968,446	)		(1,399,939	)
Cash provided by (used in) operating activities – discontinued operations		35,287			(52,734	)
CASH USED IN OPERATING ACTIVITIES		(933,159	)		(1,452,673	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in intangibles		(44,405	)		(290,290	)
Investment in equity method investment		(200,000	)		-
Net cash used in investing activities – continuing operations		(244,405	)		(290,290	)
Net cash used in investing activities – discontinued operations		(36,231	)		(37,510	)
CASH USED IN INVESTING ACTIVITIES		(280,636	)		(327,800	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes		900,000			-
Repayment of convertible notes		(11,840	)		(1,147,063	)
Repayment of federal relief loans		(2,342	)		-
Net cash provided by (used in) financing activities – continuing operations		885,818			(1,147,063	)
Net cash provided by financing activities – discontinued operations		-			9,653
NET CASH PROVIDED BY (SUED IN) FINANCING ACTIVITIES		885,818			(1,137,410	)

NET DECREASE IN CASH		(327,977	)		(2,917,883	)
Cash and cash included in assets held for sale at the beginning of the period		374,765			5,449,751
CASH AT END OF PERIOD	$	46,788		$	2,531,868
RECONCILIATION OF OPENING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS
Cash	$	373,822		$	5,367,551
Cash included in assets held for sale		943			82,200
CASH AT THE BEGINNING OF THE PERIOD	$	374,765		$	5,449,751
RECONCILIATION OF CLOSING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS
Cash	$	46,788		$	2,520,060
Cash included in assets held for sale		-			11,808
CASH AT THE END OF THE PERIOD	$	46,788		$	2,531,868
CASH PAID FOR INTEREST AND TAXES:
Cash paid for income taxes	$	-		$	-
Cash paid for interest	$	4,191		$	88,250
NON CASH INVESTING AND FINANCING ACTIVITIES
Fair value of warrants issued with convertible notes	$	381,881		$	-
Conversion of convertible debt to equity	$	25,000		$	-
Fair value of warrants issued for equity method investments	$	108,220		$	-

See notes to the unaudited condensed financial statements.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1	ORGANIZATION AND DESCRIPTION OF BUSINESS

Organizational History

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor.

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

Description of current business

The Company is currently a fintech provider of digital payment solutions presently focused on (i) operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely and (ii) through its participation in IPSIPay Express (as defined below), developing a new account-to-account payment application called Instant Settlement in RealTime as well as traditional credit card processing services.

The Company’s flagship e-wallet, IPSIPay, is fully operational. IPSIPay, which is focused on individual customers, was fully launched in July 2022 after a soft launch in December 2021. Previously the Company intended to invest in physical kiosks where any payment processing could be undertaken by customers in person. The Company has shifted its business to focus solely on downloadable apps used via smartphones and other online payment processing solutions.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1	ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

IPSIPay Express

On April 28, 2023, the Company formed a new company called IPSIPay Express LLC (“IPSIPay Express”). This entity was formed as a Delaware limited liability company joint venture with Open Path, Inc. (“Open Path”) and EfinityPay, LLC (“EfinityPay”, and the Company, collectively with Open Path and EfinityPay, the “Members”) to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.

On June 19, 2023, the Company entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”) with Open Path and EfinityPay to jointly provide for the governance of and rights of the Members with respect to IPSIPay Express. The effective date of the Operating Agreement is April 28, 2023.

IPSIPay Express was formed by the Members with the initial business purposes of providing credit card processing solutions and also a proprietary solution for real time bank-to-bank payment transactions in a manner that provides seamless and frictionless consumer and merchant experiences, with an initial focus on merchants operating in gaming and entertainment sectors. Such solutions are collectively referred to herein as “IPEX.”

The Company has agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company will make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a “Tranche”), or such lesser amounts as may be unanimously approved by the Board of Managers of IPSIPay Express. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and Open Path and EfinityPay’s percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or shall be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche shall be paid on or before September 15, 2023 and (iv) the third $500,000 Tranche shall be paid on or before October 31, 2023. Simultaneously with the funding of the initial Tranche, the Company will issue to each of Open Path and EfinityPay a five-year common stock purchase warrant (the “IPEX Warrant”) to purchase Ten Million shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. The shares of Common Stock underlying the IPEX Warrant issued in connection with the funding of the initial Tranche will be pro-rated based on the amount of the initial Tranche. Simultaneously with the funding of the second and third Tranche, the Company will issue to each of Open Path and EfinityPay an additional IPEX Warrant to purchase Five Million shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second and third Tranches. If the full IPSI Capital Contribution is funded, Open Path and EfinityPay will receive IPEX Warrants to purchase an aggregate of Forty Million shares of Common Stock.

Frictionless Financial Technologies

The Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”) on June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform (which was subsequently branded as IPSIPay) that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company had an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company; (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless, were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18 month period following the closing under the existing software services between the Company and Frictionless.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

2	ACCOUNTING POLICIES AND ESTIMATES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three and six months ended June 30, 2023 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2022, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2023.

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

Principles of Consolidation

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. – Disposed on May 12, 2023

Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

2	ACCOUNTING POLICIES AND ESTIMATES (continued)

Fair Value of Financial Instruments

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

Risks and Uncertainties

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) launching and scaling the Company’s IPSIPay and IPSIPay Express products and the use by customers of such products, (ii) developing and implementing successful marketing campaigns and other strategic initiatives; (iii) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see notes 11 and 12); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

Recent accounting pronouncements

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended June 30, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

2	ACCOUNTING POLICIES AND ESTIMATES (continued)

Reporting by Segment

No segmental information is required as the Company only has one operating segment.

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At June 30, 2023 and December 31, 2022, respectively, the Company had no cash equivalents.

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At June 30, 2023 and December 31, 2022, the balance exceed the federally insured limit by $0 and $120,580, respectively.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended June 30, 2023 and December 31, 2022.

Investments

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

Plant and Equipment

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

Description		Estimated Useful Life

Kiosks (not used in the Company’s current business)		7 years

Computer equipment		3 years

Office equipment		10 years

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

2	ACCOUNTING POLICIES AND ESTIMATES (continued)

Long-Term Assets

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

Revenue Recognition

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

identify the contract with a customer;

ii.

identify the performance obligations in the contract;

iii.

determine the transaction price;

iv.

allocate the transaction price to performance obligations in the contract; and

recognize revenue as the performance obligation is satisfied.

The Company had minimal revenues of $438 and $0 for the six months ended June 30, 2023 and 2022, respectively.

Share-Based Payment Arrangements

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

2	ACCOUNTING POLICIES AND ESTIMATES (continued)

Derivative Liabilities

ASC Topic 815, Derivatives and hedging (“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

Income Taxes

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of June 30, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.

Comprehensive income

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

3	LIQUIDITY MATTERS AND GOING CONCERN

The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For the six months ended June 30, 2023 and the year ended December 31, 2022, the Company had a net loss of $3,447,607 and $10,331,424, respectively. In connection with preparing the unaudited condensed consolidated financial statements for the six months ended June 30, 2023, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

The accompanying financial statements for the three and six months ended June 30, 2023 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing, as well as potentially launching and deriving cash from IPEX during 2023. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis (including as required to meet its funding obligations to IPSIPay Express), the Company will be required to delay, reduce the scope of or terminate the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain cash flow positive and profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

The Company has determined that there currently is substantial doubt about their ability to continue as a going concern.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

4	DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH

On May 12, 2023, the Company entered into the May 2023 Frictionless Agreement to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18 month period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023.

The assets and liabilities disposed of were as follows:

	Amount
Assets

Current Assets
Cash	$	339

Non-current assets
Intangible assets		327,211
Security deposit		15,000
Investment		500,000
		842,211
Total assets		842,550

Liabilities

Current Liabilities
Accounts payable		97,126

Net assets sold		745,424
Proceeds due on disposal		(250,000	)
Net loss on disposal	$	495,424

5	DISCONTINUED OPERATIONS

Effective May 12, 2023, the Company disposed of its investment in Beyond Fintech pursuant to the May 2023 Frictionless Agreement, as disclosed in note 4 above.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

5	DISCONTINUED OPERATIONS (continued)

The following assets and liabilities are reported as discontinued operations:

	December 31,
	2022
Current assets
Cash	$	943
Non-current assets
Intangibles, net		291,320
Investment		500,000
Security deposit		15,000
Assets held for sale	$	807,263

Current liabilities
Accounts payable	$	33,810
Liabilities held for sale	$	33,810

The statement of operations from discontinued operations is as follows:

	Three months ended			Three months ended			Six months ended			Six months ended
	June 30,			June 30,			June 30,			June 30,
	2023			2022			2023			2022

Net Revenue	$	-		$	-		$	-		$	-

Cost of Goods Sold		-			-			-			-

Gross loss		-			-			-			-

General and administrative		25,561			26,483			40,821			44,344
Depreciation and amortization		-			-			-			-
Total Expense		25,561			26,483			40,821			44,344

Loss from operations before income taxes		(25,561	)		(26,483	)		(40,821	)		(44,344	)

Income Taxes		-			-			-			-
Loss from discontinued operations, net of taxation	$	(25,561	)	$	(26,483	)	$	(40,821	)	$	(44,344	)

6	INTANGIBLES

On August 26, 2021, the Company formed Beyond Fintech to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owned 51% of Beyond Fintech with the other 49% owned by Frictionless. During the year ended December 31, 2022 and the six months ended June 30, 2023, an additional $41,320 and $35,891, respectively, was spent on the software to further enhance the Beyond Wallet product offering. On May 12, 2023, Beyond Fintech was sold to Frictionless (see note 4 above).

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the year ended December 31, 2022 and the six months ended June 30, 2023, an additional $1,127,400 and $44,405, respectively, was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment.

	June 30, 2023							December 31, 2022
	Cost		Accumulated amortization			Net Book Value		Net book value
Purchased Technology - IPSIPay	$	1,546,805	$	(355,112	)	$	1,191,693	$	1,401,491

Amortization expense was $128,348 and $0 for the three months ended June 30, 2023 and 2022, respectively, and $254,204 and $0 for the six months ended June 30, 2023, respectively.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

7	EQUITY METHOD INVESTMENT

On April 28, 2023, the Company formed IPSIPay Express with OpenPath and EFinityPay (see note 1(b) above). As described in note 1(b), the Company has agreed to make the IPSI Capital Contributions to IPSIPay Express. As of June 30, 2023, $200,000 of the initial Tranche of such capital contributions was paid by the Company to or on behalf of IPSIPay Express.

The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, The movement in equity method investments related to IPSIPay Express for the period ended June 30, 2023 is as follow:

	June 30, 2023
Cash contribution to IPSIPay Express	$	200,000
Fair value of warrants issued to third party joint venture partners		108,220
		308,220
Equity loss from joint venture		(1,381	)
	$	306,839

8	INVESTMENTS

Investment in Frictionless Financial Technologies Inc.

On May 12, 2023, the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless). refer Note 4 above.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

9	LEASES

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5^th Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90 day termination clause, for a monthly rental of $5,088.

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

Total Lease Cost

Individual components of the total lease cost incurred by the Company is as follows:

		Six months ended June 30, 2023				Six months ended June 30, 2022
Operating lease expense		$	30,528			$	28,800

Other lease information:

	Six months ended June 30, 2023			Six months ended June 30, 2022
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	(30,528	)	$	(28,800	)

Remaining lease term – operating lease		Monthly			Monthly

10	FEDERAL RELIEF LOANS

Small Business Administration Disaster Relief loan

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company.

The Company has repaid an aggregate principal amount of $2,342 and interest of $2,775 as of June 30, 2023. The loan balance outstanding as of June 30, 2023, consists of principal of $147,656 and accrued interest thereon of $13,978, of which $3,275 is disclosed as current.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

11	NOTES PAYABLE

On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “Cavalry/Mercer SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Cavalry/Mercer Notes”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Cavalry/Mercer Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of Common Stock at an exercise price of $0.24 per share.

In connection with the December 30, 2022 Note Amendment Transaction, described in more detail in Note 12 below, the Original Cavalry/Mercer Warrants were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Cavalry/Mercer Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the Original Cavalry/Mercer Warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.

The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

Notes payable to Cavalry and Mercer at June 30, 2023 consists of the following:

Description	Interest Rate			Maturity date	Principal		Accrued Interest		June 30, 2023 Amount, net		December 31, 2022 Amount, net
Cavalry Fund I LP		10	%	December 30, 2023		482,000		24,368		506,368		482,134
Mercer Street Global Opportunity Fund, LLC		10	%	December 30, 2023		482,000		24,368		506,368		482,134
Total convertible notes payable					$	964,000	$	48,736	$	1,012,736	$	964,268

Interest expense totaled $24,368 and $0 for the three months ended June 30, 2023 and 2022, respectively, and $48,468 and $0 for the six months ended June 30, 2023 and 2022, respectively.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

12	CONVERTIBLE NOTES PAYABLE

December 2022 Note Amendment Transaction

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Cavalry/Mercer Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under the Cavalry/Mercer Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 3,000,000 shares of Common Stock at an exercise price of $0.15 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.

On December 30, 2022, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:

(1)

The conversion price of the Cavalry/Mercer Notes was reduced from $0.15 to $0.0115 per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Cavalry/Mercer Notes). As a result of this change in conversion price, under the existing terms of the Cavalry/Mercer Notes, the 3,000,000 shares of Common Stock underlying the Extension Warrants was increased to 39,130,435 shares;

(2)

The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;

(3)

Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Cavalry/Mercer Notes until after March 30, 2023 and (ii) waive any events of default under the Cavalry/Mercer Notes and the Cavalry/Mercer SPAs;

(4)

Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the Common Stock is $0.06 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $0.04 per share; and

(5)

The Company was obligated to register the shares of Common Stock underlying the Cavalry/Mercer Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.

The parties also acknowledged that the principal and accrued interest under the Cavalry/Mercer Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Cavalry/Mercer Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.0115 per share. All of the shares of our Common Stock underlying the Cavalry/Mercer Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to a registration statement that was declared effective on February 6, 2023.

The amendments to the Cavalry/Mercer Notes were evaluated in terms of ASC470, Debt, to determine if the amendments to the Cavalry/Mercer Notes were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the Cavalry/Mercer Notes from $0.15 to $0.0115 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the Cavalry and Mercer valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants held by Cavalry and Mercer to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (see note 11 above) and the value of full rachet provisions of certain of the warrants issued to the Cavalry and Mercer amounting to $841,003 (see note 14 below), the amendment of the Cavalry/Mercer Notes was determined to be a debt extinguishment.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

12	CONVERTIBLE NOTES PAYABLE (continued)

Convertible notes payable consists of the following:

Description	Interest Rate			Maturity date	Principal		Accrued Interest		Unamortized debt discount			June 30, 2023 Amount, net		December 31, 2022 Amount, net
Cavalry Fund I LP		10.00	%	December 30, 2023		1,066,754		96,147		-			1,162,901		1,133,301

Mercer Street Global Opportunity Fund, LLC		10.00	%	December 30, 2023		1,091,754		96,438		-			1,188,192		1,133,301

Quick Capital, LLC		8.00	%	December 20, 2023		62,857		138		(44,340	)		18,655		-

1800 Diagonal Street Lending, LLC*		13.00	%	May 10, 2024		105,480		708		(90,782	)		15,406		-
		17.33	%	March 13, 2024		62,700		506		(58,810	)		4,396		-

2023 convertible notes		8.00	%	February 13, 2024 to June 21, 2024		700,000		16,798		(269,172	)		447,626		-

Total convertible notes payable					$	3,089,545	$	210,735	$	(463,104	)	$	2,837,176	$	2,266,602

These notes were repaid on August 3, 2023. See note 18.

Interest expense totaled $69,320 and $43,793 for the three months ended June 30, 2023 and 2022, respectively, and $129,057 and $88,172 for the six months ended June 30, 2023 and 2022, respectively.

Amortization of debt discount totaled $88,687 and $0 for the three months ended June 30, 2023 and 2022, respectively, and $111,654 and $263,200 for the six months ended June 30, 2023 and 2022, respectively.

The Cavalry, Mercer and 1800 Diagonal Street convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the Common Stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

Cavalry Fund LLP

On February 16, 2021, the Company closed a transaction with Cavalry pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of Common Stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

On May 19, 2023, Cavalry converted $25,000 of principal into 2,173,913 shares of Common Stock at a conversion price of $0.0115 per share realizing a loss on conversion of $18,478.

The balance of the Cavalry Note plus accrued interest at June 30, 2023 was $1,162,901.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

12	CONVERTIBLE NOTES PAYABLE (continued)

Mercer Street Global Opportunity Fund, LLC

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of Common Stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

The balance of the Mercer Note plus accrued interest at June 30, 2023 was $1,188,192.

Quick Capital, LLC

On June 20, 2023, the Company closed a transaction with Quick Capital, LLC pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,857 in exchange for the issuance of a $62,857 Convertible Note, bearing interest at 8% per annum, which interest is earned on issuance of the note, and maturing on December 20, 2023. The Note is convertible into shares of Common Stock at an initial conversion price of $0.0115 per share, in addition, the Company issued a warrant exercisable for 5,465,826 shares of Common Stock at an initial exercise price of $0.0115 per share.

The balance of the Quick Capital Note plus accrued interest at June 30, 2023 was $18,655, net of unamortized debt discount of $44,340.

1800 Diagonal Street Lending LLC

●

On May 10, 2023, the Company closed a transaction with 1800 Diagonal Street Lending LLC (“1800 Diagonal”) pursuant to which the Company received net proceeds of $100,000, after an original issue discount and fees of $17,320 in exchange for the issuance of a $117,320 Convertible Note (the “May 1800 Diagonal Note”), bearing interest at 13% per annum, which interest is earned on issuance of the note, and maturing on May 10, 2024. The May 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

The balance of the May 1800 Diagonal Note plus accrued interest at June 30, 2023 was $15,406, net of unamortized debt discount of $90,782.

●

On June 13 2023, the Company closed a transaction with 1800 Diagonal, pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,700 in exchange for the issuance of a $62,700 Convertible Note (the “June 1800 Diagonal Note”), bearing interest at 17.33% per annum, which interest is earned on issuance of the note, and maturing on March 13, 2024. The June 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

The balance of the June 1800 Diagonal Note plus accrued interest at June 30, 2023 was $4,396, net of unamortized debt discount of $58,810.

The two 1800 Diagonal Notes were repaid by the Company on August 3, 2023 (see note 18).

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

12	CONVERTIBLE NOTES PAYABLE (continued)

2023 Convertible Notes

Between February 13, 2023 and June 21, 2023, the Company entered into Securities Purchase Agreements with 12 accredited investors, pursuant to which the Company received an aggregate of $700,000 in gross proceeds in a private placement through the issuance of:

●

Convertible Promissory Notes (the “2023 Notes” and each a “2023 Note”); and

●

five-year warrants (the “2023 Warrants”) to purchase an aggregate 66,335,391 shares of Common Stock at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

The 2023 Notes mature in 12 months, bear interest at a rate of 8% per annum, and are convertible into shares of Common Stock at a conversion price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the 2023 Warrants for public resale.

The 2023 Notes and the 2023 Warrants contain conversion limitations providing that a holder thereof may not convert the 2023 Notes or exercise the 2023 Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

The balance of the 2023 Notes plus accrued interest at June 30, 2023 was $447,626, net of unamortized debt discount of $269,172.

13	DERIVATIVE LIABILITY

The convertible notes and warrants issued by the Company to Cavalry, Mercer and 1800 Diagonal as described herein have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

On December 30, 2022, the Company entered into the December 2022 Note Amendment transaction (“the Note Amendment”) as fully described under note 11 above. Included in the derivative liability is: (i) the Original Warrants which were exchanged for non-convertible promissory notes, (ii) the Cavalry and Mercer convertible notes which were subject to the Note Amendment and (ii) the Cavalry and Mercer Extension Warrants as well as certain other warrants due to Cavalry and Mercer and certain other warrant holders. The Note Amendment triggered a repricing of certain of these warrants.

The derivative liability on the Cavalry and Mercer convertible notes and the warrants affected by the note amendment were marked-to-market immediately prior to the Note Amendment resulting in a market to market movement on the original warrants, the convertible notes and the extension warrants and certain other warrants, which were subject to a full rachet provision, of $474,614. In addition, the Note and warrant Amendment gave rise to an additional derivative liability charge of $2,317,051 which was recorded as an expense in the loss on convertible notes charge in the statement of operations.

On May 10, 2023 and June 13, 2023, the Company entered into convertible note agreements with 1800 Diagonal which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $360,491 but limited to the cash value of the convertible notes of $150,000, using a Black-Scholes valuation model.

The net movement on the derivative liability for the three months ended June 30, 2023 was a net mark-to-market charge of $1,252,682 and for the six months ended June 30, 2023 was a net market charge of $311,932, determined by using a Black-Scholes valuation model.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

13	DERIVATIVE LIABILITY (continued)

The following assumptions were used in the Black-Scholes valuation model:

	Six months ended June 30, 2023			Year ended December 31, 2022
Conversion price	$	0.0048 to $0.0115		$	0.0115 to $0.15
Risk free interest rate		3.60 to 5.48	%		0.79 to 4.73	%
Expected life of derivative liability		9 to 50 months			1.5 to 59 months
Expected volatility of underlying stock		158.72 to 192.53	%		120.49 to 258.3	%
Expected dividend rate		0	%		0	%

The movement in derivative liability is as follows:

	June 30, 2023		December 31, 2022
Opening balance	$	2,550,642	$	407,161
Derivative financial liability arising from convertible note and warrants		150,000		238,182
Derivative financial liability arising on note amendment included in loss on convertible notes		-		2,317,051
Fair value adjustment to derivative liability		311,932		(411,752	)
	$	3,012,574	$	2,550,642

14	STOCKHOLDERS’ EQUITY

Common Stock

The Company has total authorized Common Stock of 750,000,000 shares with a par value of $0.0001 each. The Company had 379,075,592 and 376,901,679 shares of Common Stock issued and outstanding as of June 30, 2023 and December 31, 2022, respectively.

On May 19, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 2,173,913 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 11 above.

Restricted stock awards

A summary of restricted stock activity during the period January 1, 2022 to June 30, 2023 is as follows:

	Total restricted shares		Weighted average fair market value per share		Total unvested restricted shares			Weighted average fair market value per share			Total vested restricted shares		Weighted average fair market value per share
Outstanding January 1, 2022		21,495,000	$	0.049		10,247,500		$	0.049			11,247,500	$	0.049
Granted and issued		2,000,000		0.055		-			-			2,000,000		0.055
Forfeited/Cancelled		-		-		-			-			-		-
Vested		-		-		(5,123,750	)		(0.049	)		5,123,750		0.049
Outstanding December 31, 2022		23,495,000	$	0.050		5,123,750		$	0.049			18,371,250	$	0.050
Granted and issued		-		-		-			-			-		-
Forfeited/Cancelled		-		-		-			-			-		-
Vested		-		-		(5,123,750	)		(0.049	)		5,123,750		0.049
Outstanding June 30, 2023		23,495,000	$	0.050		-		$	0.049			23,495,000	$	0.050

The restricted stock granted, issued and exercisable at June 30, 2023 is as follows:

	Restricted Stock Granted and Vested
Grant date Price	Number Granted		Weighted Average Fair Value per Share
$0.049		20,495,000	$	0.049
$0.050		1,000,000		0.050
$0.055		2,000,000		0.055
		23,495,000	$	0.050

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

14	STOCKHOLDERS’ EQUITY (continued)

The Company has recorded an expense of $0 and $62,766 for the three months ended June 30, 2023 and 2022, respectively, and $0 and $125,532 for the six months ended June 30, 2023 and 2022, respectively.

Preferred Stock

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of June 30, 2023 and December 31, 2022.

Warrants

Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.

The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.

As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90^th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.

On August 30, 2022, the Company extended the maturity date of the Cavalry/Mercer Notes and agreed to grant each note holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with an expiration date of August 30, 2027.

On December 30, 2022, the Company issued to Frictionless a 5 year warrant to purchase 30,000,000 shares of Common Stock at an exercise price of $0.0115 per share as disclosed in note 5 above. The fair value of these warrants was $348,938 determined by using a Black-Scholes valuation model, which fair value was capitalized to purchased technology on the date of grant. On May 12, 2023, the Company entered into an agreement to cancel this warrant (see note 1(b)).

On December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred:

●

The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of Common Stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above;

●

The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.

●

An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

14	STOCKHOLDERS’ EQUITY (continued)

Warrants (continued)

Between February 13, 2023 and June 21, 2023, the Company entered into Securities Purchase Agreements with 14 accredited investors, as disclosed in note 11 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 66,335,391 shares of the Common Stock at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes or the 2023 Warrants for public resale.

The 2023 Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61^stday after such notice.

In connection with the formation of IPSIPay Express, the Company has agreed to issue the other venture partners, Open Path and EfinityPay, IPEX Warrants to purchase Ten Million shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. The shares of Common Stock underlying the IPEX Warrant issued in connection with the funding of the initial Tranche will be pro-rated based on the amount of the initial Tranche. Simultaneously with the funding of the second and third Tranche, the Company will issue to each of Open Path and EfinityPay an additional IPEX Warrant to purchase Five Million shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second and third Tranches. If the full IPSI Capital Contribution is funded, Open Path and EfinityPay will receive IPEX Warrants to purchase an aggregate of Forty Million shares of Common Stock. See note 1(b) above.

On June 22, 2023, in conjunction with the funding of the initial Tranche, the Company issued to each of Open Path and EfinityPay, IPEX Warrants exercisable for four million shares of Common Stock at an exercise price of $0.015 per share.

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

	Six months ended June 30, 2023
Exercise price	$	0.0115
Risk free interest rate		3.77 to 4.16	%
Expected life		5 years
Expected volatility of underlying stock		187.40 to 189.37	%
Expected dividend rate		0	%

A summary of warrant activity during the period January 1, 2022 to June 30, 2023 is as follows:

	Shares Underlying Warrants			Exercise price per share		Weighted average exercise price
Outstanding January 1, 2022		37,304,105		$	0.05 – 0.1875	$	0.12
Granted		51,000,000			0.0115 – 0.0345		0.01826
Increase in warrants due to debt amendment full rachet trigger		72,260,870			0.0115		0.0115
Cancelled on debt amendment		(4,973,914	)		0.15		0.1500
Exercised		-			-		-
Outstanding December 31, 2022		155,591,061		$	0.0115 – 0.1875	$	0.0300
Granted		74,335,391			0.0115		0.0115
Forfeited		(1,000,000	)		0.05		0.05
Cancelled on disposal of investment in Frictionless and Beyond Fintech		(30,000,000	)		0.0115		0.0115
Exercised		-			-		-
Outstanding June 30, 2023		198,926,452		$	0.0115 – 0.1875	$	0.0259

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

14	STOCKHOLDERS’ EQUITY (continued)

Warrants (continued)

The warrants outstanding and exercisable at June 30, 2023 are as follows:

		Warrants Outstanding						Warrants Exercisable
Exercise Price		Number Outstanding		Weighted Average Remaining Contractual life in years		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price		Weighted Average Remaining Contractual life in years
$	0.0115		158,333,118		4.27				158,333,118				4.27
$	0.0345		15,000,000		2.02				11,250,000				2.02
	0.015		8,000,000		4.98				8,000,000				4.98
$	0.15		15,166,667		2.72				15,166,667				2.72
$	0.1875		2,426,667		2.72				2,426,667				2.72
			198,926,452		3.99	$	0.0259		195,176,452	$	0.0259		3.99

The warrants outstanding have an intrinsic value of $395,833 and $0 as of June 30, 2023 and 2022, respectively.

Stock options

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

The maximum number of securities available under the Plan is 800,000 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock.

Under the 2021 Plan the Company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

On July 11, 2022, the Board approved, granted and issued 15,000,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $0.15 per share. This resulted in an immediate expense of $823,854 for the year ended December 31, 2022.

On September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per share. This resulted in an immediate expense of $31,970 for the year ended December 31, 2022.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

14	STOCKHOLDERS’ EQUITY (continued)

Stock options (continued)

A summary of option activity during the period January 1, 2022 to June 30, 2023 is as follows:

	Shares Underlying options		Exercise price per share		Weighted average exercise price
Outstanding January 1, 2022		30,516,666		$0.15 to 0.40	$	0.15
Granted		15,800,000		0.04 – 0.15		0.14
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding December 31, 2022		46,316,666		$0.04 to 0.40	$	0.15
Granted		-		-		-
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding June 30, 2023		46,316,666		$0.04 to 0.40	$	0.15

The options outstanding and exercisable at June 30, 2023 are as follows:

		Options Outstanding						Options Exercisable
Exercise Price		Number Outstanding		Weighted Average Remaining Contractual life in years		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price		Weighted Average Remaining Contractual life in years
$	0.04		800,000		9.21				800,000				9.21
$	0.15		45,208,333		8.44				39,375,000				8.48
$	0.24		208,333		7.65				208,333				7.65
$	0.40		100,000		5.50				100,000				5.50
			46,316,666		8.44	$	0.15		40,483,333	$	0.15		8.49

The options outstanding have an intrinsic value of $0 as of June 30, 2023 and 2022.

The option expense was $94,465 and $94,462 for the three months ended June 30, 2023 and 2022, respectively, and $188,928 and $188,928 for the six months ended June 30, 2023 and 2022, respectively.

15	NET LOSS PER SHARE

Basic loss per share is based on the weighted-average number of shares of Common Stock outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of Common Stock that have an anti-dilutive effect on net loss per share. For the three months and six months ended June 30, 2023 and 2022 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and six months ended June 30, 2023 and 2022 are as follows:

	Three and six months ended June 30, 2023 (Shares)		Three and six months ended June 30, 2022 (Shares)
Convertible debt		300,483,314		11,979,811
Stock options		46,316,666		30,516,666
Warrants to purchase shares of Common Stock		198.926,452		37,304,104
		545,726,432		79,800,582

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

16	RELATED PARTY TRANSACTIONS

The following transactions were entered into with related parties:

James Fuller

On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share.

The option expense for Mr. Fuller was $0 for the three months ended June 30, 2023 and 2022, and $0 for the six months ended June 30, 2023 and 2022.

Mr. Fuller voluntarily resigned as a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022.

William Corbett

On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 15,000,000 shares of Common Stock at an exercise price of $0.15 per share.

On June 21, 2023, Mr. Corbett advanced the company $50,000 to cover certain working capital expenses, the advance is short term in nature, bears no interest and has no fixed repayment terms.

The option expense for Mr. Corbett was $66,587 for the three months ended June 30, 2023 and 2022, and $133,174 for the six months ended June 30, 2023 and 2022.

Clifford Henry

Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.

On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

The option expense for Mr. Henry was $0 for the three months ended June 30, 2023 and 2022, and $0 for the six months ended June 30, 2023 and 2022.

Madisson Corbett

On September 13, 2022, the Company granted Ms. Corbett, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

The option expense for Ms. Corbett was $0 for the three months ended June 30, 2023 and 2022, and $0 for the six months ended June 30, 2023 and 2022.

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

16	RELATED PARTY TRANSACTIONS (continued)

David Rios

On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

The option expense for Mr. Rios was $0 for the three months ended June 30, 2023 and 2022, and $0 for the six months ended June 30, 2023 and 2022.

Richard Rosenblum

On July 11, 2022, the Company granted Mr. Rosenblum 2,000,000 restricted shares of Common Stock valued at $110,000, all of which are vested.

The option expense for Mr. Rosenblum was $27,879 for the three months ended June 30, 2023 and 2022, and $55,758 for the six months ended June 30, 2023 and 2022.

17	COMMITMENTS AND CONTINGENCIES

The Company has notes payable and convertible notes payable, disclosed under notes 11 and 12 above, which mature between December 30, 2023 and June 21, 2024. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.

18	SUBSEQUENT EVENTS

Between July 18, 2023 and August 4, 2023, the Company, entered into Securities Purchase Agreements with 8 accredited investors, pursuant to which the Company received an aggregate of $576,666 in gross proceeds through a private placement issuance of additional 2023 Notes and additional 2023 Warrants to purchase an aggregate 50,144,870 shares of Common Stock at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

On August 4, 2023, the Company made an IPSI Capital Contribution of $300,000 to IPSIPay Express, thereby completing its initial Trance contribution (see note 7). With the funding of its initial $500,000 capital contribution to IPSIPay Express, the Company received an 11.11% interest equity interest in IPSIPay Express. Such equity interest will increase to 33.33% upon the funding of next two $500,000 Tranches.

On August 3, 2023, the Company settled in full, the outstanding convertible notes owing to 1800 Diagonal, in the principal amount of $168,180 for gross proceeds of $160,000.

Other than the above, the Company has evaluated subsequent events through the date the financial statements were issued, and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

All references to “we,” “us,” “our” and the “Company” refer to Innovative Payment Solutions, Inc., a Delaware corporation and its consolidated subsidiaries unless the context requires otherwise.

Overview

We are a provider of digital payment solutions and services to businesses and consumers.

Our historical core business is focused on operating and developing “e-wallets” that enable consumers to deposit cash, convert it into a digital form, and remit the funds to Mexico and other countries quickly and securely. Our flagship e-wallet, IPSIPay^®, is focused on the consumer market and was fully launched in July 2022 after a soft launch in December 2021.

The IPSIPay platform (which can be used both business-to-business and business-to-consumer) facilitates the transfer of funds in digital form to other countries, initially Mexico but also, India and the Philippines, primarily from hand-held devices as well as on desktop or laptop computers.

In October 2022, we announced that since the commencement of our new IPSIPay marketing campaign featuring Mr. Lopez in August 2022, we achieved 10,000 downloads of IPSIPay, and of the 10,000 downloads, 1,200 have been converted to active users with wallets, meaning the users have initiated at least one transaction via IPSIPay. As of June 30, 2023, we had achieved approximately 66,000 downloads and over 6,000 active users with wallets. Despite these achievements, our revenue from IPSIPay continues to be nominal as described further below.

Our launch plan for IPSIPay continues to be to target lower income, migrant communities in California (notably in the agriculture industry), and expanding to other states with large migrant populations such as Texas and Florida. We not only believe the addressable market for IPSIPay is large and growing, but that servicing this market is socially responsible. We believe our digital payment facilitation platform and related apps will empower and enable the unbanked and under-served and payment providers who service these users, acting as a bridge to provide access to comprehensive and easy to use payment solutions. Given the large size of our addressable market, our ability to capture even a very small share of the market represents a significant revenue opportunity for our company.

In May 2023, we publicly announced a new line of business called IPSIPay Express^TM. This business is being operated via a three-way joint venture in the form of a Delaware limited liability company named IPSIPay Express, LLC (“IPSIPay Express”) between our company and payment industry veterans OpenPath, Inc. (“OpenPath”) and eFinityPay, LLC (“eFinityPay”). The purposes of IPSIPay Express is to develop and market a proprietary consumer to merchant real-time payment platform called Instant-Settlement in RealTime™ as well as to provide traditional credit card processing services initially focused on the fast-growing online gaming and entertainment sectors.

On June 19, 2023, we entered into a Limited Liability Company Operating Agreement (the “IPEX Operating Agreement”) with OpenPath and EfinityPay, to provide for the terms of the IPSIPay Express joint venture. Pursuant to the IPEX Operating Agreement, The Company has agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company shall make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a “Tranche”), or such lesser amounts as may be unanimously approved by the Board. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and Open Path and EfinityPay’s percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or shall be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche shall be paid on or before September 15, 2023 and (iv) the third $500,000 Tranche shall be paid on or before October 31, 2023. In a press release dated May 1, 2023, the Company disclosed that the IPSI Capital Contribution would be required to be funded by December 31, 2023, but the Members subsequently agreed pursuant to the Agreement to the revised timelines set forth above.

Also, May 12, 2023, we entered into an agreement with one of our technology partners, Frictionless Financial Technologies, Inc. (“Frictionless”), to, among other things, divest ourselves of our interest in Frictionless and in Beyond Fintech, Inc., a joint venture entity we owned with Frictionless which has been developing an application called Beyond Wallet. See Note 1(b) to the accompanying financial statements for further information.

Known Trends, Demands, Commitments, Events or Uncertainties Impacting Our Business

Launch and Scaling of E-Wallets; IPSIPay Express

IPSIPay

Having achieved full commercial integration and launch of the IPSIPay app during the third quarter of 2022, the key for our business for the foreseeable future is to scale the number of IPSIPay downloads achieved and revenue generated from transactions process by customers via IPSIPay. Presently, our ability to generate meaningful revenue from customer use of IPSIPay is limited, given the relatively recent commencement of launch activities, the relatively limited app downloads and active users achieved to date and our launch promotional activities. While we see great potential for IPSIPay in our initial target markets as described above, both the near- and long-term viability of our business is dependent in large part on our ability to scale our IPSIPay business and add complimentary offerings (such as our telemedicine collaboration with MeMD (also known as Walmart Health Virtual Care), which we announced in October 2022), all with the goal of increasing app downloads and active users who would generate transaction processing and other fees for our company.

We generated nominal IPSIPay-related revenue during the first half of 2023, with the goal of increasing revenues over time. In the current environment, it has proven to take longer to win a customer’s trust and resulting fee generating usage of IPSIPay. This is especially true when it relates to the unbanked and underserved sending money abroad. We initiated an aggressive digital marketing campaign late in the third quarter of 2022, and have since achieved over 66,000 downloads of IPSIPay as of June 30, 2023 and also seen a steady growth of the issuance of debit Visa cards via IPSIPay. While we have not seen any significant revenue from these endeavors, we believe the brand we are building and the impressions we have recorded should help us grow the awareness and use of IPSIPay during 2023. Our ability to reach sufficient scale of our business and generate sufficient revenue is, however, unproven and speculative at this time, so we remain faced with all of the risks associated with launching and seeking to scale a new business. If we are unable to grow our IPSIPay business, our company could be severely harmed or could fail.

IPSIPay Express

While we believe the IPSIPay Express opportunity has great promise, as of the date of this report, IPEX has not been launched and we have derived no revenue or cash distributions from IPSIPay Express. No assurances can be given that IPSIPay Express will be successfully launched or will generate revenues or otherwise have a positive impact on our results of operations. We have publicly stated that we believe IPSIPay Express could be commercially launched and generate initial revenues in the third quarter of 2023, but no assurances can be provided that this will be achieved or that (i) we will be able to raise funds satisfactory to fulfill all of our capital contributions to IPSIPay Express or (ii) that we will ever receive distributions of free cash flow from IPSIPay Express. Moreover, the IPSIPay Express product offering will be targeting so-called “high risk” sectors such as online gaming and entertainment, which also carries certain risks.

Russia’s Invasion of Ukraine

In February 2022, Russia invaded Ukraine, with Belarus complicit in the invasion. As of the date of this report, the conflict between these two countries is ongoing. We do not have any direct or indirect exposure to Ukraine, Belarus or Russia, through our operations, employee base or any investments in any of these countries. In addition, our securities are not traded on any stock exchanges in these three countries. We do not believe that the sanction levied against Russia or Belarus or individuals and entities associated with these two countries will have a material impact on our operations or business, if any. Further, we do not believe that we have any direct or indirect reliance on goods sourced from Russia, Ukraine or Belarus or countries that are supportive of Russia.

We have commercially launched our IPSIPay platform and expect to launch our IPSIPay Express platform which provide online money transfer and payment services to our customers, which may expose us to cybersecurity risks. We employ the latest encryption techniques and firewall practices and constantly monitor the usage of our software, however, this may not be sufficient to prevent the heightened risk of cybersecurity attacks emanating from Russia, Ukraine, Belarus, or any other country.

The impact of the invasion by Russia of Ukraine has increased volatility in stock trading prices and commodities throughout the world. To date, we have not seen a material impact on our operations; however, a prolonged conflict may impact on consumer spending, in general, which could have an adverse impact on the payment services industry as a whole and our business.

Inflation

Macro-economic conditions could affect consumer spending adversely and consequently our future operations. The U.S experienced a period of significant inflation over the past several years, and while inflation has abated somewhat in the U.S., continuing high consumer prices and high interest rates arising from the Federal Reserve’s efforts to contain inflation could impact consumer’s desire to purchase goods and services utilizing our payment products and services and may increase our costs overall. However, as of the date of this report, we do not expect there to be any material impact on our liquidity as forecast in our business plan due to recent inflationary concerns in the U.S.

Foreign Exchange Risks

We intend to operate in several foreign countries, including Mexico. Changes and fluctuations in the foreign exchange rate between the US Dollar and other foreign currencies, including the Mexican Peso, may in future have an effect our results of operations.

Critical Accounting Estimates

Preparation of our consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues and expenses, as well as related disclosure of contingent assets and liabilities. Significant accounting policies are fundamental to understanding our financial condition and results as they require the use of estimates and assumptions which affect the financial statements and accompanying notes. See Note 2 - Summary of Significant Accounting Policies of the Notes to the condensed Consolidated Financial Statements included in Part I, Item I of this Form 10-Q for further information.

The critical accounting policies that involved significant estimation included the following:

Derivative liabilities

We have certain short-term convertible notes and certain warrants which have fundamental transaction clauses which might result in cash settlement. The conversion feature of these convertible notes and warrants are recorded as derivative liabilities which are valued at each reporting date.

The derivative liability is valued using the following inputs:

●

Conversion prices;

●

Current market prices of our equity

●

Risk free interest rates;

●

Expected remaining life of the derivative liability;

●

Expected volatility of the underlying stock; and expected dividend rates

Any change in the above factors such as a change in risk free interest rates, a significant increase or decrease in our current stock prices and a change in the volatility of our Common Stock may result in a significant increase or decrease in the derivative liability.

Impairment of Investments and Intangible assets

We carried intangible assets of $1,191,693 as more fully described in note 6 to the accompanying condensed consolidated financial statements. The Company tests its intangible assets with an indefinite useful life annually for impairment or more frequently if indicators for impairment exist. The value of our intangibles is based upon our mutual goal of providing payment services to an underserved market. Currently our intangible assets have not produced material revenues on which to assess whether the income generated from these assets can support the carrying value of these assets. For impairment testing of intangibles we determine the fair value of the underlying assets using an income-based approach which estimates the fair value using a discounted cash flow model. Key assumptions in estimating fair values include projected revenue growth and the weighted average cost of capital. In addition, management recently reviewed the future revenue and profit projections of our e-wallet services based on management forecasts of the size of the market and expected customer growth and retention, we determined that no impairment charges were necessary, however if we are unable to achieve our forecasts over a period of time, we may need to re-evaluate our forecasts which could result in an impairment charge. Since performing this analysis we have no reason to believe that further impairment is necessary as of June 30, 2023.

Results of Operations

Results of Operations for the Three Months Ended June 30, 2023 and 2022

Net revenue

We recorded minimal revenues of $5 during the three months ended June 30, 2023 and we did not have revenues during the three months ended June 30, 2022. Our goal is to increase revenue as our IPSIPay product becomes more widely used and we are exploring different market segments to increase our revenue from our e-wallets. We have utilized financial promotional strategies to encourage downloads and use of IPSIPay, which has reduced our ability to generate revenues in the near term while such strategies are in effect. In addition, we are focusing a material amount of our efforts on developing and launching IPSIPay Express, which we believe has a higher near and longer term possibility for revenue generation.

Cost of goods sold

Cost of goods sold was $284 for the three months ended June 30, 2023 and consists primarily of bank and merchant related fees and chargebacks. We had no cost of goods sold, as we did not have revenues during the three months ended June 30, 2022.

General and administrative expenses

General and administrative expenses were $1,057,631 and $769,054 for the three months ended June 30, 2023 and 2022, respectively, an increase of $288,577 or 37.5%. The increase is primarily due to the following:

	(i)	Legal fees were $236,832 and $86,718 for the three months ended June 30, 2023 and 2022, respectively, an increase of $150,114 or 173.1%. The increase is primarily due to the legal matters relating to unfair dismissal matters which were claimed in the prior year by several individuals.

	(ii)	Professional fees were $226,870 and $93,805 for the three months ended June 30, 2023 and 2022, respectively, an increase of $133,065 or 141.9%. The increase is primarily due to professional fees from Frictionless for management fees and customer support fees after the launch of the platform in the second half of the prior year.

	(iii)	The balance of the general and administrative expenses decreased by approximately $18,628 which is made up of several individually insignificant expenses.

Depreciation and amortization

Depreciation was $139,015 and $4,497 for the three months ended June 30, 2023 and 2022, respectively, an increase of $134,518, primarily due to the depreciation of the software platform of $128,348 which commenced in the third quarter of 2022.

Loss on debt conversion

Loss on debt conversion was $18,478 and $0 for the three months ended June 30, 2023 and 2022, respectively, an increase of $18,478 or 100%. The loss on debt conversion related to the conversion of $25,000 of convertible debt into 2,173,913 shares of common stock.

Interest expense, net

Interest expense was $95,079 and $45,196 for the three months ended June 30, 2023 and 2022, respectively, an increase of $49,883 or 110.4%. The increase is related to the additional $900,000 of convertible note funding raised during the current year to fund our investment in the IPSIPay Express joint venture which is expected to become operational in the second half of 2023.

Amortization of debt discount

Amortization of debt discount was $88,687 and $0 for the three months ended June 30, 2023 and 2022, respectively, an increase of $88,687 or 100.0%. The increase is primarily due to the additional debt discount of $88,687 on convertible debt related to the valuation of warrants, derivative liabilities and OID’s and fees paid on the $900,000 of convertible debt raised during the current year.

Derivative liability movements

Derivative liability movements were $(1,252,682) and $(242,102) for the three months ended June 30, 2023 and 2022, respectively, an increase of $1,010,580 or 417.4%. The derivative liability arose due to the issuance of convertible securities and warrants with a fundamental transaction clause allowing for a cash settlement of the convertible note at the option of the holder. The charge during the current period represents the increase in the mark-to-market value of the derivative liability due to an increase in the share price and the increase in interest rates over the prior year.

Net loss from equity method investment

Net loss from equity method investment was $1,381 and $0 for the three months ended June 30, 2023 and 2022, respectively, an increase of $1,381 or 100.0%. On April 28, 2023, we formed a new Delaware limited liability company called IPSIPay Express LLC as a three-way joint venture with two other entities to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. On June 19, 2023, we entered into the IPEX Operating Agreement with Open Path, Inc. and EfinityPay, LLC to memorialize the terms of our IPSIPay Express joint venture. The loss represents our proportionate share of the initial operating expenses of the joint venture.

Net loss from continuing operations

Net loss from continuing operations was $2,653,232 and $1,060,849 for the three months ended June 30, 2023 and 2022, respectively, an increase in loss of $1,591,383 or 150.0%. The increase is primarily due to the increase in general and administrative expenses, depreciation and amortization, the increase in interest expense and amortization of debt discount and derivative liability movements which are discussed in detail above.

Operating loss from discontinued operations

Operating loss from discontinued operations was $25,561 and $26,483 for the three months ended June 30, 2023 and 2022, respectively, a decrease of $922 or 3.5%. This amount is immaterial.

Loss on disposal of subsidiary

Loss on disposal of subsidiary was $495,424 and $0 for the three months ended June 30, 2023 and 2022, respectively, an increase of $495,424 or 100.0%. On May 12, 2023, the Company entered into an Agreement with Frictionless to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. The Company assigned to Frictionless all common stock of Frictionless owned by the Company and all shares of common stock of Beyond Fintech owned by the Company. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was $250,000, resulting in a net loss on disposal of $495,424.

Net loss

Net loss was $3,174,217 and $1,074,355 for the three months ended June 30, 2023 and 2022, respectively, an increase of $2,099,862 or 195.5%. The increase is primarily attributable to the increase in net loss from continuing operations, the increase in the movement in derivative liabilities and the loss on disposal of subsidiary and investment, as discussed in detail above.

Results of Operations for the Six Months Ended June 30, 2023 and June 30, 2022

Net revenue

We recorded minimal revenues of $438 during the six months ended June 30, 2023 and we did not have revenues during the six months ended June 30, 2022. Our goal is to increase revenue as IPSIPay becomes more widely used and we are exploring different market segments to increase our revenue from our e-wallets. We have utilized financial promotional strategies to encourage downloads and use of IPSIPay, which has reduced our ability to generate revenues in the near term while such strategies are in effect. In addition, we are focusing a material amount of our efforts on developing and launching IPSIPay Express, which we believe has a higher near and longer term possibility for revenue generation.

Cost of goods sold

Cost of goods sold was $2,369 for the six months ended June 30, 2023 and consists primarily of bank and merchant related fees and chargebacks. We had no cost of goods sold, as we did not have revenues during the six months ended June 30, 2022.

General and administrative expenses

General and administrative expenses were $2,007,578 and $1,620,580 for the six months ended June 30, 2023 and 2022, respectively, an increase of $386,998 or 23.8%. The increase is primarily due to the following:

	(i)	Selling and marketing expenses were $260,642 and $182,500 for the six months ended June 30, 2023 and 2022, respectively, an increase of $78,142 or 42.8%. The increase is primarily due to the amortization of the Mario Lopez endorsement deal entered into during the current period, offset by a reduction in social media spend as we concentrate on developing the IPSIPay Express joint venture.

	(ii)	Legal fees were $372,355 and $137,048 for the six months ended June 30, 2023 and 2022, respectively, an increase of $235,307 or 171.7%. The increase is primarily due to the legal matters relating to unfair dismissal matters which were claimed in the prior year by several individuals.

	(iii)	Professional fees were $432,006 and $127,310 for the six months ended June 30, 2023 and 2022, respectively, an increase of $304,696 or 239.3%. The increase is primarily due to professional fees from Frictionless for management of the IPSIPay platform by Frictionless.

	(iv)	Payroll expenses were $560,542 and $725,991 for the six months ended June 30, 2022 and 2021, respectively, a decrease of $165,449 or 22.8%. The decrease is primarily due to the reduction in head count and the amortization of restricted stock expense in the prior period.

	(v)	Other general and administrative expenses were $382,032 and $447,731 for the six months ended June 30, 2023 and 2022, respectively, a decrease of $65,699 or 14.7%. The decrease includes a decrease in audit fees of $16,500, due to the timing of invoices received, a decrease in directors fees of $33,000 by reducing the directors’ fees by 50% and the resignation of one director during the prior year and a decrease in investor relations expenses of $22,500 due to budgetary constraints.

Depreciation

Depreciation was $279,705 and $8,993 for the six months ended June 30, 2023 and 2022, respectively, an increase of $270,712, primarily due to the depreciation of the software platform of $254,204 which commenced in the third quarter of 2022.

Loss on debt conversion

Loss on debt conversion was $18,478 and $0 for the six months ended June 30, 2023 and 2022, respectively, an increase of $18,478 or 100%. The loss on debt conversion related to the conversion of $25,000 of convertible debt into 2,173,913 shares of common stock.

Penalty on convertible notes

Penalty on convertible notes was $0 and $719,558 for the six months ended June 30, 2023 and 2022, a decrease of $719,558 or 100.0%. The decrease is due to the repayment of one convertible note and the modification of the maturity date of two convertible notes in the prior period, resulting in the triggering of the repayment penalty per the convertible note agreements as well as an additional 10% penalty for the extension of the maturity date.

Interest expense, net

Interest expense was $180,300 and $90,962 for the six months ended June 30, 2023 and 2022, respectively, an increase of $89,338 or 98.2%. The increase is related to the additional $900,000 of convertible note funding raised during the current year to fund the company’s investment in the IPSIPay Express joint venture which is expected to become operational in the second half of the year.

Amortization of debt discount

Amortization of debt discount was $111,654 and $263,200 for the six months ended June 30, 2023 and 2022, respectively, a decrease of $151,546 or 57.6%. The decrease is primarily due to the accelerated amortization of debt discount related to notes converted to equity during the first quarter of the prior year, offset by the amortization of additional debt discount of $111,654 on convertible debt related to the valuation of warrants, derivative liabilities and OID’s and fees paid on the $900,000 of convertible debt raised during the current year.

Derivative liability movements

Derivative liability movements were $(311,932) and $(149,941) for the six months ended June 30, 2023 and 2022, respectively, an increase of $161,991 or 108.0%. The derivative liability arose due to the issuance of convertible securities and warrants with a fundamental transaction clause allowing for a cash settlement of the convertible note at the option of the holder. The charge during the current period represents the increase in the mark-to-market value of the derivative liability due to an increase in the share price and the increase in interest rates over the prior year.

Net loss from equity method investment

Net loss from equity method investment was $1,381 and $0 for the three months ended June 30, 2023 and 2022, respectively, an increase of $1,381 or 100.0%. On April 28, 2023, we formed a new Delaware limited liability company called IPSIPay Express LLC as a three-way joint venture with two other entities to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. On June 19, 2023, we entered into the IPEX Operating Agreement with Open Path, Inc. and EfinityPay, LLC to memorialize the terms of our joint venture. The loss represents our proportionate share of the initial operating expenses of the joint venture.

Net loss from continuing operations

Net loss from continuing operations was $2,912,959 and $2,853,234 for the six months ended June 30, 2023 and 2022, respectively, an increase in loss of $66,725 or 2.3%. The decrease is primarily due to the increase in general and administrative expenses, the increase in depreciation and amortization, and the increase in interest expense, the increase in derivative liability movement, offset by the prior period penalty on convertible notes and the decrease in amortization of debt discount, all discussed in detail above.

Operating loss from discontinued operations

Operating loss from discontinued operations was $40,821 and $44,344 for the six months ended June 30, 2023 and 2022, respectively, a decrease of $3,523 or 7.9%. This amount is immaterial.

Loss on disposal of subsidiary

Loss on disposal of subsidiary was $495,424 and $0 for the six months ended June 30, 2023 and 2022, respectively, an increase of $495,424 or 100.0%. On May 12, 2023, the Company entered into an Agreement with Frictionless to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. The Company assigned to Frictionless all common stock of Frictionless owned by the Company and all shares of common stock of Beyond Fintech owned by the Company. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was $250,000, resulting in a net loss on disposal of $495,424.

Net loss

Net loss was $3,447,607 and $2,875,849 for the six months ended June 30, 2023 and 2022, respectively, an increase of $571,758 or 19.9%. the increase is primarily attributable to the increase in net loss from continuing operations and the loss on disposal of subsidiary and investment, as discussed in detail above.

Liquidity and Capital Resources

To date, our primary sources of cash have been funds raised primarily from the sale of our debt and equity securities.

We have an accumulated deficit of $55,847,465 through June 30, 2023 and incurred negative cash flow from operations of $933,159 for the six months ended June 30, 2023. Our primary focus was on launching and operating e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely, which will require us to spend, substantial amounts in connection with implementing our business strategy. During the second quarter we formed a new Delaware limited liability company called IPSIPay Express LLC as a three-way joint venture with two other entities to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. On June 19, 2023, we entered into the IPEX Operating Agreement to memorialize the terms of the joint venture.

At June 30, 2023, we had cash of $46,788 and working capital deficit of $8,048,534 including a derivative liability of $3,012,574. After eliminating the derivative liability our working capital deficit is $6,035,960. Subsequent to June 30, 2023, between July 18, 2023 and August 4, 2023 we raised $576,666 through the issuance of convertible notes to accredited investors.

We used cash of $933,159 and $1,452,673 in operations for the six months ended June 30, 2023 and 2022, respectively. Overall cash used in operations decreased by $519,514, due to cost containment to preserve cash balances.

We invested a further $80,296 in our e-wallet platforms to enhance the product offering and to further develop the Beyond Wallet application (which was discontinued in May 2023). We also invested $200,000 in our IPSIPay Express joint venture to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. Subsequent to June 30, 2023, we invested a further $300,000 in IPSIPay Express, completing the first tranche due in terms of the IPEX Operating Agreement.

We generated cash of $885,818 during the current period primarily $900,000 from convertible notes issued to investors to bridge our working capital. Cash utilized in financing activities for the six months ended June 30, 2022 included the repayment of a convertible note of $1,147,063.

At June 30, 2023, we had outstanding convertible notes, including interest thereon of $3,300,280 (before unamortized debt discount of $463,104) and outstanding promissory notes, including interest thereon of $1,012,736. The notes contain certain covenants, such as restrictions on: (i) distributions on capital stock, (ii) stock repurchases, and (iii) sales and the transfer of assets. The notes bear interest at a rates of 8% to 17.3% per annum. and are convertible into our common stock at conversion prices ranging from fixed conversion prices of$0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events), to variable conversion prices of 60% of lowest trading prices over a 20 trading day period. Should the investors choose not to convert these convertible notes, we may need to repay these notes together with interest thereon which will impact on our liquidity.

We expect to restrict our investment in our e-wallet products, capital expenditure is expected to be less than $100,000 during the next twelve month period.

However, given our losses and negative cash flows, we will be required to raise significant additional funds to progress our business as planned by issuing equity or equity-linked securities. Should this occur, our stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support our operations on favorable terms, or at all.

There is also a significant risk that none of our plans to raise financing will be implemented in a manner necessary to sustain us for an extended period of time. If adequate funds are not available to us when needed, we may be required to continue with reduced or discontinued operations or to obtain funds through arrangements that may require us to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on our company. In addition, our inability to secure additional funding when needed could cause our business to fail or become bankrupt or force us to wind down or discontinue operations.

We do not have any off balance sheet financing arrangements as of the date of this report.

Item 3. Quantitative and Qualitative Disclosures About Market Risks

Not required for smaller reporting companies.

Item 4. Controls and Procedures

(a) Evaluation of disclosure controls and procedures

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), our management carried out an evaluation, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures as of June 30, 2023 are not effective due to a lack of written policies and procedures to address all material transactions and developments impacting our financial statements.

(b) Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our fiscal quarter ended June 30, 2023.

Our management is committed to improving our controls and procedures by, among other matters, continuing to consider and adopt appropriate policies and procedures to address all material transactions and developments impacting our financial statements. However, our management does not expect that our disclosure controls and procedures and our internal control processes, even if improved, will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of error or fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that the breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

Part II. Other Information

Item 1. Legal Proceedings.

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Below is a description of our outstanding pending litigation matters. Litigation is subject to inherent uncertainties and an adverse result in the below described or other matters may arise from time to time that may harm our business.

Voloshin v. Innovative Payment Solutions, Inc.

On October 20, 2021, a complaint was filed against our company and certain of its officers and directors with the Occupational Safety and Health Administration of the United States Department of Labor (“OSHA”), captioned Naum Voloshin, Yulia Rey, Alexander Voloshin, Andrey Novikov, and Frank Perez v. Innovative Payment Solutions, Inc., William Corbett, Richard Rosenblum, Madisson Corbett, Jim Fuller, Cliff Henry and David Rios. The complaint generally alleged that complainants, four former employees of our company and one employee who was on suspension, did not receive compensation to which they claim they were entitled and that they were wrongfully terminated for engaging in protected activities in violation of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1514A. The complaint sought reinstatement of complainants’ employment, monetary damages including back pay, raises, bonuses, benefits, overtime, emotional distress and loss of reputation, orders of abatement and injunctive relief, and costs of litigation.

In early 2022, OSHA dismissed the claims of Ms. Rey and Mr. Perez; they appealed that decision. We moved to dismiss the remaining claims and as of this writing OSHA took no action with respect to that motion.

On May 25, 2022, the parties held a mediation in an attempt to resolve the matters. The mediation was unsuccessful.

On October 26, 2022, OSHA scheduled a hearing on Ms. Rey’s and Mr. Perez’s appeal for April 5, 2023. On November 8, 2022, the claimants’ counsel informed us that all five claimants intended to exercise their right to file a lawsuit in federal court and asked if we would stipulate to dismissal of Rey’s and Perez’s OSHA claims without prejudice. We agreed and a stipulation of dismissal without prejudice was filed on November 10, 2022.

On November 7, 2022, the same five employees filed a lawsuit, not in federal court, but in the California Superior Court for the County of Los Angeles, against IPSI and the same individuals against whom they had asserted their OSHA claim. The complaint asserted claims for, inter alia, breach of contract, failure to pay wages and failure to reimburse expenses under the California Labor Code and asserting retaliation claims under the California Labor Code. On December 16, 2022, the same five employees filed an amended complaint dropping all defendants from the case except Mr. Corbett and IPSI. The amended complaint asserts claims for violations of California Labor Code Section 1102.5; wrongful termination in violation of public policy; breach of contract; breach of covenant of good faith and fair dealing; violation of California Labor Code Section 201; waiting time penalties (Cal. Lab. Code Sections 201 & 203) and violation of California Labor Code Section 2802

Defendants moved to compel arbitration on February 17, 2023. As a result of that motion and a stipulated order entered by the court, all proceedings are stayed until the motion to compel arbitration is heard and decided. The hearing for the motion to compel arbitration was scheduled for May 4, 2023. The court held its ruling in abeyance to allow limited discovery and additional briefing. The court has issued a tentative ruling denying our motion to compel arbitration. The court is, however, allowing argument on that motion at which we will attempt to convince the court to change its tentative ruling. The court rescheduled the motion hearing to Monday, August 14, 2023.

We may engage in alternative dispute resolution with the plaintiffs but there can be no assurance that these efforts will be successful. While the outcome of the anticipated civil action is uncertain at this point, we intend to vigorously defend against the action.

Minkovich v. Corbett, et al.

On May 26, 2022, Mr. Jan Minkovich (“Minkovich”) filed a lawsuit in California Superior Court in Los Angeles County (Minkovich v. Corbett, et al., CASE NO. 22CHCV00377) against our company and our Chairman and Chief Executive Officer William Corbett. The complaint asserts six causes of action for: (I) breach of contract; (II) nonpayment of wages; (III) waiting time penalties; (IV) failure to indemnify for alleged employee business expenses; (V) violation of Section 17200 of the California Business and Professional Code; and (VI) wrongful termination of employment in violation of public policy. Minkovich seeks $570,000 in damages, penalties, and attorneys’ fees plus shares equal to five percent (5%) ownership of our company.

We are vigorously defending these claims, which are premised upon a putative three-year employment agreement that is not signed by our company or Mr. Corbett, and which Minkovich admits in his complaint that we expressly refused to sign.

We and Mr. Corbett filed a motion to compel arbitration. The motion was denied on October 4, 2022. We and Mr. Corbett have appealed that decision to the California Court of Appeal. As a result of the appeal, the court case is stayed until the appeal is decided, which we expect to take at least six months. As a result of the stay, the demurrer (the equivalent of a motion to dismiss) we and Mr. Corbett filed has yet to be decided and will not be decided unless the court’s decision is sustained on appeal. Otherwise, the case shall proceed to arbitration. We filed our opening brief on July 14, 2023, the case is in abeyance while we appeal our motion to compel arbitration. The plaintiffs brief is due on August 21, 2023.

Other than as set forth above, we are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition or cash flows.

Item 1A. Risk Factors.

Not applicable to smaller reporting companies.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

(a) Between February 13, 2023 and June 21, 2023, we entered into Securities Purchase Agreements with 12 accredited investors, pursuant to which we received an aggregate of $700,000 in gross proceeds from the Investors through the initial closing of a private placement issuance of:

●

Convertible Notes Promissory (the “Notes” and each a “Note”); and

●

five-year warrants (the “Warrants” and each a “Warrant”) to purchase an aggregate 66,335,391shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

The Notes mature in 12 months, bears interest at a rate of 8% per annum, and are convertible into shares of Common Stock at a conversion price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

The Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale.

(b) On May 10, 2023, we entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC (“1800”) pursuant to which we issued a promissory note (the “1800 Note”) to 1800 in the aggregate principal amount of $117,320 (including $12,570 of original issue discount) for gross proceeds to us of $104,750. The 1800 Note carries a one-time interest charge equal to thirteen percent (13%) of the principal amount of the 1800 Note. The 1800 Note is unsecured, has a maturity date of May 10, 2024, carries a default interest rate of twenty-two percent (22%) per annum and contains customary events of default. We are required to begin mandatory monthly repayments of the 1800 Note beginning June 15, 2023 in the amount of $13,257.10 per month. Only following an event of default under the 1800 Note, the principal amount then outstanding under the 1800 Note (plus, at 1800’s option accrued interest thereon, including default interest if applicable) is convertible into shares of Common Stock at a price equal to sixty (60%) multiplied by the lowest trading price for the Common Stock during the twenty (20) trading days prior to the date of conversion. On August 3, 2023, we settled this note together with the June 13, 2023 note, disclosed below for gross proceeds of $160,000, as agreed to with the lender.

(c) On June 13, 2023, we entered into a Securities Purchase Agreement with 1800 pursuant to which we issued a promissory note (the “Second 1800 Note”) to 1800 in the aggregate principal amount of $62,700 (including $12,700 of original issue discount) for gross proceeds to us of $50,000. The Second 1800 Note carries a one-time interest charge equal to thirteen percent (13%) of the principal amount of the 1800 Note. The 1800 Note is unsecured, has a maturity date of March 13, 2024, carries a default interest rate of twenty-two percent (22%) per annum and contains customary events of default. We are required to begin mandatory monthly repayments of the Second 1800 Note beginning July 14, 2023 in the amount of $7,868.34 per month. Only following an event of default under the second 1800 Note, the principal amount then outstanding under the Second 1800 Note (plus, at 1800’s option accrued interest thereon, including default interest if applicable) is convertible into shares of Common Stock at a price equal to sixty (60%) multiplied by the lowest trading price for the Common Stock during the twenty (20) trading days prior to the date of conversion. On August 3, 2023, we settled this note together with the May 10, 2023 note, disclosed above for gross proceeds of $160,000, as agreed to with the lender.

(d) On June 20,2023, we entered into a Securities Purchase Agreement with Quick Capital LLC (“Quick Capital”) pursuant to which we issued a promissory note (the “QC Note”) to Quick Capital in the aggregate principal amount of $62,857 (including $12,857 of original issue discount and fees) for gross proceeds to us of $50,000. The QC Note carries a one-time interest charge equal to eight percent per annum (8%) of the principal amount of the QC Note. The QC Note is unsecured, has a maturity date of December 20, 2023, carries a default interest rate of twenty-two percent (22%) per annum and contains customary events of default. The QC Note is convertible into shares of common stock at an initial conversion price of $0.0115 per share, in addition, the Company issued a warrant exercisable for 5,465,826 shares of common stock at an initial exercise price of $0.0115 per share.

(e) Between July 18, 2023 and August 4, 2023, we entered into Securities Purchase Agreements with 8 accredited investors, pursuant to which we received an aggregate of $576,666 in gross proceeds from the Investors through the initial closing of a private placement issuance of:

●

Convertible Notes Promissory (the “Notes” and each a “Note”); and

●

five-year warrants (the “Warrants” and each a “Warrant”) to purchase an aggregate 50,144,870 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

The Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale.

The securities described above were sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Rule 506(b) of Regulation D promulgated thereunder. The Investors are accredited investors who have purchased the securities as an investment in a private placement that did not involve a general solicitation. The Common Stock to be issued upon conversion of the Notes or the 1800 Note and the exercise of the Warrants have not been registered under the Securities Act and may not be offered or sold in the United States in the absence of an effective registration statement or exemption from the registration requirements.

Item 3. Defaults upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits

Exhibit No.		Exhibit Description

4.1*		Form of Convertible Promissory Note issued by the Company in connection with 2023 Note Financings
10.1*		Form of Securities Purchase Agreement entered into by the Company with the investors in the 2023 Note Financings
10.2*		Form of Warrant issued by the Company in connection with 2023 Note Financings
31.1*		Certification of William Corbett, Chief Executive Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a)
31.2*		Certification of Richard Rosenblum, Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule15d-14(a)
32.1*		Certification of William Corbett, Chief Executive Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
32.2*		Certification of Richard Rosenblum, Chief Financial Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
101.INS		Inline XBRL Instance Document.*
101.SCH		Inline XBRL Taxonomy Extension Schema Document.*
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*

*	Filed herewith

SIGNATURES

Pursuant to the requirements of the Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	INNOVATIVE PAYMENT SOLUTIONS, INC.

Date: August 14, 2023	By:	/s/ William D. Corbett
		William D. Corbett
		Chief Executive Officer
		(Principal Executive Officer)

Date: August 14, 2023	By:	/s/ Richard Rosenblum
		Richard Rosenblum
		President & Chief Financial Officer
		(Principal Financial and Accounting Officer)

0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 367901679 367901679 377403351 377905023 198.926452 198.926452 false --12-31 Q2 0001591913 0001591913 2023-01-01 2023-06-30 0001591913 2023-08-11 0001591913 2023-06-30 0001591913 2022-12-31 0001591913 2023-04-01 2023-06-30 0001591913 2022-04-01 2022-06-30 0001591913 2022-01-01 2022-06-30 0001591913 us-gaap:PreferredStockMember 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001591913 us-gaap:RetainedEarningsMember 2022-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-12-31 0001591913 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001591913 2023-01-01 2023-03-31 0001591913 us-gaap:PreferredStockMember 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-03-31 0001591913 2023-03-31 0001591913 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001591913 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001591913 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001591913 us-gaap:PreferredStockMember 2023-06-30 0001591913 us-gaap:CommonStockMember 2023-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001591913 us-gaap:RetainedEarningsMember 2023-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2023-06-30 0001591913 us-gaap:PreferredStockMember 2021-12-31 0001591913 us-gaap:CommonStockMember 2021-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591913 us-gaap:RetainedEarningsMember 2021-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-12-31 0001591913 2021-12-31 0001591913 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001591913 2022-01-01 2022-03-31 0001591913 us-gaap:PreferredStockMember 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-03-31 0001591913 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001591913 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001591913 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001591913 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001591913 us-gaap:PreferredStockMember 2022-06-30 0001591913 us-gaap:CommonStockMember 2022-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001591913 us-gaap:RetainedEarningsMember 2022-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2022-06-30 0001591913 2022-06-30 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001591913 ipsi:QpagosCorporationsCapitalStockMember us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001591913 ipsi:QpagosCorporationsCapitalStockMember 2023-01-01 2023-06-30 0001591913 us-gaap:CommonStockMember 2019-11-01 0001591913 2019-11-01 0001591913 2019-12-31 2019-12-31 0001591913 2019-12-31 0001591913 ipsi:GastonPereiraMember 2019-12-31 0001591913 ipsi:AndreyNovikovMember 2019-12-31 0001591913 ipsi:JosephAbramsMember 2019-12-31 0001591913 ipsi:CapitalContributionMember 2023-01-01 2023-06-30 0001591913 2023-06-21 0001591913 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-08-04 0001591913 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-09-15 0001591913 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-10-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001591913 srt:MinimumMember ipsi:CapitalContributionMember 2023-01-01 2023-06-30 0001591913 srt:MaximumMember ipsi:CapitalContributionMember 2023-01-01 2023-06-30 0001591913 ipsi:FrictionlessMember 2021-06-22 0001591913 ipsi:FrictionlessMember 2023-06-30 0001591913 ipsi:FrictionlessMember 2023-01-01 2023-06-30 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2023-06-30 0001591913 ipsi:BeyondFintechMember 2021-08-01 2021-08-26 0001591913 2021-08-01 2021-08-26 0001591913 2023-05-12 2023-05-12 0001591913 ipsi:BeyondFintechIncMember 2023-06-30 0001591913 ipsi:KiosksMember 2023-06-30 0001591913 us-gaap:ComputerEquipmentMember 2023-06-30 0001591913 us-gaap:OfficeEquipmentMember 2023-06-30 0001591913 srt:MinimumMember 2023-01-01 2023-06-30 0001591913 srt:MaximumMember 2022-01-01 2022-12-31 0001591913 ipsi:OwnershipMember 2023-05-12 0001591913 ipsi:BeyondFintechMember 2023-05-12 0001591913 2023-05-12 0001591913 2022-01-01 2022-12-31 0001591913 2021-01-01 2021-12-31 0001591913 ipsi:OwnershipMember 2023-05-12 0001591913 2023-01-01 2023-01-01 0001591913 2020-07-07 2020-07-07 0001591913 2020-07-07 0001591913 2021-02-10 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2021-02-10 2021-02-16 0001591913 2021-02-16 0001591913 ipsi:AmendmentTransactionMember 2021-02-16 0001591913 us-gaap:ConvertibleDebtMember 2023-06-30 0001591913 ipsi:AmendmentTransactionMember 2023-01-01 2023-06-30 0001591913 ipsi:CavalryFundILPMember 2023-06-30 0001591913 ipsi:CavalryFundILPMember 2023-01-01 2023-06-30 0001591913 ipsi:CavalryFundILPMember 2022-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-06-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-01-01 2023-06-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-31 0001591913 2022-02-01 2022-02-03 0001591913 ipsi:CavalryAndMercerMember 2022-02-03 0001591913 ipsi:CavalryAndMercerMember 2022-11-16 2022-11-16 0001591913 srt:MinimumMember ipsi:CavalryAndMercerMember 2023-06-30 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2023-06-30 0001591913 2021-02-01 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2022-01-01 2022-12-31 0001591913 2022-12-01 2022-12-28 0001591913 ipsi:CavalryAndMercerMember 2022-12-01 2022-12-28 0001591913 srt:MinimumMember 2023-06-30 0001591913 srt:MaximumMember 2023-06-30 0001591913 ipsi:CavalryFundILPMember 2021-02-01 2021-02-16 0001591913 ipsi:CavalryFundILPMember 2021-02-16 0001591913 ipsi:CavalryFundILPMember 2022-11-16 0001591913 ipsi:CavalryFundILPMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember ipsi:CavalryFundILPMember 2022-11-16 0001591913 srt:MaximumMember ipsi:CavalryFundILPMember 2022-11-16 0001591913 ipsi:CavalryFundILPMember 2023-05-01 2023-05-19 0001591913 ipsi:CavalryFundILPMember 2023-05-19 0001591913 2023-05-01 2023-05-19 0001591913 ipsi:CavalryFundILPMember 2023-06-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-01 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 srt:MaximumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-06-30 0001591913 ipsi:QuickCapitalLLCMember 2023-06-01 2023-06-20 0001591913 ipsi:QuickCapitalLLCMember 2023-06-20 0001591913 ipsi:QuickCapitalLLCMember 2023-06-30 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-05-01 2023-05-10 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-05-10 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-06-30 0001591913 ipsi:CavalryAndMercerMember 2021-02-01 2021-02-16 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-06-13 0001591913 us-gaap:ConvertibleDebtMember ipsi:DiagonalStreetLendingLLCMember 2023-06-30 0001591913 us-gaap:WarrantMember 2023-06-30 0001591913 ipsi:QuickCapitalLLCMember 2023-06-30 0001591913 ipsi:QuickCapitalLLCMember 2023-01-01 2023-06-30 0001591913 ipsi:QuickCapitalLLCMember 2022-12-31 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-06-30 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-01-01 2023-06-30 0001591913 ipsi:DiagonalStreetLendingLLCMember 2022-12-31 0001591913 ipsi:DiagonalStreetLendingLLCOneMember 2023-06-30 0001591913 ipsi:DiagonalStreetLendingLLCOneMember 2023-01-01 2023-06-30 0001591913 ipsi:DiagonalStreetLendingLLCOneMember 2022-12-31 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-06-30 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-01-01 2023-06-30 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2022-12-31 0001591913 us-gaap:ConvertibleNotesPayableMember 2023-06-30 0001591913 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-06-30 0001591913 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0001591913 2023-05-10 0001591913 2023-06-13 0001591913 ipsi:BlackScholesMember 2023-04-01 2023-06-30 0001591913 ipsi:BlackScholesMember 2023-01-01 2023-06-30 0001591913 srt:MaximumMember 2023-01-01 2023-06-30 0001591913 srt:MinimumMember 2022-01-01 2022-12-31 0001591913 2023-05-19 2023-05-19 0001591913 us-gaap:CommonStockMember 2022-08-30 0001591913 us-gaap:CommonStockMember 2022-08-01 2022-08-30 0001591913 2022-08-01 2022-08-30 0001591913 us-gaap:WarrantMember 2022-12-30 2022-12-30 0001591913 us-gaap:CommonStockMember 2022-12-30 0001591913 2022-12-30 2022-12-30 0001591913 ipsi:DebtConversionNoticesMember 2023-06-21 2023-06-21 0001591913 2023-06-22 2023-06-22 0001591913 ipsi:TwoThousandEighteenStockIncentivePlanMember 2023-01-01 2023-06-30 0001591913 srt:MaximumMember 2023-06-30 0001591913 srt:MaximumMember us-gaap:CommonStockMember 2023-06-30 0001591913 ipsi:TwoThousandTwentyOnePlanMember 2021-10-22 2021-10-22 0001591913 ipsi:TwoThousandTwentyOnePlanMember srt:MaximumMember 2021-10-22 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-01 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001591913 2022-09-01 2022-09-13 0001591913 us-gaap:CommonStockMember 2022-09-01 2022-09-13 0001591913 2022-09-13 0001591913 ipsi:TotalRestrictedSharesMember 2021-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2021-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2021-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2022-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2023-01-01 2023-06-30 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-06-30 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-01-01 2023-06-30 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-06-30 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-01-01 2023-06-30 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-06-30 0001591913 ipsi:TotalRestrictedSharesMember 2023-06-30 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-06-30 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-06-30 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-06-30 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-06-30 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-06-30 0001591913 ipsi:ExercisePrice0049Member 2023-01-01 2023-06-30 0001591913 ipsi:ExercisePriceRange5Member 2023-01-01 2023-06-30 0001591913 ipsi:ExercisePrice0055Member 2023-01-01 2023-06-30 0001591913 ipsi:WarrantsMember 2023-06-30 0001591913 srt:MinimumMember ipsi:WarrantsMember 2023-01-01 2023-06-30 0001591913 srt:MaximumMember ipsi:WarrantsMember 2023-01-01 2023-06-30 0001591913 ipsi:WarrantsMember 2023-01-01 2023-06-30 0001591913 us-gaap:WarrantMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2021-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 us-gaap:WarrantMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-06-30 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-06-30 0001591913 ipsi:ExercisePrice00115Member 2023-06-30 0001591913 ipsi:ExercisePrice00115Member 2023-01-01 2023-06-30 0001591913 ipsi:ExercisePrice00345Member 2023-06-30 0001591913 ipsi:ExercisePrice00345Member 2023-01-01 2023-06-30 0001591913 ipsi:ExercisePrice0015Member 2023-06-30 0001591913 ipsi:ExercisePrice0015Member 2023-01-01 2023-06-30 0001591913 ipsi:ExercisePrice015Member 2023-06-30 0001591913 ipsi:ExercisePrice015Member 2023-01-01 2023-06-30 0001591913 ipsi:ExercisePrice0187Member 2023-06-30 0001591913 ipsi:ExercisePrice0187Member 2023-01-01 2023-06-30 0001591913 us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-12-31 0001591913 us-gaap:StockOptionMember 2022-12-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 us-gaap:StockOptionMember 2023-01-01 2023-06-30 0001591913 us-gaap:StockOptionMember 2023-06-30 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-01-01 2023-06-30 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-01-01 2023-06-30 0001591913 ipsi:ExercisePrice004Member 2023-06-30 0001591913 ipsi:ExercisePrice004Member 2023-01-01 2023-06-30 0001591913 ipsi:ExercisePrice024Member 2023-06-30 0001591913 ipsi:ExercisePrice024Member 2023-01-01 2023-06-30 0001591913 ipsi:ExercisePrice040Member 2023-06-30 0001591913 ipsi:ExercisePrice040Member 2023-01-01 2023-06-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2023-04-01 2023-06-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-06-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-04-01 2022-06-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-06-30 0001591913 ipsi:StockOptionsMember 2023-04-01 2023-06-30 0001591913 ipsi:StockOptionsMember 2023-01-01 2023-06-30 0001591913 ipsi:StockOptionsMember 2022-04-01 2022-06-30 0001591913 ipsi:StockOptionsMember 2022-01-01 2022-06-30 0001591913 us-gaap:WarrantMember 2023-04-01 2023-06-30 0001591913 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001591913 us-gaap:WarrantMember 2022-04-01 2022-06-30 0001591913 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001591913 ipsi:MrFullerMember 2022-09-01 2022-09-13 0001591913 ipsi:MrFullerMember 2023-04-01 2023-06-30 0001591913 ipsi:MrFullerMember 2022-04-01 2022-06-30 0001591913 ipsi:MrFullerMember 2023-01-01 2023-06-30 0001591913 ipsi:MrFullerMember 2022-01-01 2022-06-30 0001591913 ipsi:WilliamCorbettMember 2022-07-01 2022-07-11 0001591913 ipsi:WilliamCorbettMember 2023-06-21 0001591913 ipsi:WilliamCorbettMember 2022-01-01 2022-12-31 0001591913 ipsi:WilliamCorbettMember 2023-01-01 2023-06-30 0001591913 ipsi:CliffordHenryMember 2023-01-01 2023-06-30 0001591913 ipsi:CliffordHenryMember 2022-09-01 2022-09-13 0001591913 ipsi:CliffordHenryMember 2022-09-13 0001591913 ipsi:MrHenryMember 2023-04-01 2023-06-30 0001591913 ipsi:MrHenryMember 2022-04-01 2022-06-30 0001591913 ipsi:MrHenryMember 2023-01-01 2023-06-30 0001591913 ipsi:MrHenryMember 2022-01-01 2022-06-30 0001591913 ipsi:MadissonCorbettMember 2022-09-01 2022-09-13 0001591913 ipsi:MadissonCorbettMember 2022-09-13 0001591913 ipsi:MsCorbettMember 2023-04-01 2023-06-30 0001591913 ipsi:MsCorbettMember 2022-04-01 2022-06-30 0001591913 ipsi:MsCorbettMember 2023-01-01 2023-06-30 0001591913 ipsi:MsCorbettMember 2022-01-01 2022-06-30 0001591913 ipsi:DavidRiosMember 2022-09-01 2022-09-13 0001591913 ipsi:DavidRiosMember 2022-09-13 0001591913 ipsi:MrRiosMember 2023-04-01 2023-06-30 0001591913 ipsi:MrRiosMember 2022-04-01 2022-06-30 0001591913 ipsi:MrRiosMember 2023-01-01 2023-06-30 0001591913 ipsi:MrRiosMember 2022-01-01 2022-06-30 0001591913 ipsi:MrRosenblumMember 2022-07-01 2022-07-11 0001591913 ipsi:MrRosenblumMember 2022-07-11 0001591913 ipsi:MrRosenblumMember 2023-04-01 2023-06-30 0001591913 ipsi:MrRosenblumMember 2022-04-01 2022-06-30 0001591913 ipsi:MrRosenblumMember 2023-01-01 2023-06-30 0001591913 ipsi:MrRosenblumMember 2022-01-01 2022-06-30 0001591913 us-gaap:SubsequentEventMember 2023-07-18 2023-08-04 0001591913 us-gaap:SubsequentEventMember 2023-08-04 0001591913 us-gaap:SubsequentEventMember 2023-08-04 2023-08-04 0001591913 us-gaap:SubsequentEventMember 2023-08-03 0001591913 us-gaap:SubsequentEventMember 2023-08-03 2023-08-03 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 4.1

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

Original Issue Date: _______

_______ Principal Amount

CONVERTIBLE PROMISSORY NOTE

THIS CONVERTIBLE PROMISSORY NOTE (the “Note”) is duly authorized and validly issued by Innovative Payment Solutions, Inc., a Nevada corporation (the “Company”).

FOR VALUE RECEIVED, the Company promises to pay to _______ or its permitted assigns (the “Holder”), the principal sum of $_______ on______ (the “Maturity Date”) or such earlier date as this Note is required or permitted to be repaid as provided hereunder, and to pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Note in accordance with the provisions hereof. This Note is subject to the following additional provisions:

Section 1. Definitions. For the purposes hereof, (a) capitalized terms not otherwise defined herein shall have the meanings set forth in the Purchase Agreement and (b) the following words and phrases shall have the following meanings:

“Alternate Consideration” shall have the meaning set forth in Section 5(e).

“Bankruptcy Event” means any of the following events: (a) the Company or any Subsidiary thereof commences a case or other proceeding under any bankruptcy, reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the Company or any Subsidiary thereof, (b) there is commenced against the Company or any Subsidiary thereof any such case or proceeding that is not dismissed within 60 days after commencement, (c) the Company or any Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding is entered, (d) the Company or any Subsidiary thereof suffers any appointment of any custodian or the like for it or any substantial part of its property that is not discharged or stayed within 60 calendar days after such appointment, (e) the Company or any Subsidiary thereof makes a general assignment for the benefit of creditors, (f) the Company or any Subsidiary thereof calls a meeting of its creditors with a view to arranging a composition, adjustment or restructuring of its debts or (g) the Company or any Subsidiary thereof, by any act or failure to act, expressly indicates its consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of effecting any of the foregoing.

“Beneficial Ownership Limitation” shall have the meaning set forth in Section 4(e).

“Common Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

“Conversion” shall have the meaning ascribed to such term in Section 4.

“Conversion Date” shall have the meaning set forth in Section 4(a). “Conversion Price” shall have the meaning set forth in Section 4(b).

“Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of this Note in accordance with the terms hereof.

“DWAC” means the Deposit or Withdrawal at Custodian system at The Depository Trust Company. “Event of Default” shall have the meaning set forth in Section 7(a).

“Exchange Act” means the Securities Exchange Act of 1934, and the rules and regulations promulgated thereunder.

“Fundamental Transaction” shall have the meaning set forth in Section 5(e).

“Indebtedness” means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company’s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $125,000 due under leases required to be capitalized in accordance with GAAP.

“Liens” shall have the meaning set forth in the Purchase Agreement. “Note Register” shall have the meaning set forth in Section 3(c). “Notice of Conversion” shall have the meaning set forth in Section 4(a).

“Original Issue Date” means the date of the first issuance of this Note, regardless of any transfers of this Note and regardless of the number of instruments which may be issued to evidence this Note.

“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Purchase Agreement” means the Securities Purchase Agreement, dated of even date herewith, among the Company and purchaser parties signatory thereto (including the Holder), as amended, modified or supplemented from time to time in accordance with its terms.

“SEC” means the Securities and Exchange Commission.

“Securities Act” means the Securities Act of 1933, and the rules and regulations promulgated thereunder. “Share Delivery Date” shall have the meaning set forth in Section 4(c)(ii).

“Successor Entity” shall have the meaning set forth in Section 5(e).

“Trading Day” means a day on which the principal Trading Market is open for trading.

“Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, the NYSE American, or any market of the OTC Markets, Inc. (or any successors to any of the foregoing).

“Transaction Documents” means the Note, the Purchase Agreement and the Warrant.

Section 2. Interest/Prepayment.

(a) Interest. Interest shall accrue to the Holder on the aggregate unconverted and then outstanding principal amount of this Note at the rate of 8% per annum, calculated on the basis of a 360-day year and shall accrue daily commencing on the Original Issue Date until payment in full of the outstanding principal (or conversion to the extent applicable), together with all accrued and unpaid interest, liquidated damages and other amounts which may become due hereunder, has been made.

(b) Prepayment. All or any portion of the principal and accrued interest under this Note may be prepaid by the Company at any time without penalty.

Section 3. Registration of Transfers and Exchanges.

(a) Different Denominations. This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations, as requested by the Holder surrendering the same. No service charge or other fees will be payable for such registration of transfer or exchange.

(b) Investor Representations. This Note has been issued subject to certain investment representations of the original Holder set forth in the Purchase Agreement and may be transferred or exchanged only in compliance with the Purchase Agreement and applicable federal and state securities laws and regulations.

(c) Reliance on Note Register. Prior to due presentment for transfer to the Company of this Note, the Company and any agent of the Company may treat the Person in whose name this Note is duly registered on the Note Register as the owner hereof for the purpose of receiving payment as herein provided and for all other purposes, whether or not this Note is overdue, and neither the Company nor any such agent shall be affected by notice to the contrary.

Section 4. Conversion.

(a) Conversion. After the Original Issue Date until this Note is no longer outstanding, this Note shall be convertible, in whole or in part, at any time, and from time to time, into Conversion Shares at the option of the Holder. The Holder shall effect conversions by delivering to the Company a Notice of Conversion, the form of which is attached hereto as Annex A (each, a “Notice of Conversion”), specifying therein the principal amount of this Note to be converted and the date on which such conversion shall be effected (such date, the “Conversion Date”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. To effect conversions hereunder, the Holder shall not be required to physically surrender this Note to the Company unless the entire principal amount of this Note, plus all accrued and unpaid interest thereon, has been so converted. Conversions hereunder shall have the effect of lowering the outstanding principal amount of this Note in an amount equal to the applicable conversion. The Holder and the Company shall maintain records showing the principal amount(s) converted in each conversion, the date of each conversion, and the Conversion Price in effect at the time of each conversion. The Company may deliver an objection to any Notice of Conversion within two Trading Days of delivery of such Notice of Conversion. In the event of any dispute or discrepancy, the records of the Holder shall be controlling and determinative in the absence of manifest error. The Holder, and any assignee by acceptance of this Note, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid and unconverted principal amount of this Note may be less than the amount stated on the face hereof.

(b) Conversion Price. The “Conversion Price” shall be $0.0115 per share (as may be adjusted as provided for herein).

(i) Conversion Shares Issuable Upon Conversion of Principal Amount. The number of Conversion Shares issuable upon a conversion hereunder shall be determined by the quotient obtained by dividing (x) the outstanding principal amount of this Note to be converted by (y) the Conversion Price in effect at the time of such conversion.

(ii) Delivery of Certificate Upon Conversion. Not later than two Trading Days after each Conversion Date (the “Share Delivery Date”), the Company shall deliver, or cause to be delivered, to the Holder any certificate or certificates required to be delivered by the Company under this Section 4(c) which shall be free of restrictive legends and trading restrictions except as provided by the Securities Act (other than those which may then be required by the Purchase Agreement) and such shares shall be delivered electronically through the Depository Trust Company or another established clearing corporation performing similar functions.

(iii) Failure to Deliver Conversion Shares. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Company at any time on or before its receipt of such Conversion Shares, to rescind such conversion, in which event the Company shall promptly return to the Holder any original Note delivered to the Company.

(iv) Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of this Note. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Company shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion Price or round up to the next whole share.

(v) Transfer Taxes and Expenses. The issuance of Conversion Shares on conversion of this Note shall be made without charge to the Holder hereof for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such certificates. The Company shall pay all Transfer Agent fees required for same- day processing of any Notice of Conversion and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares.

(vi) Attorneys’ Fees etc. The Company shall pay the reasonable fees of the law firm of the Holder’s choice (in an amount not to exceed $500 per opinion) in connection with the conversion of the Note.

(d) Holder’s Conversion Limitations. The Company shall not effect any conversion of this Note, and a Holder shall not have the right to convert any portion of this Note, to the extent that after giving effect to the conversion set forth on the applicable Notice of Conversion, the Holder (together with the Holder’s Affiliates, and any Persons acting as a group together with the Holder or any of the Holder’s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon conversion of this Note with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i) conversion of the remaining, unconverted principal amount of this Note beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, any other Notes or the Warrants) beneficially owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 4(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this Section 4(d) applies, the determination of whether this Note is convertible (in relation to other securities owned by the Holder together with any Affiliates) and of which principal amount of this Note is convertible shall be in the sole discretion of the Holder, and the submission of a Notice of Conversion shall be deemed to be the Holder’s determination of whether this Note may be converted (in relation to other securities owned by the Holder together with any Affiliates) and which principal amount of this Note is convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, the Holder will be deemed to represent to the Company each time it delivers a Notice of Conversion that such Notice of Conversion has not violated the restrictions set forth in this Section 4(d) and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 4(d), in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as stated in the most recent of the following: (i) the Company’s most recent periodic or annual report filed with the SEC, as the case may be, (ii) a more recent public announcement by the Company, or (iii) a more recent written notice by the Company or the Company’s transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Note, by the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of this Note held by the Holder. The Holder, upon not less than 61 days’ prior notice to the Company, may increase the Beneficial Ownership Limitation provisions of this Section 4(d) to 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of this Note held by the Holder. In all events, the provisions of this Section 4(d) shall continue to apply. Any such increase or decrease will not be effective until the 61st day after such notice is delivered to the Company. The Holder may also decrease the Beneficial Ownership Limitation provisions of this Section 4(d) solely with respect to the Holder’s Note at any time, which decrease shall be effectively immediately upon delivery of notice to the Company. The Beneficial Ownership Limitation provisions of this Section 4(d) shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 4(d) to correct any portion which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this Section 4(d) shall apply to a successor holder of this Note.

Section 5. Certain Adjustments.

(a) Stock Dividends and Stock Splits. If the Company, at any time while this Note is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any Common Stock Equivalents, (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Company, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Company) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 5(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re- classification.

(b) [Reserved].

(c) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 5(a) above, if at any time the Company grants, issues or sells any Common Stock, Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Note (without regard to any limitations on conversion hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

(d) Pro Rata Distributions. During such time as this Note is outstanding, if the Company shall declare or make any dividend or other distribution of its assets or rights or warrants to acquire its assets, or subscribe for or purchase any security other than Common Stock, to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Note, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Note (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation with respect to the Company or any other publicly-traded corporation subject to Section 13(d) of the Exchange Act, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation with respect to the Company or any other publicly-traded corporation subject to Section 13(d) of the Exchange Act).

(e) Fundamental Transaction. If, at any time while this Note is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent conversion of this Note, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation on the conversion of this Note), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Note is convertible immediately prior to such Fundamental Transaction (without regard to any limitation on the conversion of this Note). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Note following such Fundamental Transaction. The Company shall not effect a Fundamental Transaction unless it gives the Holder at least 5 Trading Days prior notice together with sufficient details so the Holder can make an informed decision as to whether it elects to accept the Alternative Consideration. If a public announcement of the Fundamental Transaction has not been made, the notice to the Holder may not be given until the Company files a Form 8-K or other report disclosing the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Note and the other Transaction Documents in accordance with the provisions of this Section 5(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Note a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Note which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Note (without regard to any limitations on the conversion of this Note) prior to such Fundamental Transaction, and with a conversion price which applies the Conversion Price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Note immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Note and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Note and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.

(f) Calculations. All calculations under this Section 5 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 5, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Company) issued and outstanding.

(g) Notice to the Holder.

(i) Adjustment to Conversion Price. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 5, the Company shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

(ii) Notice to Allow Conversion by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on its Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of its Common Stock, (C) the Company shall authorize the granting to all holders of its Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of its Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby its Common Stock is converted into other securities, cash or property or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be filed at each office or agency maintained for the purpose of conversion of this Note, and shall cause to be delivered to the Holder at its last address as it shall appear upon the Note Register, at least 5 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of its Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of its Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. .The Holder shall remain entitled to convert this Note during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

Section 6. [Reserved].

Section 7. Events of Default.

(a) “Event of Default” means, wherever used herein, any of the following events (whatever the reason for such event and whether such event shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body):

(i) any default in the payment of (A) principal and interest payment under this Note or any other Indebtedness, or (B) late fees, liquidated damages and other amounts owing to the Holder of this Note, as and when the same shall become due and payable (whether on a Conversion Date, or the Maturity Date, or by acceleration or otherwise), which default, solely in the case of a default under clause (B) above, is not cured within five Trading Days;

(ii) the Company shall fail to observe or perform any other material covenant or agreement contained in this Note (other than a breach by the Company of its obligations to deliver Conversion Shares, which breach is addressed in clause (x) below) or any Transaction Document which failure is not cured, if possible to cure, within the earlier to occur of 15 Trading Days after notice of such failure is sent by the Holder or by any other Holder to the Company and (B) 10 Trading Days after the Company has become aware of such failure;

(iii) except for payment defaults covered under Section 7(a)(i), the Company shall breach, or a default or event of default (subject to any grace or cure period provided in the applicable agreement, document or instrument) shall occur under any of the Transaction Documents;

(iv) any representation or warranty made in this Note or any other Transaction Document shall be untrue or incorrect in any material respect as of the date when made or deemed made, which failure is not cured, if possible to cure, within the earlier to occur of 10 Trading Days after notice of such failure is sent by the Holder or by any other Holder to the Company;

(v) the Company or any Subsidiary shall be subject to a Bankruptcy Event;

(vi) the Company or any Subsidiary shall: (A) apply for or consent to the appointment of a receiver, trustee, custodian or liquidator of it or any of its properties; (B) admit in writing its inability to pay its debts as they mature; (C) make a general assignment for the benefit of creditors; (D) be adjudicated as bankrupt or insolvent or be the subject of an order for relief under Title 11 of the United States Code or any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution or liquidation law or statute of any other jurisdiction or foreign country; or (E) file a voluntary petition in bankruptcy, or a petition or an answer seeking reorganization or an arrangement with creditors or to take advantage or any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution or liquidation law or statute, or an answer admitting the material allegations of a petition filed against it in any proceeding under any such law, or (F) take or permit to be taken any action in furtherance of or for the purpose of effecting any of the foregoing;

(vii) if any order, judgment or decree shall be entered, without the application, approval or consent of the Company or any Subsidiary, by any court of competent jurisdiction, approving a petition seeking liquidation or reorganization of the Company or any Subsidiary, or appointing a receiver, trustee, custodian or liquidator of the Company or any Subsidiary, or of all or any substantial part of its assets, and such order, judgment or decree shall continue unstayed and in effect for any period of 60 days;

(viii) any provision of any Transaction Document shall at any time for any reason (other than pursuant to the express terms thereof) cease to be valid and binding on or enforceable against the parties thereto, or the validity or enforceability thereof shall be contested by any party thereto, or a proceeding shall be commenced by the Company or any Subsidiary or any governmental authority having jurisdiction over any of them, seeking to establish the invalidity or unenforceability thereof, or the Company or any Subsidiary shall deny in writing that it has any liability or obligation purported to be created under any Transaction Document;

(ix) the Company fails to use the proceeds in the manner as described in Section 4.7 of the Purchase Agreement;

(x) the Company’s Common Stock is not listed or quoted for trading on a Trading Market which failure is not cured, if possible to cure, within the earlier to occur of 10 Trading Days after notice of such failure is sent by the Holder or by any other Holder to the Company or the transfer of shares of Common Stock through the Depository Trust Company System is no longer available or is subject to a “chill” by the Depository Trust Company or any successor;

(xi) the Company shall fail for any reason, except if caused by the action or inaction of the Holder to deliver Conversion Shares to the Holder prior to the third Trading Day after a Conversion Date pursuant to Section 4(c) or the Company shall provide at any time notice to the Holder, including by way of public announcement, of the Company’s intention to not honor requests for conversions of this Note in accordance with the terms hereof; or

(xii) the Company fails to file with the SEC any required reports under Section 13 or 15(d) of the Exchange Act within the time required (including any applicable extension period) by the rules and regulations thereunder.

(b) Remedies Upon Event of Default. If any Event of Default occurs, the outstanding principal amount of this Note, plus liquidated damages and other amounts owing in respect thereof through the date of acceleration, shall become, at the Holder’s election, immediately due and payable in cash. Upon the payment in full of the principal and accrued interest under this Note, the Holder shall promptly surrender this Note to or as directed by the Company. In connection with such acceleration described herein, the Holder need not provide, and the Company hereby waives, any presentment, demand, protest or other notice of any kind, and the Holder may immediately and without expiration of any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable law. Such acceleration may be rescinded and annulled by Holder at any time prior to payment hereunder and the Holder shall have all rights as a holder of the Note until such time, if any, as the Holder receives full payment pursuant to this Section 7(b). No such rescission or annulment shall affect any subsequent Event of Default or impair any right consequent thereon.

Section 8. Miscellaneous.

(a) No Rights as Stockholder Until Conversion. This Note does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the conversion hereof other than as explicitly set forth in Section 5.

(b) Notices. All notices, offers, acceptance and any other acts under this Agreement (except payment) shall be in writing, and shall be sufficiently given if delivered pursuant to Section 5.4 of the Purchase Agreement:

(c) Absolute Obligation. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, liquidated damages and accrued interest and late fees, as applicable, on this Note at the time, place, and rate, and in the coin or currency, herein prescribed. This Note is a direct debt obligation of the Company.

(d) Lost or Mutilated Note. If this Note shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed Note, a new Note for the principal amount of this Note so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of this Note, and of the ownership hereof, reasonably satisfactory to the Company.

(e) Exclusive Jurisdiction; Governing Law; Prevailing Party Attorneys’ Fees. All questions concerning the construction, validity, enforcement and interpretation of this Note and venue shall be governed by and construed and enforced in accordance with Section 5.9 of the Purchase Agreement. If any party shall commence an Action or Proceeding to enforce or otherwise relating to this Note, then, in addition to the other obligations of the Company elsewhere in this Note, the prevailing party in such action or proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.

(f) Waiver. Any waiver by the Company or the Holder of a breach of any provision of this Note shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Note. The failure of the Company or the Holder to insist upon strict adherence to any term of this Note on one or more occasions shall not be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Note on any other occasion. Any waiver by the Company or the Holder must be in writing.

(g) Severability. If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law. The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law or other law which would prohibit or forgive the Company from paying all or any portion of the principal of or interest on this Note as contemplated herein, wherever enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this Note, and the Company (to the extent it may lawfully do so) hereby expressly waives all benefits or advantage of any such law, and covenants that it will not, by resort to any such law, hinder, delay or impede the execution of any power herein granted to the Holder, but will suffer and permit the execution of every such as though no such law has been enacted.

(h) Remedies, Characterizations, Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note and any of the other Transaction Documents at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the Holder’s right to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Note. The Company covenants to the Holder that there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, conversion and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach would be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available remedies, to an injunction restraining any such breach or any such threatened breach, without the necessity of showing economic loss and without any bond or other security being required. The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable the Holder to confirm the Company’s compliance with the terms and conditions of this Note.

(i) Next Trading Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Trading Day, such payment shall be made on the next succeeding Trading Day.

G) Headings. The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be deemed to limit or affect any of the provisions hereof.

IN WITNESS WHEREOF, the Company has caused this Note to be duly executed by a duly authorized officer as of the date first above indicated.


	Name:	William Corbett
	Title:	Chief Executive Officer

ANNEX A

NOTICE OF CONVERSION

The undersigned hereby elects to convert principal under the Original Issue Discount Convertible Note due______ of Innovative Payment Solutions, Inc, a Nevada corporation (the “Company”), into shares of common stock (the “Common Stock”), of the Company according to the conditions hereof, as of the date written below.

By the delivery of this Notice of Conversion the undersigned represents and warrants to the Company that its ownership of the Common Stock does not exceed the amounts specified under Section 4(e) of this Note, as determined in accordance with Section 13(d) of the Exchange Act.

The undersigned agrees to comply with the prospectus delivery requirements under the applicable securities laws in connection with any transfer of the aforesaid shares of Common Stock.

Conversion calculations:

	Date to Effect Conversion:
	Principal Amount of Note to be Converted:
	Number of shares of Common Stock to be issued:
	Signature:
	Name:
	DWAC Instructions:
	Broker No:
	Account No:

Exhibit 10.1

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

COMMON STOCK PURCHASE WARRANT

Warrant Shares:

Initial Exercise Date: _________

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ______, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the fifth year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Innovative Payment Solutions, Inc., a Nevada corporation (the “Company”), up to ______ shares of Common Stock (subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant issued pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) entered into as of the Initial Exercise Date between the Company and the initial Holder.

Section 1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the “Purchase Agreement”), dated as of the Initial Exercise Date among the Company, the Holder and the other purchaser parties thereto.

Section 2. Exercise.

(a) Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed copy of the Notice of Exercise Form annexed hereto. Within two Trading Days following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank, unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. Notwithstanding anything herein to the contrary (although the Holder may surrender the Warrant to, and receive a replacement Warrant from, the Company), the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within two Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise Form within one Trading Day of delivery of such notice. The Holder by acceptance of this Warrant or any transferee, acknowledges and agrees that, by reason of the provisions of this Section 2(a), following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

(b) Exercise Price. The initial exercise price per share of the Common Stock under this Warrant shall be equal to $0.0115 per share, subject to adjustment under Section 3 (the “Exercise Price”).

(d) Mechanics of Exercise.

(i) Delivery of Certificates Upon Exercise. Certificates for the shares of Common Stock purchased hereunder shall be transmitted to the Holder by the Transfer Agent by crediting the account of the Holder’s prime broker with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or otherwise by physical delivery of certificate for (or book entry notation of) the Warrant Shares to the address specified by the Holder in the Notice of Exercise by the date that is two Trading Days after the latest of (A) the delivery to the Company of the Notice of Exercise and (B) payment of the aggregate Exercise Price as set forth above. The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price. In addition to any other remedies which may be available to the Holder, in the event that the Company fails for any reason to effect delivery of the Warrant Shares by the Warrant Share Delivery Date, the Holder may revoke all or part of the relevant Warrant exercise by delivery of a notice to such effect to the Company, whereupon the Company and the Holder shall each be restored to their respective positions immediately prior to the exercise of the relevant portion of this Warrant.

(ii) Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant, at the time of delivery of the certificate or certificates representing Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical to this Warrant. Unless the Warrant has been fully exercised, the Holders shall not be required to surrender this Warrant as a condition of exercise.

(iii) No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

(iv) Charges, Taxes and Expenses. Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate including any charges of any clearing firm, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the Holder. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise. The Company shall pay the reasonable legal fees of the Holder’s choice (in an amount not to exceed $500 per opinion, and not more often than once per week) in connection with the exercise of this Warrant.

(v) Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

(e) Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon not less than 61 days’ prior notice to the Company, may increase the Beneficial Ownership Limitation provisions of this Section 2(e) solely with respect to the Holder’s Warrant, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any such increase will not be effective until the 61st day after such notice is delivered to the Company. The Holder may also decrease the Beneficial Ownership Limitation provisions of this Section 2(e) solely with respect to the Holder’s Warrant at any time, which decrease shall be effectively immediately upon delivery of notice to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

Section 3. Certain Adjustments.

(a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant or pursuant to any of the other Transaction Documents), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

(b) [Reserved].

(d) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). Notwithstanding the foregoing, no Purchase Rights will be made under this Section 3(d) in respect of an Exempt Issuance.

(e) Pro Rata Distributions. If the Company, at any time while this Warrant is outstanding, shall distribute to all holders of Common Stock (and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants to subscribe for or purchase any security other than the Common Stock (which shall be subject to Section 3(d)), then in each such case the Exercise Price shall be adjusted by multiplying the Exercise Price in effect immediately prior to the record date fixed for determination of stockholders entitled to receive such distribution by a fraction of which the denominator shall be the VWAP determined as of the record date mentioned above, and of which the numerator shall be such VWAP on such record date less the then per share fair market value at such record date of the portion of such assets or evidence of indebtedness so distributed applicable to one outstanding share of the Common Stock as determined by the Board of Directors in good faith. In either case the adjustments shall be described in a statement provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription rights applicable to one share of Common Stock. Such adjustment shall be made whenever any such distribution is made and shall become effective immediately after the record date mentioned above.

(f) Fundamental Transaction.

(i) If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions engages in any Fundamental Transaction, as defined in the Note, then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation on the exercise of this Warrant), at the option of the Holder the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall not effect a Fundamental Transaction unless it gives the Holder at least 5 Trading Days prior notice together with sufficient details so the Holder can make an informed decision as to whether it elects to accept the Alternative Consideration. If a public announcement of the Fundamental Transaction has not been made, the notice to the Holder may not be given until the Company files a Form 8-K or other report disclosing the Fundamental Transaction.

(ii) If Section 3(f)(i) is not applicable, the Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(f)(ii) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant prior to such Fundamental Transaction (without regard to any limitation on the exercise of this Warrant), and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.

(g) Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

(h) Notice to Holder.

(i) Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly email to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment. The Holder may supply an email address to the Company and change such address.

(ii) Notice to Allow Exercise by the Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall deliver to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 5 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to email such notice or any defect therein or in the emailing thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries (as determined in good faith by the Company), the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

Section 4. Transfer of Warrant.

(a) Transferability. Subject to compliance with any applicable securities laws and the provisions of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney. Upon such surrender, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. The Warrant, if properly assigned in accordance herewith, may be exercised by a new Holder for the purchase of Warrant Shares without having a new Warrant issued.

(b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

(c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

Section 5. Miscellaneous.

(a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof other than as explicitly set forth in Section 3.

(b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it, and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate. In no event shall the Holder be required to deliver a bond or other security.

(c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.

(d) Authorized Shares. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its Articles of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction ther

(e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.

(f) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered or if not exercised on a cashless basis when Rule 144 (or any successor law or rule) is available, may have restrictions upon resale imposed by state and federal securities laws.

(g) Non-waiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of the Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

(h) Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.

(i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

(j) Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate or that there is no irreparable harm and not to require the posting of a bond or other security.

(k) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder of Warrant Shares.

(l) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and Holders of in excess of 50% of the outstanding Warrants issued pursuant to the Purchase Agreement.

(m) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

(n) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date indicated above.


	Name:	William Corbett
	Title:	Chief Executive Officer

NOTICE OF EXERCISE

TO: Innovative Payment Solutions, Inc.

(1) The undersigned hereby elects to purchase _____ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

(2) Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is specified below:

(3) After giving effect to this Notice of Exercise, the undersigned will not have exceeded the Beneficial Ownership Limitation.

The Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:

SIGNATURE OF HOLDER

Name of Investing Entity:

Signature of Authorized Signatory of Investing Entity:

Name of Authorized Signatory:

Title of Authorized Signatory:  

Date:  

ASSIGNMENT FORM

(To assign the foregoing warrant, execute this form and supply required information.

Do not use this form to exercise the warrant.)

Innovative Payment Solutions, Inc.

FOR VALUE RECEIVED, ____ all of or ___ shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to ______________________________________whose address is _____________________________________.

Dated: _________, ___

Holder’s Signature:

Holder’s Address:

Signature Guaranteed:

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

Exhibit 10.2

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of _____ by and between Innovative Payment Solutions, Inc., a Nevada corporation (the “Company”), and each lender party that executes the signature page hereto as a purchaser (each, a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Securities Act, as defined, contained in Section 4(a)(2) thereof and/or Rule 506(b) thereunder, the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:

ARTICLE I.
DEFINITIONS

1.1 Definitions. In addition to the words and terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:

“Acquiring Person” shall have the meaning ascribed to such term in Section 4.5.

“Action” shall have the meaning ascribed to such term in Section 3.1(j).

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

“Board of Directors” means the board of directors of the Company.

“Closing” means the closing of the purchase and sale of the Notes pursuant to Section 2.1.

“Closing Date” means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchaser’s obligations to pay the Subscription Amount and (ii) the Company’s obligations to deliver the Securities to be issued and sold, in each case, have been satisfied or waived, but in no event later than the second Trading Day following the date hereof.

“Common Stock” means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

“Company Counsel” means Ellenoff Grossman & Schole LLP.

“Evaluation Date” shall have the meaning ascribed to such term in Section 3.1(s).

“Exchange Act” means the Securities Exchange Act of 1934, and the rules and regulations promulgated thereunder.

“FCPA” means the Foreign Corrupt Practices Act of 1977, as amended.

“GAAP” shall have the meaning ascribed to such term in Section 3.1(h).

“Indebtedness” shall have the meaning ascribed to such term in Section 3.1(aa).

“Intellectual Property” means all of the following in any jurisdiction throughout the world: (a) all inventions (whether patentable or unpatentable and whether or not reduced to practice), all improvements thereto, and all U.S. and foreign patents, patent applications, and patent disclosures, together with all reissuances, continuations, continuations-in-part, revisions, extensions, and reexaminations thereof, (b) all trademarks, service marks, brand names, certification marks, trade dress, logos, trade names, domain names, assumed names and corporate names, together with all colorable imitations thereof, and including all goodwill associated therewith, and all applications, registrations, and renewals in connection therewith, (c) all copyrights, and all applications, registrations, and renewals in connection therewith, (d) all trade secrets under applicable state laws and the common law and know-how (including formulas, techniques, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information, and business and marketing plans and proposals), (e) all computer software (including source code, object code, diagrams, data and related documentation), and (f) all copies and tangible embodiments of the foregoing (in whatever form or medium).

“Licensed Intellectual Property Agreement” means all licenses, sublicenses, agreements and permissions (each as amended to date) that any third party owns and that the Company uses, including off-the-shelf software purchased or licensed by the Company.

“Liens” means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

“Material Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

“Notes” means the Original Issue Discount Convertible Promissory Notes issued to the Purchasers, in the form of Exhibit A attached hereto.

“Note Conversion Price” means $0.0115 per share, subject to adjustment as provided in the Note.

“Original Issue Date” means the date of the first issuance of the Notes, regardless of any transfers of any Note and regardless of the number of instruments which may be issued to evidence such Notes.

“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.

“Purchaser Party” shall have the meaning ascribed to such term in Section 4.8.

“Regulation FD” means Regulation FD promulgated by the SEC pursuant to the Exchange Act, as such Regulation may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Regulation

“Reserve” shall have the meaning ascribed to such term in Section 4.9.

“Required Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

“Rule 144” means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.

“SEC” means the United States Securities and Exchange Commission.

“SEC Reports” shall have the meaning ascribed to such term in Section 3.1(h).

“Securities” means the Notes, the Warrants and the Shares.

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Shares” means the Common Stock issuable upon conversion of the Notes.

“Short Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock).

“Subscription Amount” means the amount of the principal amount of Notes that each Purchaser subscribes for pursuant to this Agreement.

“Subsidiary” means with respect to any entity at any date, any direct or indirect corporation, limited or general partnership, limited liability company, trust, estate, association, joint venture or other business entity of which (A) more than 50% of (i) the outstanding capital stock having (in the absence of contingencies) ordinary voting power to elect a majority of the Board of Directors or other managing body of such entity, (ii) in the case of a partnership or limited liability company, the interest in the capital or profits of such partnership or limited liability company or (iii) in the case of a trust, estate, association, joint venture or other entity, the beneficial interest in such trust, estate, association or other entity business is, at the time of determination, owned or controlled directly or indirectly through one or more intermediaries, by such entity, or (B) is under the actual control of the Company.

“Trading Day” means a day on which the principal Trading Market is open for trading.

“Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, the OTCQB, the OTCQX, or the OTC Pink Marketplace (or any successors to any of the foregoing).

“Transaction Documents” means this Agreement, the Notes, the Warrants, and any other documents or agreements executed in connection with the transactions contemplated hereunder, including, but not limited to, the documents referenced in Section 2.3(a).

“Transfer Agent” means Nevada Agency & Transfer Company, and any successor transfer agent of the Company.

“Warrants” means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which Warrants shall be exercisable immediately and have a term of exercise equal to five years from such initial exercise date, in the form of Exhibit B attached hereto.

“Warrant Exercise Price” means $0.0115 per share.

“Warrant Shares” means the shares of Common Stock issuable upon exercise of the Warrants at the Warrant Exercise Price.

ARTICLE II.
PURCHASE AND SALE

2.1 Closing. On the Closing Dates, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and Purchasers, severally and not jointly, agree to purchase up to an aggregate of (i) up to $600,000 face value of Notes, and (ii) Warrants to purchase up to 52,173,913 shares of Common Stock. On the Closing Date, each Purchaser shall deliver to the Company, via wire transfer immediately available funds, cash equal to the Purchaser’s Subscription Amount, and the Company shall deliver to the Purchaser the Note as determined pursuant to Section 2.2(a), and the Company and the Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 (a) and 2.3(b), the Closing shall occur at the offices of Company Counsel or such other location as the parties shall mutually agree (including via remote electronic delivery of Closing documentation).

2.2 Deliveries.

(a) On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:

(i) this Agreement duly executed by the Company;

(ii) a Note in the principal amount of such Purchaser’s Subscription Amount, convertible at the Note Conversion Price, registered in the name of the Purchaser;

(iii) a Warrant to purchase a number of Warrant Shares determined by dividing such Purchaser’s Subscription Amount of the Warrant Exercise Price, which Warrant will be exercisable at the Warrant Exercise Price, registered in the name of such Purchaser;

(iv) a Board Consent approving the issuance of the Notes and the execution of the Transaction Documents on behalf of the Company.

(b) On or prior to the Closing Date each Purchaser shall deliver or cause to be delivered to the Company the following:

(i) this Agreement duly executed by the Purchaser; and

(iii) the Purchaser’s Subscription Amount by wire transfer of immediately available funds to the Company.

2.3 Closing Conditions.

(a) The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Purchaser contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);

(ii) all obligations, covenants and agreements of the Purchaser required to be performed at or prior to the Closing Date shall have been performed;

(iii) the delivery by the Purchaser of the items set forth in Section 2.2(b) of this Agreement; and

(b) The respective obligations of each Purchaser hereunder in connection with the Closing are subject to the following conditions being met:

(i) accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);

(ii) all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;

(iii) the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

(iv) there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and

(v) from the date hereof to the Closing Date trading in the Common Stock shall not have been suspended by the SEC or the Company’s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of the Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.

ARTICLE III.
REPRESENTATIONS AND WARRANTIES

3.1 Representations and Warranties of the Company. The Company hereby makes the following representations and warranties to each Purchaser as of the date hereof:

3.2 Subsidiaries. All of the direct and indirect Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.

3.3 Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or Articles of Incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

3.4 Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith other than in connection with the Required Approvals. Subject to obtaining the Required Approvals, this Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

3.5 No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) subject to the Required Approvals, conflict with or violate any provision of the Company’s or any Subsidiary’s Certificate or Articles of Incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

3.6 Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.4 of this Agreement, blue sky filings or a Form D filing(ii) application(s) to each applicable Trading Market for the listing of the Shares for trading thereon in the time and manner required thereby, (iii) such filings as are required to be made under applicable state securities laws (the “Required Approvals”).

3.7 Issuance of the Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Shares, when issued upon conversion of the Notes will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company shall reserve from its duly authorized capital stock a number of shares of Common Stock issuable pursuant to the Securities.

3.8 Capitalization. The capitalization of the Company is as set forth in the SEC Reports. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock awards under the Company’s equity incentive plans, the issuance of shares of Common Stock to employees pursuant to the Company’s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as set forth in the SEC Reports, as a result of the purchase and sale of the Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchaser) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders.

3.9 SEC Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the “SEC Reports”). As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The consolidated financial statements of the Company included in the SEC Reports, together with the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and any of its Subsidiaries as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders’ equity of the Company for the periods specified and have been prepared in compliance with the requirements of the Securities Act and Exchange Act and in conformity with United States generally accepted accounting principles (“GAAP”) applied on a consistent basis during the periods involved; there are no financial statements (historical or pro forma) that are required to be included in the SEC Reports that are not included as required; the Company and its Subsidiaries do not have any material liabilities or obligations, direct or contingent (including any off-balance sheet obligations), not described in the SEC Reports; and all disclosures contained in the SEC Reports, if any, regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the SEC) comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent applicable. The financial data set forth in each of the SEC Reports fairly presents the information set forth therein on a basis consistent with that of the audited financial statements contained in the Company’s SEC Reports. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the SEC Reports fairly presents the information called for in all material respects and has been prepared in accordance with the SEC’s rules and guidelines applicable thereto.

3.10 Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest financial statements included within the SEC Reports (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the SEC, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company equity incentive plans. The Company does not have pending before the SEC any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one Trading Day prior to the date that this representation is made.

3.11 Litigation. Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation, inquiry or other similar proceeding of any federal or state government unit pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the issuance of the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. The Company has no present reason to believe that an Action will be filed against it in the future. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim for fraud or breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation or inquiry by the SEC involving the Company or any current or former director or officer of the Company. The SEC has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Securities Act, and the Company has no reason to believe it will do so in the future.

3.12 Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no effort is underway to unionize or organize the employees of the Company or any Subsidiary. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. There is no workmen’s compensation liability matter, employment-related charge, complaint, grievance, investigation, inquiry or obligation of any kind pending, or to the Company’s knowledge, threatened, relating to an alleged violation or breach by the Company or its Subsidiaries of any law, regulation or contract that could, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

3.13 Compliance. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.

3.14 Environmental Laws. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (“Environmental Laws”); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.

3.15 Regulatory Permits. The Company and each of its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such certificates, authorizations or permits would not have, individually or in the aggregate, a Material Adverse Effect, and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit. There is no agreement, commitment, judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries or to which the Company or any of its Subsidiaries is a party which has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of the Company or any of its Subsidiaries, any acquisition of property by the Company or any of its Subsidiaries or the conduct of business by the Company or any of its Subsidiaries as currently conducted other than such effects, individually or in the aggregate, which have not had and would not reasonably be expected to have a Material Adverse Effect on the Company or any of its Subsidiaries.

3.16 Title to Assets. Subject to the Liens of the outstanding secured senior debt, the Company and the Subsidiaries have good and marketable title in fee simple to all personal property owned by them that is material to the business of the Company and the Subsidiaries. The Company owns no real property. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.

3.17 Intellectual Property.

(i) Subject to the Liens of any outstanding secured senior debt, to the Company’s knowledge, the Company owns or possesses or has the right to use pursuant to a valid and enforceable written license, sublicense, agreement, or permission all Intellectual Property necessary for the operation of the business of the Company as presently conducted.

(ii) To the Company’s knowledge, the Intellectual Property does not interfere with, infringe upon, misappropriate, or otherwise come into conflict with, any Intellectual Property rights of third parties, and the Company has no knowledge that facts exist which indicate a likelihood of the foregoing. The Company has not received any charge, complaint, claim, demand, or notice alleging any such interference, infringement, misappropriation, or conflict (including any claim that the Company must license or refrain from using any Intellectual Property rights of any third party). To the knowledge of the Company, no third party has interfered with, infringed upon, misappropriated, or otherwise come into conflict with, any Intellectual Property rights of the Company.

(iii) With respect to each Licensed Intellectual Property Agreement:

(A) The Licensed Intellectual Property Agreement is legal, valid, binding, enforceable, and in full force and effect;

(B) To the Company’s knowledge, no party to the Licensed Intellectual Property Agreement is in breach or default, and no event has occurred that with notice or lapse of time would constitute a breach or default or permit termination, modification, or acceleration thereunder, which as to any such breach, default or event could have a Material Adverse Effect on the Company;

(D) Except as set forth in such Licensed Intellectual Property Agreement, the Company has not received written or verbal notice or otherwise has knowledge that the underlying item of Intellectual Property is subject to any outstanding injunction, judgment, order, decree, ruling, or charge; and

(E) The Company has not granted any sublicense or similar right with respect to the license, sublicense, agreement, or permission.

(iv) The Company has complied with and is presently in compliance with all foreign, federal, state, local, governmental (including, but not limited to, the Federal Trade Commission and State Attorneys General), administrative, or regulatory laws, regulations, guidelines, and rules applicable to any personal identifiable information.

(v) Each Person who participated in the creation, conception, invention or development of the Intellectual Property currently used in the business of the Company (each, a “Developer”) which is not licensed from third parties has executed one or more agreements containing industry standard confidentiality, work for hire and assignment provisions, whereby the Developer has assigned to the Company all copyrights, patent rights, Intellectual Property rights and other rights in the Intellectual Property, including all rights in the Intellectual Property that existed prior to the assignment of rights by such Person to the Company.

(vi) Each Developer has signed a perpetual non-disclosure agreement with the Company.

3.18 Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.

3.19 Transactions With Affiliates and Employees. Except as disclosed in the SEC Reports, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock award agreements under any equity incentive plan of the Company.

3.20 Sarbanes-Oxley; Internal Accounting Controls. Except as disclosed in the SEC Reports, the Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the SEC thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls as set forth in the SEC Reports. The Company’s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.

3.21 Certain Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchaser shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due by the Company in connection with the transactions contemplated by the Transaction Documents.

3.22 Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject to registration under the Investment Company Act of 1940, as amended.

3.23 Registration Rights. Except as disclosed in the SEC Reports, no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.

3.24 Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the SEC is contemplating terminating such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.

3.25 Application of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company’s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchaser as a result of the Purchaser and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company’s issuance of the Securities and the Purchaser’s ownership of the Securities.

3.26 [Reserved].

3.27 No Integrated Offering. Assuming the accuracy of the Purchaser’s representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable stockholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.

3.28 [Reserved].

3.29 Tax Status. The Company and each of its Subsidiaries have filed all federal, state, local and foreign tax returns which have been required to be filed and paid all taxes shown thereon through the date hereof, to the extent that such taxes have become due and are not being contested in good faith, except where the failure to so file or pay would not have a Material Adverse Effect. No tax deficiency has been determined adversely to the Company or any of its Subsidiaries which has had, or would have, individually or in the aggregate, a Material Adverse Effect. The Company has no knowledge of any federal, state or other governmental tax deficiency, penalty or assessment which has been or might be asserted or threatened against it which would have a Material Adverse Effect

3.30 Foreign Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated any provision of FCPA.

3.31 Accountants. The Company’s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm registered with the Public Company Accounting Oversight Board as required by the Exchange Act and (ii) will express its opinion with respect to the financial statements included in the Company’s Annual Report for the fiscal year ending December 31, 2022.

3.32 Acknowledgment Regarding Purchaser’s Purchase of Securities. The Company acknowledges and agrees that the Purchaser is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchaser’s purchase of the Securities. The Company further represents to the Purchaser that the Company’s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.

3.33 Acknowledgement Regarding Purchaser’s Trading Activity. Notwithstanding anything in this Agreement or elsewhere to the contrary (except for Sections 3.2(f) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) the Purchaser has not been asked by the Company to agree, nor has the Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or “derivative” securities based on securities issued by the Company or to hold the Securities for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or “derivative” transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company’s publicly-traded securities; (iii) any Purchaser, and counter-parties in “derivative” transactions to which the Purchaser is a party, directly or indirectly, presently may have a “short” position in the Common Stock, and (iv) the Purchaser shall not be deemed to have any affiliation with or control over any arm’s length counter-party in any “derivative” transaction. The Company further understands and acknowledges that (y) the Purchaser may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders’ equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.

3.34 Regulation M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company.

3.35 Private Placement. Assuming the accuracy of each Purchaser’s representations and warranties set forth in Section 3.1, no registration under the Securities Act is required for the offer and sale of the Notes or the Shares issuable upon conversion thereof by the Company to the Purchasers as contemplated hereby.

3.36 No General Solicitation. Neither the Company nor any person acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation or general advertising. The Company offered the Securities for sale only to the Purchaser and certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.

3.37 No Disqualification Events. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506(b) under the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale, nor any Person, including a placement agent, who will receive a commission or fees for soliciting purchasers (each, an “Issuer Covered Person” and, together, “Issuer Covered Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchaser a copy of any disclosures provided thereunder.

3.38 [Reserved].

3.39 Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

3.40 U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser’s request.

3.41 Bank Holding Company Act. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

3.42 Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering Laws”), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.

Representations and Warranties of the Purchaser. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein):

3.43 Organization; Authority. The Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by this Agreement and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and performance by the Purchaser of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of the Purchaser. Each Transaction Document to which it is a party has been duly executed by the Purchaser, and when delivered by the Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of the Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

3.44 Understandings or Arrangements. The Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting the Purchaser’s right to sell the Securities in compliance with applicable federal and state securities laws). The Purchaser is acquiring the Securities hereunder in the ordinary course of its business. The Purchaser understands that the Securities are “restricted securities” and have not been registered under the Securities Act or any applicable state securities law and is acquiring such Securities as principal for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting the Purchaser’s right to sell such Securities in compliance with applicable federal and state securities laws). The Purchaser acknowledges that the Company is under no obligation to register the Securities for sale or resale under the Securities Act.

3.45 Purchaser Status. At the time the Purchaser was offered the Securities, it was, and as of the date hereof it is, an accredited investor within the meaning of Rule 501 under the Securities Act. The Purchaser is not subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3).

3.46 Experience of the Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

3.47 Access to Information. The Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and has been afforded, subject to Regulation FD, (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment; provided, however, that the Purchaser has not requested nor been provided by the Company with any non-public information regarding the Company, its financial condition, results of operations, business, properties, management and prospects. The Purchaser acknowledges and agrees that neither the Company nor anyone else has provided the Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired. The Purchaser has reviewed all of the SEC Reports (including the risk factors contained herein) and understands that there are significant risks associated with an investment in the Securities, including the loss of Purchaser’s entire investment.

3.48 Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, the Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with the Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that the Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of the Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of the Purchaser’s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to the Purchaser’s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, the Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.

The Company acknowledges and agrees that the representations contained in this Article III shall not modify, amend or affect the Purchaser’s right to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transaction contemplated hereby.

ARTICLE IV.
OTHER AGREEMENTS OF THE PARTIES

4.1 Removal of Legends.

(a) The Shares, the Warrants and Warrant Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of the Shares, Warrants or Warrant Shares other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company at the cost of the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Shares, Warrants or Warrant Shares under the Securities Act.

(b) Each Purchaser agrees to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Shares, the Warrants or Warrant Shares in the following form:

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

(c) The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in some or all of the Shares or Warrant Shares to a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of this Agreement and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Shares or Warrant Shares to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Shares and Warrant Shares may reasonably request in connection with a pledge or transfer of the Shares or Warrant Shares.

(d) Certificates evidencing the Shares and the Warrant Shares (or the Transfer Agent’s records if held in book entry form) shall not contain any legend (including the legend set forth in Section 4.1(b) hereof): (i) while a registration statement covering the resale of such securities is effective under the Securities Act (the “Effective Date”), (ii) following any sale of such Shares or Warrant Shares pursuant to and in compliance with Rule 144, or (iii) if such legend is not required under applicable requirements of the Securities Act (including Sections 4(a)(1) and 4(a)(7) judicial interpretations and pronouncements issued by the staff of the SEC). The Company shall, if any of the provisions in clause (i) –(iii) above are applicable, at its expense, cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder.

(e) In the event a Purchaser shall request delivery of unlegended shares as described in this Section 4.1 and the Company is required to deliver such unlegended shares, it shall pay all fees and expenses associated with or required by the legend removal and/or transfer including but not limited to legal fees, Transfer Agent fees and overnight delivery charges and taxes, if any, imposed by any applicable government upon the issuance of Common Stock

4.2 Furnishing of Information. Until the earliest of the time that (i) no Purchaser owns Shares and Warrant Shares or (ii) the Warrants have expired, the Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.

4.3 Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2(a)(1) of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.

4.4 Securities Laws Disclosure; Publicity. The Company shall, by the time required by Form 8-K under the Exchange Act, file a Current Report on Form 8-K disclosing the material terms of this Agreement, including the Transaction Documents as exhibits thereto, with the SEC within the time required by the Exchange Act.

4.5 Stockholder Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchaser.

4.6 [Reserved].

4.7 Use of Proceeds. The Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes, and shall not use such proceeds: (a) for the redemption of any Common Stock or Common Stock Equivalents, (b) in violation of FCPA or OFAC regulations, or (c) to lend money, give credit, or make advances to any officers, directors, employees or affiliates of the Company.

4.8 Indemnification of Purchaser.

(a) Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers, stockholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls the Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, stockholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation (including local counsel, if retained) that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents, (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a breach of such Purchaser Party’s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which constitutes fraud, gross negligence, willful misconduct or malfeasance) or (c) any untrue or alleged untrue statement of a material fact contained in any registration statement, any prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel (in addition to local counsel, if retained). The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The Purchaser Parties shall have the right to settle any action against any of them by the payment of money provided that they cannot agree to any equitable relief and the Company, its officers, directors and Affiliates receive unconditional releases in customary form. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.

(b) Settlement Without Consent if Failure to Reimburse. If an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for reasonable fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section 4.8 effected without its written consent if (1) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (2) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (3) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.

4.9 Reservation of Common Stock. Beginning on the Closing Date, until no portion of the Notes remains outstanding the Company shall reserve and keep available at all times in favor of the Purchaser, on a pro rata basis based on the Purchasers’ Subscription Amount, free of preemptive rights, a the number of Shares issuable to the Purchasers upon conversion of the Notes and Warrants (subject to adjustment for stock splits and dividends, combinations and similar events) (the “Reserve”). To the extent that the Company's authorized Common Stock is unable to accommodate the Reserve, the Company shall, at its next annual meeting of stockholders, take such action as is necessary to increase the Company’s authorized shares of Common Stock in in a minimum amount necessary to accommodate the Reserve

4.10 Listing of Common Stock. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares, and will take such other action as is necessary to cause all of the Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action necessary to continue the listing and trading of its Common Stock on a Trading Market and will use commercially reasonable efforts to comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Trading Market. While any Purchaser holds Securities, the Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.

4.11 [Reserved].

4.12 Certain Transactions and Confidentiality. The Purchaser covenants that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company’s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced. Each Purchaser covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, the Purchaser will maintain the confidentiality of the existence and terms of this transaction. Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the public announcement of the transactions contemplated hereby. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of the Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of the Purchaser’s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.

4.13 Conversion Procedures. The forms of Conversion Notice included in the Notes set forth the totality of the procedures required of the Purchaser to exercise the Notes. No additional legal opinion, other information or instructions shall be required of the Purchaser to convert their Note. Without limiting the preceding sentences, no ink-original Conversion Notice shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Conversion Notice form be required to convert the Notes. The Company shall honor conversions of the Notes and shall deliver Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.

ARTICLE V.
MISCELLANEOUS

5.1 Termination. This Agreement may be terminated by a Purchaser by written notice to the Company if the Closing has not been consummated on or before the fifth (5^th) Trading Day following the date hereof; provided, however, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).

5.2 Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchaser.

5.3 Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

5.4 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered by email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. ( Eastern Standard or Daylight Savings Time, as applicable) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second Trading Day following the date of transmission, if sent by U.S. nationally recognized overnight delivery service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the SEC pursuant to a Current Report on Form 8-K, or which failure to do so will subject the Company to the liquidated damages provided for in Section 5.

5.5 Amendments; Waivers. Except as provided in the last sentence of this Section 5.5, no provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and a majority in interest of the outstanding balance of the Note or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any amendment effected in accordance with accordance with this Section 5.5 shall be binding upon the Purchaser and holder of Securities and the Company.

5.6 Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.

5.7 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser. Each Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the Purchaser.

5.8 No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.9.

5.9 Governing Law; Exclusive Jurisdiction; Attorneys’ Fees. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, stockholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the New York County, New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the New York County, New York for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company elsewhere in this Agreement, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.

5.10 Survival. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.

5.11 Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf' format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf' signature page were an original thereof.

5.12 Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

5.13 Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then that Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however, that in the case of a rescission of an conversion of a Note, the Purchaser shall be required to return any Shares subject to any such rescinded Conversion Notice concurrently with the restoration of such Purchaser’s right to acquire such shares pursuant to the Purchaser’s Note.

5.14 Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction without requiring the posting of any bond.

5.15 Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.

5.16 Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

5.17 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.

5.18 Liquidated Damages. The Company’s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.

5.19 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.

5.20 Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.

5.21 Waiver of Jury Trial. In any action, suit, or proceeding in any jurisdiction brought by any party against any other party, the parties each knowingly and intentionally, to the greatest extent permitted by applicable law, hereby absolutely, unconditionally, irrevocably and expressly waive forever trial by jury.

5.22 Non-Circumvention. The Company hereby covenants and agrees that the Company will not, by amendment of its Articles of Incorporation, including any Certificates of Designation, or Bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Agreement, and will at all times in good faith carry out all of the provision of this Agreement and take all action as may be required to protect the rights of all holders of the Securities. Without limiting the generality of the foregoing or any other provision of this Agreement or the other Transaction Documents, the Company (a) shall not increase the par value of any Shares issuable upon conversion of the Notes above the Note Conversion Price then in effect and (b) shall take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Shares upon the conversion of the Notes. Notwithstanding anything herein to the contrary, if after 180 days from the original issuance date, the Purchasers are not permitted to convert the Note, in full, for any reason, subject to the Purchaser’s compliance with Rule 144 the Company shall use its best efforts to promptly remedy such failure, including, without limitation, obtaining such consent or approvals as necessary to permit such conversion or exercise.

(Signature Pages Follow)

IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

Innovative Payment Solutions, Inc.

Address for Notice:

By:			56B 5th Street, Lot 1, AT#
	Name:	William Corbett	Carmel by the Sea, CA, 93921
	Title:	Chief Executive Officer	Email: bill@ipsipay.com

With a copy to (which shall not constitute notice):

Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas

New York, NY 10105

Attention: Richard I. Anslow, Esq.

Email: ranslow@egsllp.com

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

[SIGNATURE PAGE FOR PURCHASERS FOLLOWS]

INNOVATIVE PAYMENT SOLUTIONS, INC.

PURCHASER SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

Name of Purchaser: _________________________________________________________________________

Signature of Authorized Signatory of Purchaser: __________________________________________________

Name of Authorized Signatory: ________________________________________________________________

Title of Authorized Signatory: _________________________________________________________________

Email Address of Authorized Signatory: _________________________________________________________

Address for Notice to Purchaser: _______________________________________________________________

Address for Delivery of Securities to Purchaser (if not same as address for notice):

___________________________________________________________________________________________

Subscription Amount: $_____________________

Social Securiy/EIN Number: __________________

[Purchaser Signature Page]

EXHIBIT A

Form of Note

EXHIBIT B

Form of Warrant

Exhibit 31.1

CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE

15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, William Corbett, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.:

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and.

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2023	/s/ William Corbett
	William Corbett
	Chief Executive Officer
	(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE

15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Richard Rosenblum, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.:

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(a)

(b)

(c)

(d)

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2023	/s/ Richard Rosenblum
	Richard Rosenblum
	President and Chief Financial Officer
	(Principal Financial and Accounting Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Innovative Payment Solutions, Inc. (the “Registrant”) on Form 10-Q for the quarterly period ended year ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William Corbett, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: August 14, 2023	By:	/s/ William Corbett
		William Corbett
		Chief Executive Officer
		(Principal Executive Officer)

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Innovative Payment Solutions, Inc. (the “Registrant”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard Rosenblum, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: August 14, 2023	By:	/s/ Richard Rosenblum
		Richard Rosenblum
		President and Chief Financial Officer
		(Principal Financial and Accounting Officer)

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2023	Aug. 11, 2023
Document Information Line Items
Entity Registrant Name	INNOVATIVE PAYMENT SOLUTIONS, INC.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		379,075,592
Amendment Flag	false
Entity Central Index Key	0001591913
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jun. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-55648
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	33-1230229
Entity Address, Address Line One	56B 5th Avenue
Entity Address, Address Line Two	Lot 1 #AT
Entity Address, City or Town	Carmel By The Sea
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	93921
City Area Code	(866)
Local Phone Number	477-4729
Entity Interactive Data Current	Yes

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current Assets
Cash	$ 46,788	$ 373,822
Receivable from equity method investment	22,103
Receivable on sale of subsidiary	166,668
Other current assets	19,080	97,042
Assets held for sale		807,263
Total Current Assets	254,639	1,278,127
Non-current assets
Plant and equipment	14,861	40,362
Intangible assets	1,191,693	1,401,491
Receivable on sale of subsidiary	64,768
Security deposit	19,800	32,592
Equity method investment	306,839
Investment
Total Non-Current Assets	1,597,961	1,474,445
Total Assets	1,852,600	2,752,572
Current Liabilities
Accounts payable	1,387,412	727,922
Liabilities held for sale		33,810
Related party payables	50,000
Federal relief loans – current portion	3,275
Notes payable	1,012,736	964,268
Convertible debt, net of unamortized discount of $463,104 and $0, respectively	2,837,176	2,266,602
Derivative liability	3,012,574	2,550,642
Total Current Liabilities	8,303,173	6,543,244
Federal relief loans	158,360	163,978
Total Non-Current Liabilities	158,360	163,978
Total Liabilities	8,461,533	6,707,222
Equity (Deficit)
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of June 30, 2023 and December 31, 2022.
Common stock, $0.0001 par value; 750,000,000 shares authorized, 379,075,592 and 376,901,679 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively.	37,908	37,690
Additional paid-in-capital	49,200,624	48,405,921
Accumulated deficit	(55,847,465)	(52,399,858)
Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders	(6,608,933)	(3,956,247)
Non-controlling interest		1,597
Total Equity (Deficit)	(6,608,933)	(3,954,650)
Total Liabilities and Equity (Deficit)	$ 1,852,600	$ 2,752,572

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Convertible debt, net of unamortized discount (in Dollars)	$ 463,104	$ 0
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	25,000,000	25,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	750,000,000	750,000,000
Common stock, shares issued	379,075,592	376,901,679
Common stock, shares outstanding	379,075,592	376,901,679

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Net Revenue	$ 5		$ 438
Cost of Goods Sold	284		2,369
Gross loss	(279)		(1,931)
General and administrative	1,057,631	769,054	2,007,578	1,620,580
Depreciation and amortization	139,015	4,497	279,705	8,993
Total Expense	1,196,646	773,551	2,287,283	1,629,573
Loss from Operations	(1,196,925)	(773,551)	(2,289,214)	(1,629,573)
Loss on debt conversion	(18,478)		(18,478)
Penalty on convertible notes				(719,558)
Interest expense	(95,079)	(45,196)	(180,300)	(90,962)
Amortization of debt discount	(88,687)		(111,654)	(263,200)
Derivative liability movements	(1,252,682)	(242,102)	(311,932)	(149,941)
Loss before Income Taxes	(2,651,851)	(1,060,849)	(2,911,578)	(2,853,234)
Income Taxes
Net Loss after income taxes	(2,651,851)	(1,060,849)	(2,911,578)	(2,853,234)
Net loss from equity method investments	(1,381)		(1,381)
Net loss from continuing operations	(2,653,232)	(1,060,849)	(2,912,959)	(2,853,234)
Discontinued operations
Operating loss from discontinued operations	(25,561)	(26,483)	(40,821)	(44,344)
Loss on disposal of subsidiary and investment	(495,424)		(495,424)
Discontinued operations	(520,985)	(26,483)	(536,245)	(44,344)
Net loss	(3,174,217)	(1,087,332)	(3,449,204)	(2,897,578)
Net loss attributable to non-controlling interest		12,977	1,597	21,729
Net loss attributable to Innovative Payment Solutions, Inc., stockholders	$ (3,174,217)	$ (1,074,355)	$ (3,447,607)	$ (2,875,849)
Basic and diluted loss per share
Continuing operations (in Dollars per share)	$ (0.01)	$ 0	$ (0.01)	$ (0.01)
Discontinued operations (in Dollars per share)	0	0	0	0
Basic and diluted loss per share total (in Dollars per share)	$ (0.01)	$ 0	$ (0.01)	$ (0.01)
Weighted Average Number of Shares Outstanding – Basic (in Shares)	377,905,023	367,901,679	377,403,351	367,901,679

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Continuing operations diluted	$ (0.01)	$ 0.00	$ (0.01)	$ (0.01)
Discontinued operations diluted	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted Average Number of Shares Outstanding – Diluted (in Shares)	377,905,023	367,901,679	377,403,351	367,901,679

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Non-controlling shareholders interest	Total
Balance at Dec. 31, 2021	$ 36,790	$ 45,771,012	$ (42,111,701)	$ 35,211	$ 3,731,312
Balance (in Shares) at Dec. 31, 2021	367,901,679
Stock based option expense		94,466			94,466
Restricted stock awards		62,766			62,766
Net loss			(1,801,494)	(8,752)	(1,810,246)
Balance at Mar. 31, 2022	$ 36,790	45,928,244	(43,913,195)	26,459	2,078,298
Balance (in Shares) at Mar. 31, 2022	367,901,679
Balance at Dec. 31, 2021	$ 36,790	45,771,012	(42,111,701)	35,211	3,731,312
Balance (in Shares) at Dec. 31, 2021	367,901,679
Fair value of warrants issued for equity method investments
Net loss					(2,897,578)
Balance at Jun. 30, 2022	$ 36,790	46,085,472	(44,987,550)	23,135	1,157,847
Balance (in Shares) at Jun. 30, 2022	367,901,679
Balance at Mar. 31, 2022	$ 36,790	45,928,244	(43,913,195)	26,459	2,078,298
Balance (in Shares) at Mar. 31, 2022	367,901,679
Contribution by minority shareholders				9,653	9,653
Stock based option expense		94,462			94,462
Restricted stock awards		62,766			62,766
Net loss			(1,074,355)	(12,977)	(1,087,332)
Balance at Jun. 30, 2022	$ 36,790	46,085,472	(44,987,550)	23,135	1,157,847
Balance (in Shares) at Jun. 30, 2022	367,901,679
Balance at Dec. 31, 2022	$ 37,690	48,405,921	(52,399,858)	1,597	(3,954,650)
Balance (in Shares) at Dec. 31, 2022	376,901,679
Fair value of warrants issued to convertible debt holders		251,856			251,856
Stock based compensation		130,671			130,671
Net loss			(273,390)	(1,597)	(274,987)
Balance at Mar. 31, 2023	$ 37,690	48,788,448	(52,673,248)		(3,847,110)
Balance (in Shares) at Mar. 31, 2023	376,901,679
Balance at Dec. 31, 2022	$ 37,690	48,405,921	(52,399,858)	1,597	(3,954,650)
Balance (in Shares) at Dec. 31, 2022	376,901,679
Fair value of warrants issued for equity method investments					108,220
Net loss					(3,449,204)
Balance at Jun. 30, 2023	$ 37,908	49,200,624	(55,847,465)		(6,608,933)
Balance (in Shares) at Jun. 30, 2023	379,075,592
Balance at Mar. 31, 2023	$ 37,690	48,788,448	(52,673,248)		(3,847,110)
Balance (in Shares) at Mar. 31, 2023	376,901,679
Conversion of convertible debt	$ 218	43,260			43,478
Conversion of convertible debt (in Shares)	2,173,913
Fair value of warrants issued to convertible debt holders		130,025			130,025
Fair value of warrants issued for equity method investments		108,220			108,220
Stock based compensation		130,671			130,671
Net loss			(3,174,217)		(3,174,217)
Balance at Jun. 30, 2023	$ 37,908	$ 49,200,624	$ (55,847,465)		$ (6,608,933)
Balance (in Shares) at Jun. 30, 2023	379,075,592

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,174,217)	$ (274,987)	$ (1,087,332)	$ (1,810,246)	$ (3,449,204)	$ (2,897,578)
Net loss from discontinued operations	520,985		26,483		536,245	44,344
Net loss from continuing operations	(2,653,232)		(1,060,849)		(2,912,959)	(2,853,234)
Adjustments to reconcile net loss to net cash used in operating activities:
Derivative liability movements					311,932	149,941
Depreciation					279,705	8,993
Amortization of debt discount					111,654	263,200
Loss on conversion of debt to equity					18,478
Penalty on convertible debt						719,558
Unrealized loss on equity method investments					1,381
Stock based compensation					261,342	314,460
Changes in Assets and Liabilities
Receivable from equity method investments					(22,103)
Receivable from disposal of subsidiary					18,570
Other current assets					77,957	58,312
Accounts payable and accrued expenses					659,490	(63,881)
Related party payables					50,000
Interest accruals					176,107	2,712
Cash used in operating activities – continuing operations					(968,446)	(1,399,939)
Cash provided by (used in) operating activities – discontinued operations					35,287	(52,734)
CASH USED IN OPERATING ACTIVITIES					(933,159)	(1,452,673)
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in intangibles					(44,405)	(290,290)
Investment in equity method investment					(200,000)
Net cash used in investing activities – continuing operations					(244,405)	(290,290)
Net cash used in investing activities – discontinued operations					(36,231)	(37,510)
CASH USED IN INVESTING ACTIVITIES					(280,636)	(327,800)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes					900,000
Repayment of convertible notes					(11,840)	(1,147,063)
Repayment of federal relief loans					(2,342)
Net cash provided by (used in) financing activities – continuing operations					885,818	(1,147,063)
Net cash provided by financing activities – discontinued operations						9,653
NET CASH PROVIDED BY (SUED IN) FINANCING ACTIVITIES					885,818	(1,137,410)
NET DECREASE IN CASH					(327,977)	(2,917,883)
Cash and cash included in assets held for sale at the beginning of the period		$ 374,765		$ 5,449,751	374,765	5,449,751	$ 5,449,751
CASH AT END OF PERIOD	46,788		2,531,868		46,788	2,531,868	374,765
RECONCILIATION OF OPENING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS
Cash	373,822		5,367,551		373,822	5,367,551
Cash included in assets held for sale	943		82,200		943	82,200
CASH AT THE BEGINNING OF THE PERIOD	374,765		5,449,751		374,765	5,449,751
RECONCILIATION OF CLOSING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS
Cash	46,788		2,520,060		46,788	2,520,060	373,822
Cash included in assets held for sale			11,808			11,808	$ 943
CASH AT THE END OF THE PERIOD	46,788		$ 2,531,868		46,788	2,531,868
CASH PAID FOR INTEREST AND TAXES:
Cash paid for income taxes
Cash paid for interest					4,191	88,250
NON CASH INVESTING AND FINANCING ACTIVITIES
Fair value of warrants issued with convertible notes					381,881
Conversion of convertible debt to equity					25,000
Fair value of warrants issued for equity method investments	$ 108,220				$ 108,220

Organization and Description of Business

6 Months Ended

Jun. 30, 2023

Organization and Description of Business [Abstract]

ORGANIZATION AND DESCRIPTION OF BUSINESS

1	ORGANIZATION AND DESCRIPTION OF BUSINESS

Organizational History

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

Description of current business

IPSIPay Express

Frictionless Financial Technologies

Accounting Policies and Estimates

6 Months Ended

Jun. 30, 2023

Accounting Policies and Estimates [Abstract]

ACCOUNTING POLICIES AND ESTIMATES

2	ACCOUNTING POLICIES AND ESTIMATES

Basis of Presentation

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

Principles of Consolidation

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. – Disposed on May 12, 2023

Use of Estimates

Contingencies

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

Fair Value of Financial Instruments

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Risks and Uncertainties

Recent accounting pronouncements

Reporting by Segment

No segmental information is required as the Company only has one operating segment.

Cash and Cash Equivalents

Accounts Receivable and Allowance for Doubtful Accounts

Investments

Plant and Equipment

Description		Estimated Useful Life

Kiosks (not used in the Company’s current business)		7 years

Computer equipment		3 years

Office equipment		10 years

Long-Term Assets

Revenue Recognition

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

identify the contract with a customer;

ii.

identify the performance obligations in the contract;

iii.

determine the transaction price;

iv.

allocate the transaction price to performance obligations in the contract; and

recognize revenue as the performance obligation is satisfied.

The Company had minimal revenues of $438 and $0 for the six months ended June 30, 2023 and 2022, respectively.

Share-Based Payment Arrangements

Derivative Liabilities

Income Taxes

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

Comprehensive income

Liquidity Matters and Going Concern

6 Months Ended

Jun. 30, 2023

Liquidity Matters and Going Concern [Abstract]

LIQUIDITY MATTERS AND GOING CONCERN

3	LIQUIDITY MATTERS AND GOING CONCERN

The Company has determined that there currently is substantial doubt about their ability to continue as a going concern.

Disposal of Investment in Frictionless and Beyond Fintech

6 Months Ended

Jun. 30, 2023

Disposal of Investment in Frictionless and Beyond Fintech [Abstract]

DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH

4	DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH

The assets and liabilities disposed of were as follows:

	Amount
Assets

Current Assets
Cash	$	339

Non-current assets
Intangible assets		327,211
Security deposit		15,000
Investment		500,000
		842,211
Total assets		842,550

Liabilities

Current Liabilities
Accounts payable		97,126

Net assets sold		745,424
Proceeds due on disposal		(250,000	)
Net loss on disposal	$	495,424

Discontinued Operations

6 Months Ended

Jun. 30, 2023

Discontinued Operations [Abstract]

DISCONTINUED OPERATIONS

5	DISCONTINUED OPERATIONS

Effective May 12, 2023, the Company disposed of its investment in Beyond Fintech pursuant to the May 2023 Frictionless Agreement, as disclosed in note 4 above.

The following assets and liabilities are reported as discontinued operations:

	December 31,
	2022
Current assets
Cash	$	943
Non-current assets
Intangibles, net		291,320
Investment		500,000
Security deposit		15,000
Assets held for sale	$	807,263

Current liabilities
Accounts payable	$	33,810
Liabilities held for sale	$	33,810

The statement of operations from discontinued operations is as follows:

	Three months ended			Three months ended			Six months ended			Six months ended
	June 30,			June 30,			June 30,			June 30,
	2023			2022			2023			2022

Net Revenue	$	-		$	-		$	-		$	-

Cost of Goods Sold		-			-			-			-

Gross loss		-			-			-			-

General and administrative		25,561			26,483			40,821			44,344
Depreciation and amortization		-			-			-			-
Total Expense		25,561			26,483			40,821			44,344

Loss from operations before income taxes		(25,561	)		(26,483	)		(40,821	)		(44,344	)

Income Taxes		-			-			-			-
Loss from discontinued operations, net of taxation	$	(25,561	)	$	(26,483	)	$	(40,821	)	$	(44,344	)

Intangibles

6 Months Ended

Jun. 30, 2023

Intangibles [Abstract]

INTANGIBLES

6	INTANGIBLES

	June 30, 2023							December 31, 2022
	Cost		Accumulated amortization			Net Book Value		Net book value
Purchased Technology - IPSIPay	$	1,546,805	$	(355,112	)	$	1,191,693	$	1,401,491

Amortization expense was $128,348 and $0 for the three months ended June 30, 2023 and 2022, respectively, and $254,204 and $0 for the six months ended June 30, 2023, respectively.

Equity Method Investment

6 Months Ended

Jun. 30, 2023

Equity Method Investment [Abstract]

EQUITY METHOD INVESTMENT

7	EQUITY METHOD INVESTMENT

	June 30, 2023
Cash contribution to IPSIPay Express	$	200,000
Fair value of warrants issued to third party joint venture partners		108,220
		308,220
Equity loss from joint venture		(1,381	)
	$	306,839

Investments

6 Months Ended

Jun. 30, 2023

Investments [Abstract]

INVESTMENTS

8	INVESTMENTS

Investment in Frictionless Financial Technologies Inc.

On May 12, 2023, the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless). refer Note 4 above.

Leases

6 Months Ended

Jun. 30, 2023

Leases [Abstract]

LEASES

9	LEASES

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

Total Lease Cost

Individual components of the total lease cost incurred by the Company is as follows:

		Six months ended June 30, 2023				Six months ended June 30, 2022
Operating lease expense		$	30,528			$	28,800

Other lease information:

	Six months ended June 30, 2023			Six months ended June 30, 2022
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	(30,528	)	$	(28,800	)

Remaining lease term – operating lease		Monthly			Monthly

Federal Relief Loans

6 Months Ended

Jun. 30, 2023

Federal Relief Loans [Abstract]

FEDERAL RELIEF LOANS

10	FEDERAL RELIEF LOANS

Small Business Administration Disaster Relief loan

Notes Payable

6 Months Ended

Jun. 30, 2023

Notes Payable [Abstract]

NOTES PAYABLE

11	NOTES PAYABLE

Notes payable to Cavalry and Mercer at June 30, 2023 consists of the following:

Description	Interest Rate			Maturity date	Principal		Accrued Interest		June 30, 2023 Amount, net		December 31, 2022 Amount, net
Cavalry Fund I LP		10	%	December 30, 2023		482,000		24,368		506,368		482,134
Mercer Street Global Opportunity Fund, LLC		10	%	December 30, 2023		482,000		24,368		506,368		482,134
Total convertible notes payable					$	964,000	$	48,736	$	1,012,736	$	964,268

Interest expense totaled $24,368 and $0 for the three months ended June 30, 2023 and 2022, respectively, and $48,468 and $0 for the six months ended June 30, 2023 and 2022, respectively.

Convertible Notes Payable

6 Months Ended

Jun. 30, 2023

Convertible Notes Payable [Abstract]

CONVERTIBLE NOTES PAYABLE

12	CONVERTIBLE NOTES PAYABLE

December 2022 Note Amendment Transaction

(1)

(2)

(3)

(4)

(5)

Convertible notes payable consists of the following:

Description	Interest Rate			Maturity date	Principal		Accrued Interest		Unamortized debt discount			June 30, 2023 Amount, net		December 31, 2022 Amount, net
Cavalry Fund I LP		10.00	%	December 30, 2023		1,066,754		96,147		-			1,162,901		1,133,301

Mercer Street Global Opportunity Fund, LLC		10.00	%	December 30, 2023		1,091,754		96,438		-			1,188,192		1,133,301

Quick Capital, LLC		8.00	%	December 20, 2023		62,857		138		(44,340	)		18,655		-

1800 Diagonal Street Lending, LLC*		13.00	%	May 10, 2024		105,480		708		(90,782	)		15,406		-
		17.33	%	March 13, 2024		62,700		506		(58,810	)		4,396		-

2023 convertible notes		8.00	%	February 13, 2024 to June 21, 2024		700,000		16,798		(269,172	)		447,626		-

Total convertible notes payable					$	3,089,545	$	210,735	$	(463,104	)	$	2,837,176	$	2,266,602

These notes were repaid on August 3, 2023. See note 18.

Interest expense totaled $69,320 and $43,793 for the three months ended June 30, 2023 and 2022, respectively, and $129,057 and $88,172 for the six months ended June 30, 2023 and 2022, respectively.

Cavalry Fund LLP

On May 19, 2023, Cavalry converted $25,000 of principal into 2,173,913 shares of Common Stock at a conversion price of $0.0115 per share realizing a loss on conversion of $18,478.

The balance of the Cavalry Note plus accrued interest at June 30, 2023 was $1,162,901.

Mercer Street Global Opportunity Fund, LLC

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of Common Stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

The balance of the Mercer Note plus accrued interest at June 30, 2023 was $1,188,192.

Quick Capital, LLC

The balance of the Quick Capital Note plus accrued interest at June 30, 2023 was $18,655, net of unamortized debt discount of $44,340.

1800 Diagonal Street Lending LLC

●

The balance of the May 1800 Diagonal Note plus accrued interest at June 30, 2023 was $15,406, net of unamortized debt discount of $90,782.

●

The balance of the June 1800 Diagonal Note plus accrued interest at June 30, 2023 was $4,396, net of unamortized debt discount of $58,810.

The two 1800 Diagonal Notes were repaid by the Company on August 3, 2023 (see note 18).

2023 Convertible Notes

●

Convertible Promissory Notes (the “2023 Notes” and each a “2023 Note”); and

●

The balance of the 2023 Notes plus accrued interest at June 30, 2023 was $447,626, net of unamortized debt discount of $269,172.

Derivative Liability

6 Months Ended

Jun. 30, 2023

Derivative Liability [Abstract]

DERIVATIVE LIABILITY

13	DERIVATIVE LIABILITY

The following assumptions were used in the Black-Scholes valuation model:

	Six months ended June 30, 2023			Year ended December 31, 2022
Conversion price	$	0.0048 to $0.0115		$	0.0115 to $0.15
Risk free interest rate		3.60 to 5.48	%		0.79 to 4.73	%
Expected life of derivative liability		9 to 50 months			1.5 to 59 months
Expected volatility of underlying stock		158.72 to 192.53	%		120.49 to 258.3	%
Expected dividend rate		0	%		0	%

The movement in derivative liability is as follows:

	June 30, 2023		December 31, 2022
Opening balance	$	2,550,642	$	407,161
Derivative financial liability arising from convertible note and warrants		150,000		238,182
Derivative financial liability arising on note amendment included in loss on convertible notes		-		2,317,051
Fair value adjustment to derivative liability		311,932		(411,752	)
	$	3,012,574	$	2,550,642

Stockholders’ Equity

6 Months Ended

Jun. 30, 2023

Stockholders’ Equity [Abstract]

STOCKHOLDERS’ EQUITY

14	STOCKHOLDERS’ EQUITY

Common Stock

Restricted stock awards

A summary of restricted stock activity during the period January 1, 2022 to June 30, 2023 is as follows:

	Total restricted shares		Weighted average fair market value per share		Total unvested restricted shares			Weighted average fair market value per share			Total vested restricted shares		Weighted average fair market value per share
Outstanding January 1, 2022		21,495,000	$	0.049		10,247,500		$	0.049			11,247,500	$	0.049
Granted and issued		2,000,000		0.055		-			-			2,000,000		0.055
Forfeited/Cancelled		-		-		-			-			-		-
Vested		-		-		(5,123,750	)		(0.049	)		5,123,750		0.049
Outstanding December 31, 2022		23,495,000	$	0.050		5,123,750		$	0.049			18,371,250	$	0.050
Granted and issued		-		-		-			-			-		-
Forfeited/Cancelled		-		-		-			-			-		-
Vested		-		-		(5,123,750	)		(0.049	)		5,123,750		0.049
Outstanding June 30, 2023		23,495,000	$	0.050		-		$	0.049			23,495,000	$	0.050

The restricted stock granted, issued and exercisable at June 30, 2023 is as follows:

	Restricted Stock Granted and Vested
Grant date Price	Number Granted		Weighted Average Fair Value per Share
$0.049		20,495,000	$	0.049
$0.050		1,000,000		0.050
$0.055		2,000,000		0.055
		23,495,000	$	0.050

Preferred Stock

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of June 30, 2023 and December 31, 2022.

Warrants

On December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred:

●

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

	Six months ended June 30, 2023
Exercise price	$	0.0115
Risk free interest rate		3.77 to 4.16	%
Expected life		5 years
Expected volatility of underlying stock		187.40 to 189.37	%
Expected dividend rate		0	%

A summary of warrant activity during the period January 1, 2022 to June 30, 2023 is as follows:

	Shares Underlying Warrants			Exercise price per share		Weighted average exercise price
Outstanding January 1, 2022		37,304,105		$	0.05 – 0.1875	$	0.12
Granted		51,000,000			0.0115 – 0.0345		0.01826
Increase in warrants due to debt amendment full rachet trigger		72,260,870			0.0115		0.0115
Cancelled on debt amendment		(4,973,914	)		0.15		0.1500
Exercised		-			-		-
Outstanding December 31, 2022		155,591,061		$	0.0115 – 0.1875	$	0.0300
Granted		74,335,391			0.0115		0.0115
Forfeited		(1,000,000	)		0.05		0.05
Cancelled on disposal of investment in Frictionless and Beyond Fintech		(30,000,000	)		0.0115		0.0115
Exercised		-			-		-
Outstanding June 30, 2023		198,926,452		$	0.0115 – 0.1875	$	0.0259

The warrants outstanding and exercisable at June 30, 2023 are as follows:

		Warrants Outstanding						Warrants Exercisable
Exercise Price		Number Outstanding		Weighted Average Remaining Contractual life in years		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price		Weighted Average Remaining Contractual life in years
$	0.0115		158,333,118		4.27				158,333,118				4.27
$	0.0345		15,000,000		2.02				11,250,000				2.02
	0.015		8,000,000		4.98				8,000,000				4.98
$	0.15		15,166,667		2.72				15,166,667				2.72
$	0.1875		2,426,667		2.72				2,426,667				2.72
			198,926,452		3.99	$	0.0259		195,176,452	$	0.0259		3.99

The warrants outstanding have an intrinsic value of $395,833 and $0 as of June 30, 2023 and 2022, respectively.

Stock options

The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock.

A summary of option activity during the period January 1, 2022 to June 30, 2023 is as follows:

	Shares Underlying options		Exercise price per share		Weighted average exercise price
Outstanding January 1, 2022		30,516,666		$0.15 to 0.40	$	0.15
Granted		15,800,000		0.04 – 0.15		0.14
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding December 31, 2022		46,316,666		$0.04 to 0.40	$	0.15
Granted		-		-		-
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding June 30, 2023		46,316,666		$0.04 to 0.40	$	0.15

The options outstanding and exercisable at June 30, 2023 are as follows:

		Options Outstanding						Options Exercisable
Exercise Price		Number Outstanding		Weighted Average Remaining Contractual life in years		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price		Weighted Average Remaining Contractual life in years
$	0.04		800,000		9.21				800,000				9.21
$	0.15		45,208,333		8.44				39,375,000				8.48
$	0.24		208,333		7.65				208,333				7.65
$	0.40		100,000		5.50				100,000				5.50
			46,316,666		8.44	$	0.15		40,483,333	$	0.15		8.49

The options outstanding have an intrinsic value of $0 as of June 30, 2023 and 2022.

The option expense was $94,465 and $94,462 for the three months ended June 30, 2023 and 2022, respectively, and $188,928 and $188,928 for the six months ended June 30, 2023 and 2022, respectively.

Net Loss Per Share

6 Months Ended

Jun. 30, 2023

Net Loss Per Share [Abstract]

NET LOSS PER SHARE

15	NET LOSS PER SHARE

	Three and six months ended June 30, 2023 (Shares)		Three and six months ended June 30, 2022 (Shares)
Convertible debt		300,483,314		11,979,811
Stock options		46,316,666		30,516,666
Warrants to purchase shares of Common Stock		198.926,452		37,304,104
		545,726,432		79,800,582

Related Party Transactions

6 Months Ended

Jun. 30, 2023

RELATED PARTY TRANSACTIONS

16	RELATED PARTY TRANSACTIONS

The following transactions were entered into with related parties:

James Fuller

On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share.

The option expense for Mr. Fuller was $0 for the three months ended June 30, 2023 and 2022, and $0 for the six months ended June 30, 2023 and 2022.

Mr. Fuller voluntarily resigned as a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022.

William Corbett

On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 15,000,000 shares of Common Stock at an exercise price of $0.15 per share.

On June 21, 2023, Mr. Corbett advanced the company $50,000 to cover certain working capital expenses, the advance is short term in nature, bears no interest and has no fixed repayment terms.

The option expense for Mr. Corbett was $66,587 for the three months ended June 30, 2023 and 2022, and $133,174 for the six months ended June 30, 2023 and 2022.

Clifford Henry

The option expense for Mr. Henry was $0 for the three months ended June 30, 2023 and 2022, and $0 for the six months ended June 30, 2023 and 2022.

Madisson Corbett

The option expense for Ms. Corbett was $0 for the three months ended June 30, 2023 and 2022, and $0 for the six months ended June 30, 2023 and 2022.

David Rios

The option expense for Mr. Rios was $0 for the three months ended June 30, 2023 and 2022, and $0 for the six months ended June 30, 2023 and 2022.

Richard Rosenblum

On July 11, 2022, the Company granted Mr. Rosenblum 2,000,000 restricted shares of Common Stock valued at $110,000, all of which are vested.

The option expense for Mr. Rosenblum was $27,879 for the three months ended June 30, 2023 and 2022, and $55,758 for the six months ended June 30, 2023 and 2022.

Commitments and Contingencies

6 Months Ended

Jun. 30, 2023

Commitments and Contingencies [Abstract]

COMMITMENTS AND CONTINGENCIES

17	COMMITMENTS AND CONTINGENCIES

Subsequent Events

6 Months Ended

Jun. 30, 2023

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

18	SUBSEQUENT EVENTS

On August 3, 2023, the Company settled in full, the outstanding convertible notes owing to 1800 Diagonal, in the principal amount of $168,180 for gross proceeds of $160,000.

Accounting Policies, by Policy (Policies)

6 Months Ended

Jun. 30, 2023

Accounting Policies and Estimates [Abstract]

Basis of Presentation

Basis of Presentation

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

Principles of Consolidation

Principles of Consolidation

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. – Disposed on May 12, 2023

Use of Estimates

Use of Estimates

Contingencies

Contingencies

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Risks and Uncertainties

Risks and Uncertainties

Recent accounting pronouncements

Recent accounting pronouncements

Reporting by Segment

Reporting by Segment

No segmental information is required as the Company only has one operating segment.

Cash and Cash Equivalents

Cash and Cash Equivalents

Accounts Receivable and Allowance for Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts

Investments

Investments

Plant and Equipment

Plant and Equipment

Description		Estimated Useful Life

Kiosks (not used in the Company’s current business)		7 years

Computer equipment		3 years

Office equipment		10 years

Long-Term Assets

Long-Term Assets

Revenue Recognition

Revenue Recognition

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

identify the contract with a customer;

ii.

identify the performance obligations in the contract;

iii.

determine the transaction price;

iv.

allocate the transaction price to performance obligations in the contract; and

recognize revenue as the performance obligation is satisfied.

The Company had minimal revenues of $438 and $0 for the six months ended June 30, 2023 and 2022, respectively.

Share-Based Payment Arrangements

Share-Based Payment Arrangements

Derivative Liabilities

Derivative Liabilities

Income Taxes

Income Taxes

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

Comprehensive income

Comprehensive income

Accounting Policies and Estimates (Tables)

6 Months Ended

Jun. 30, 2023

Accounting Policies and Estimates [Abstract]

Schedule of Estimated Useful Lives of the Assets

Description		Estimated Useful Life

Kiosks (not used in the Company’s current business)		7 years

Computer equipment		3 years

Office equipment		10 years

Disposal of Investment in Frictionless and Beyond Fintech (Tables)

6 Months Ended

Jun. 30, 2023

Disposal of Investment in Frictionless and Beyond Fintech [Abstract]

Schedule of Assets and Liabilities

The assets and liabilities disposed of were as follows:

	Amount
Assets

Current Assets
Cash	$	339

Non-current assets
Intangible assets		327,211
Security deposit		15,000
Investment		500,000
		842,211
Total assets		842,550

Liabilities

Current Liabilities
Accounts payable		97,126

Net assets sold		745,424
Proceeds due on disposal		(250,000	)
Net loss on disposal	$	495,424

Discontinued Operations (Tables)

6 Months Ended

Jun. 30, 2023

Discontinued Operations [Abstract]

Schedule of Assets and Liabilities

The following assets and liabilities are reported as discontinued operations:

	December 31,
	2022
Current assets
Cash	$	943
Non-current assets
Intangibles, net		291,320
Investment		500,000
Security deposit		15,000
Assets held for sale	$	807,263

Current liabilities
Accounts payable	$	33,810
Liabilities held for sale	$	33,810

Schedule of Statement of Operations from Discontinued Operations

The statement of operations from discontinued operations is as follows:

	Three months ended			Three months ended			Six months ended			Six months ended
	June 30,			June 30,			June 30,			June 30,
	2023			2022			2023			2022

Net Revenue	$	-		$	-		$	-		$	-

Cost of Goods Sold		-			-			-			-

Gross loss		-			-			-			-

General and administrative		25,561			26,483			40,821			44,344
Depreciation and amortization		-			-			-			-
Total Expense		25,561			26,483			40,821			44,344

Loss from operations before income taxes		(25,561	)		(26,483	)		(40,821	)		(44,344	)

Income Taxes		-			-			-			-
Loss from discontinued operations, net of taxation	$	(25,561	)	$	(26,483	)	$	(40,821	)	$	(44,344	)

Intangibles (Tables)

6 Months Ended

Jun. 30, 2023

Intangibles [Abstract]

Schedule of Facilitate the Functioning of the IPSIPay Software

respectively, was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment.

	June 30, 2023							December 31, 2022
	Cost		Accumulated amortization			Net Book Value		Net book value
Purchased Technology - IPSIPay	$	1,546,805	$	(355,112	)	$	1,191,693	$	1,401,491

Equity Method Investment (Tables)

6 Months Ended

Jun. 30, 2023

Equity Method Investment [Abstract]

Schedule of Equity Method Investments

	June 30, 2023
Cash contribution to IPSIPay Express	$	200,000
Fair value of warrants issued to third party joint venture partners		108,220
		308,220
Equity loss from joint venture		(1,381	)
	$	306,839

Leases (Tables)

6 Months Ended

Jun. 30, 2023

Leases [Abstract]

Schedule of Total Lease Cost

Individual components of the total lease cost incurred by the Company is as follows:

		Six months ended June 30, 2023				Six months ended June 30, 2022
Operating lease expense		$	30,528			$	28,800

Schedule of Other Lease Information

Other lease information:

	Six months ended June 30, 2023			Six months ended June 30, 2022
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	(30,528	)	$	(28,800	)

Remaining lease term – operating lease		Monthly			Monthly

Notes Payable (Tables)

6 Months Ended

Jun. 30, 2023

Notes Payable [Abstract]

Schedule of Notes Payable

Notes payable to Cavalry and Mercer at June 30, 2023 consists of the following:

Description	Interest Rate			Maturity date	Principal		Accrued Interest		June 30, 2023 Amount, net		December 31, 2022 Amount, net
Cavalry Fund I LP		10	%	December 30, 2023		482,000		24,368		506,368		482,134
Mercer Street Global Opportunity Fund, LLC		10	%	December 30, 2023		482,000		24,368		506,368		482,134
Total convertible notes payable					$	964,000	$	48,736	$	1,012,736	$	964,268

Convertible Notes Payable (Tables)

6 Months Ended

Jun. 30, 2023

Convertible Notes Payable [Abstract]

Schedule of Convertible Notes Payable

Convertible notes payable consists of the following:

Description	Interest Rate			Maturity date	Principal		Accrued Interest		Unamortized debt discount			June 30, 2023 Amount, net		December 31, 2022 Amount, net
Cavalry Fund I LP		10.00	%	December 30, 2023		1,066,754		96,147		-			1,162,901		1,133,301

Mercer Street Global Opportunity Fund, LLC		10.00	%	December 30, 2023		1,091,754		96,438		-			1,188,192		1,133,301

Quick Capital, LLC		8.00	%	December 20, 2023		62,857		138		(44,340	)		18,655		-

1800 Diagonal Street Lending, LLC*		13.00	%	May 10, 2024		105,480		708		(90,782	)		15,406		-
		17.33	%	March 13, 2024		62,700		506		(58,810	)		4,396		-

2023 convertible notes		8.00	%	February 13, 2024 to June 21, 2024		700,000		16,798		(269,172	)		447,626		-

Total convertible notes payable					$	3,089,545	$	210,735	$	(463,104	)	$	2,837,176	$	2,266,602

These notes were repaid on August 3, 2023. See note 18.

Derivative Liability (Tables)

6 Months Ended

Jun. 30, 2023

Derivative Liability [Abstract]

Schedule of Assumptions Were Used in the Black-Scholes Valuation Model

The following assumptions were used in the Black-Scholes valuation model:

	Six months ended June 30, 2023			Year ended December 31, 2022
Conversion price	$	0.0048 to $0.0115		$	0.0115 to $0.15
Risk free interest rate		3.60 to 5.48	%		0.79 to 4.73	%
Expected life of derivative liability		9 to 50 months			1.5 to 59 months
Expected volatility of underlying stock		158.72 to 192.53	%		120.49 to 258.3	%
Expected dividend rate		0	%		0	%

Schedule of Movement in Derivative Liability

The movement in derivative liability is as follows:

	June 30, 2023		December 31, 2022
Opening balance	$	2,550,642	$	407,161
Derivative financial liability arising from convertible note and warrants		150,000		238,182
Derivative financial liability arising on note amendment included in loss on convertible notes		-		2,317,051
Fair value adjustment to derivative liability		311,932		(411,752	)
	$	3,012,574	$	2,550,642

Stockholders’ Equity (Tables)

6 Months Ended

Jun. 30, 2023

Stockholders’ Equity [Abstract]

Schedule of Restricted Stock Activity

A summary of restricted stock activity during the period January 1, 2022 to June 30, 2023 is as follows:

	Total restricted shares		Weighted average fair market value per share		Total unvested restricted shares			Weighted average fair market value per share			Total vested restricted shares		Weighted average fair market value per share
Outstanding January 1, 2022		21,495,000	$	0.049		10,247,500		$	0.049			11,247,500	$	0.049
Granted and issued		2,000,000		0.055		-			-			2,000,000		0.055
Forfeited/Cancelled		-		-		-			-			-		-
Vested		-		-		(5,123,750	)		(0.049	)		5,123,750		0.049
Outstanding December 31, 2022		23,495,000	$	0.050		5,123,750		$	0.049			18,371,250	$	0.050
Granted and issued		-		-		-			-			-		-
Forfeited/Cancelled		-		-		-			-			-		-
Vested		-		-		(5,123,750	)		(0.049	)		5,123,750		0.049
Outstanding June 30, 2023		23,495,000	$	0.050		-		$	0.049			23,495,000	$	0.050

Schedule of Restricted Stock Granted Issued and Exercisable

The restricted stock granted, issued and exercisable at June 30, 2023 is as follows:

	Restricted Stock Granted and Vested
Grant date Price	Number Granted		Weighted Average Fair Value per Share
$0.049		20,495,000	$	0.049
$0.050		1,000,000		0.050
$0.055		2,000,000		0.055
		23,495,000	$	0.050

Schedule of Fair Value of the Warrants Granted and Issued Black Scholes Valuation Model

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

	Six months ended June 30, 2023
Exercise price	$	0.0115
Risk free interest rate		3.77 to 4.16	%
Expected life		5 years
Expected volatility of underlying stock		187.40 to 189.37	%
Expected dividend rate		0	%

Schedule of Warrant Activity

A summary of warrant activity during the period January 1, 2022 to June 30, 2023 is as follows:

	Shares Underlying Warrants			Exercise price per share		Weighted average exercise price
Outstanding January 1, 2022		37,304,105		$	0.05 – 0.1875	$	0.12
Granted		51,000,000			0.0115 – 0.0345		0.01826
Increase in warrants due to debt amendment full rachet trigger		72,260,870			0.0115		0.0115
Cancelled on debt amendment		(4,973,914	)		0.15		0.1500
Exercised		-			-		-
Outstanding December 31, 2022		155,591,061		$	0.0115 – 0.1875	$	0.0300
Granted		74,335,391			0.0115		0.0115
Forfeited		(1,000,000	)		0.05		0.05
Cancelled on disposal of investment in Frictionless and Beyond Fintech		(30,000,000	)		0.0115		0.0115
Exercised		-			-		-
Outstanding June 30, 2023		198,926,452		$	0.0115 – 0.1875	$	0.0259

Schedule of Warrants Outstanding and Exercisable

The warrants outstanding and exercisable at June 30, 2023 are as follows:

		Warrants Outstanding						Warrants Exercisable
Exercise Price		Number Outstanding		Weighted Average Remaining Contractual life in years		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price		Weighted Average Remaining Contractual life in years
$	0.0115		158,333,118		4.27				158,333,118				4.27
$	0.0345		15,000,000		2.02				11,250,000				2.02
	0.015		8,000,000		4.98				8,000,000				4.98
$	0.15		15,166,667		2.72				15,166,667				2.72
$	0.1875		2,426,667		2.72				2,426,667				2.72
			198,926,452		3.99	$	0.0259		195,176,452	$	0.0259		3.99

Schedule of Option Activity

A summary of option activity during the period January 1, 2022 to June 30, 2023 is as follows

	Shares Underlying options		Exercise price per share		Weighted average exercise price
Outstanding January 1, 2022		30,516,666		$0.15 to 0.40	$	0.15
Granted		15,800,000		0.04 – 0.15		0.14
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding December 31, 2022		46,316,666		$0.04 to 0.40	$	0.15
Granted		-		-		-
Forfeited/Cancelled		-		-		-
Exercised		-		-		-
Outstanding June 30, 2023		46,316,666		$0.04 to 0.40	$	0.15

Schedule of Options Outstanding and Exercisable

The options outstanding and exercisable at June 30, 2023 are as follows:

		Options Outstanding						Options Exercisable
Exercise Price		Number Outstanding		Weighted Average Remaining Contractual life in years		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price		Weighted Average Remaining Contractual life in years
$	0.04		800,000		9.21				800,000				9.21
$	0.15		45,208,333		8.44				39,375,000				8.48
$	0.24		208,333		7.65				208,333				7.65
$	0.40		100,000		5.50				100,000				5.50
			46,316,666		8.44	$	0.15		40,483,333	$	0.15		8.49

Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2023

Net Loss Per Share [Abstract]

Schedule of Dilutive Shares

	Three and six months ended June 30, 2023 (Shares)		Three and six months ended June 30, 2022 (Shares)
Convertible debt		300,483,314		11,979,811
Stock options		46,316,666		30,516,666
Warrants to purchase shares of Common Stock		198.926,452		37,304,104
		545,726,432		79,800,582

Organization and Description of Business (Details) - USD ($)					1 Months Ended		6 Months Ended
	May 12, 2023	Dec. 30, 2022	Feb. 03, 2022	Dec. 31, 2019	Dec. 28, 2022	Aug. 26, 2021	Jun. 30, 2023	Oct. 31, 2023	Sep. 15, 2023	Aug. 04, 2023	Jun. 21, 2023	Aug. 30, 2022	Jun. 22, 2021	Feb. 16, 2021	Nov. 01, 2019
Organization and Description of Business [Abstract]
Shares of common stock (in Shares)	30,000,000		3,000,000				621,920
Aggregate shares of common stock (in Shares)							2,500							51,901,711
Retained shares of common stock (in Shares)	30,000,000						500,000
Outstanding shares of common stock (in Shares)															32,047,817
Exchange shares (in Shares)				2,250,000
Stock purchase agreement (in Shares)				2,250,000
Shares of vivi				9.00%
Aggregate amount (in Dollars)					$ 2,264,784
Percentage of membership interest							11.11%
Initial tranche (in Dollars)											$ 200,000
Percentage of remaining shares owned						49.00%
Beyond fintech shares (in Dollars)							$ 250,000
Percentage of credits against invoices							20.00%
Beyond Fintech [Member]
Organization and Description of Business [Abstract]
Stake owned percentage						51.00%
Common Stock [Member]
Organization and Description of Business [Abstract]
Common stock, par value (in Dollars per share)							$ 0.0001
Shares of common stock (in Shares)							500,000
Aggregate shares of common stock (in Shares)												3,000,000
Common stock outstanding, percentage							91.00%
Outstanding shares of common stock (in Shares)															320,477,867
Warrant [Member]
Organization and Description of Business [Abstract]
Stock purchase agreement (in Shares)		30,000,000
Purchase shares of common stock (in Dollars)							$ 10,000,000
Share-Based Payment Arrangement, Tranche One [Member]
Organization and Description of Business [Abstract]
Initial tranche (in Dollars)										$ 300,000
Share-Based Payment Arrangement, Tranche Two [Member]
Organization and Description of Business [Abstract]
Initial tranche (in Dollars)									$ 500,000
Share-Based Payment Arrangement, Tranche Three [Member]
Organization and Description of Business [Abstract]
Initial tranche (in Dollars)								$ 500,000
Capital Contribution [Member]
Organization and Description of Business [Abstract]
Aggregate amount (in Dollars)							1,500,000
Capital contribution (in Dollars)							500,000
Capital Contribution [Member] \| Minimum [Member]
Organization and Description of Business [Abstract]
Purchase shares of common stock (in Dollars)							5,000,000
Capital Contribution [Member] \| Maximum [Member]
Organization and Description of Business [Abstract]
Purchase shares of common stock (in Dollars)							$ 40,000,000
Frictionless Financial Technologies, Inc. [Member]
Organization and Description of Business [Abstract]
Acquired percentage							1.00%
Frictionless [Member]
Organization and Description of Business [Abstract]
Strategic interest													10.00%
Common stock outstanding percentage							41.00%
Purchase price (in Dollars)							$ 300,000
Qpagos Corporation’s Capital Stock [Member]
Organization and Description of Business [Abstract]
Shares of common stock (in Shares)							4,992,900
Qpagos Corporation’s Capital Stock [Member] \| Common Stock [Member]
Organization and Description of Business [Abstract]
Shares of common stock (in Shares)							497,500
Gaston Pereira [Member]
Organization and Description of Business [Abstract]
Shares of vivi				5.00%
Andrey Novikov [Member]
Organization and Description of Business [Abstract]
Shares of vivi				2.50%
Joseph Abrams [Member]
Organization and Description of Business [Abstract]
Shares of vivi				1.50%

Accounting Policies and Estimates (Details)	6 Months Ended
Accounting Policies and Estimates (Details)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
Accounting Policies and Estimates [Abstract]
Ownership percentage	20.00%
Operating segment	1
Federally insured limit	$ 0		$ 120,580
Plant and equipment costs	1,000
Revenues	$ 438	$ 0
Beyond Fintech Inc. [Member]
Accounting Policies and Estimates [Abstract]
Ownership percentage	51.00%

Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets	Jun. 30, 2023
Kiosks [Member]
Estimated useful lives	7 years
Computer equipment [Member]
Estimated useful lives	3 years
Office equipment [Member]
Estimated useful lives	10 years

Liquidity Matters and Going Concern (Details) - USD ($)	6 Months Ended	12 Months Ended
Liquidity Matters and Going Concern (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Minimum [Member]
Schedule of liquidity matters and going concern [Abstract]
Net loss	$ 3,447,607
Maximum [Member]
Schedule of liquidity matters and going concern [Abstract]
Net loss		$ 10,331,424

Disposal of Investment in Frictionless and Beyond Fintech (Details) - USD ($)		6 Months Ended
	May 12, 2023	Jun. 30, 2023
Disposal of Investment in Frictionless and Beyond Fintech (Details) [Line Items]
Common stock (in Shares)	30,000,000	500,000
Consideration amount (in Dollars)	$ 250,000
Credit rate	20.00%
Ownership [Member]
Disposal of Investment in Frictionless and Beyond Fintech (Details) [Line Items]
Ownership interest rate	10.00%
Beyond Fintech [Member]
Disposal of Investment in Frictionless and Beyond Fintech (Details) [Line Items]
Ownership interest rate	51.00%

Disposal of Investment in Frictionless and Beyond Fintech (Details) - Schedule of Assets and Liabilities	Jun. 30, 2023 USD ($)
Current Assets
Cash	$ 339
Non-current assets
Intangible assets	327,211
Security deposit	15,000
Investment	500,000
Total Non-current assets	842,211
Total assets	842,550
Current Liabilities
Accounts payable	97,126
Net assets sold	745,424
Proceeds due on disposal	(250,000)
Net loss on disposal	$ 495,424

Discontinued Operations (Details) - Schedule of Assets and Liabilities - USD ($)	12 Months Ended
	Dec. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Current assets
Cash	$ 943		$ 11,808
Non-current assets
Intangibles, net	291,320
Investment	500,000
Security deposit	15,000
Assets held for sale	807,263
Current liabilities
Accounts payable	33,810
Liabilities held for sale	$ 33,810

Discontinued Operations (Details) - Schedule of Statement of Operations from Discontinued Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Schedule of Statement of Operations From Discontinued Operations [Abstract]
Net Revenue
Cost of Goods Sold
Gross loss	(279)		(1,931)
General and administrative	25,561	26,483	40,821	44,344
Depreciation and amortization
Total Expense	25,561	26,483	40,821	44,344
Loss from operations before income taxes	(25,561)	(26,483)	(40,821)	(44,344)
Income Taxes
Loss from discontinued operations, net of taxation	$ (25,561)	$ (26,483)	$ (40,821)	$ (44,344)

Intangibles (Details) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
Intangibles (Details) - USD ($)	Aug. 26, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Intangibles [Abstract]
Gross proceeds	$ 250,000						$ 375,000
Beyond fintech percentage	51.00%
Owned frictionless percentage	49.00%
Additional amount of software				$ 35,891		$ 41,320
IPSIPay software amount				44,405		$ 1,127,400
Amortization expense		$ 128,348	$ 0	$ 254,204	$ 0

Intangibles (Details) - Schedule of Facilitate the Functioning of the IPSIPay Software - USD ($)	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Schedule of Facilitate the Functioning of the IPSIPay Software [Abstract]
Cost	$ 1,546,805
Accumulated amortization	(355,112)
Net Book Value	$ 1,191,693	$ 1,401,491

Equity Method Investment (Details) - Schedule of Equity Method Investments - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Schedule of Equity Method Investments [Abstract]
Cash contribution to IPSIPay Express	$ 200,000		$ 200,000
Fair value of warrants issued to third party joint venture partners			108,220
Equity total			308,220
Equity loss from joint venture	$ (1,381)		(1,381)
Joint venture total			$ 306,839

Investments (Details)	May 12, 2023
Ownership [Member]
Investments (Details) [Line Items]
Ownership interest	10.00%

Leases (Details) - USD ($)		6 Months Ended
Leases (Details) - USD ($)	Jan. 01, 2023	Jun. 30, 2023
Leases [Abstract]
Lease, description		The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022.
Lease amount		$ 4,800
Monthly rent	$ 5,088

Leases (Details) - Schedule of Total Lease Cost - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Schedule of Total Lease Cost [Abstract]
Operating lease expense	$ 30,528	$ 28,800

Leases (Details) - Schedule of Other Lease Information - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$ (30,528)	$ (28,800)
Remaining lease term – operating lease	Monthly	Monthly

Federal Relief Loans (Details) - USD ($)		6 Months Ended
Federal Relief Loans (Details) - USD ($)	Jul. 07, 2020	Jun. 30, 2023
Federal Relief Loans [Abstract]
Disaster loan amount	$ 150,000
Bearing interest, percentage	3.75%
Repayable in monthly installments	$ 731
Principal amount		$ 2,342
Aggregate principal amount interest		2,775
Loan balance outstanding		147,656
Accrued interest		13,978
Disclosed amount of accrued interest		$ 3,275

Notes Payable (Details) - USD ($)		1 Months Ended	3 Months Ended		6 Months Ended
Notes Payable (Details) - USD ($)	Feb. 16, 2021	Feb. 16, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Notes Payable (Details) [Line Items]
Company received	$ 500,500
Interest rate	12.50%
Repayment of notes payables		$ 62,700
Common stock, shares (in Shares)	2,486,957	2,486,957
Exercise price per share (in Dollars per share)	$ 0.24
Non-convertible promissory notes	$ 482,000	$ 482,000
Notes issued					$ 964,000
Other interest expense			$ 24,368	$ 0	48,468	$ 0
Warrant [Member]
Notes Payable (Details) [Line Items]
Warrants					$ 43,608
Amendment Transaction [Member]
Notes Payable (Details) [Line Items]
Interest rate					10.00%
Non-convertible promissory notes	482,000	$ 482,000
Maturity date					Dec. 30, 2023
Common stock shares (in Shares)					51,901,711
Convertible Debt [Member]
Notes Payable (Details) [Line Items]
Convertible debt			$ 920,392		$ 920,392
Cavalry and Mercer [Member]
Notes Payable (Details) [Line Items]
Company received	500,500
Repayment of notes payables	$ 572,000

Notes Payable (Details) - Schedule of Notes Payable - USD ($)	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Notes Payable (Details) - Schedule of Notes Payable [Line Items]
Principal	$ 964,000
Accrued Interest	48,736
Amount, net	$ 1,012,736	$ 964,268
Cavalry Fund I LP [Member]
Notes Payable (Details) - Schedule of Notes Payable [Line Items]
Interest Rate	10.00%
Maturity date	December 30, 2023
Principal	$ 482,000
Accrued Interest	24,368
Amount, net	$ 506,368	482,134
Mercer Street Global Opportunity Fund, LLC [Member]
Notes Payable (Details) - Schedule of Notes Payable [Line Items]
Interest Rate	10.00%
Maturity date	December 30, 2023
Principal	$ 482,000
Accrued Interest	24,368
Amount, net	$ 506,368	$ 482,134

Convertible Notes Payable (Details) - USD ($)						1 Months Ended					3 Months Ended		6 Months Ended		12 Months Ended
Convertible Notes Payable (Details) - USD ($)	May 12, 2023	May 10, 2023	Nov. 16, 2022	Feb. 03, 2022	Feb. 16, 2021	Jun. 20, 2023	May 19, 2023	Dec. 28, 2022	Nov. 16, 2022	Feb. 16, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Jun. 13, 2023
Convertible Notes Payable (Details) [Line Items]
Maturity date				Aug. 16, 2022						Dec. 30, 2023
Interest rate percentage					10.00%					10.00%	8.00%		8.00%
Additional shares of common stock (in Shares)	30,000,000			3,000,000									621,920
Exercise price per share (in Dollars per share)								$ 0.0115					$ 0.0115
Common stock shares (in Shares)					17.33					17.33	3,000,000		3,000,000
Warrant exercisable (in Shares)											39,130,435		39,130,435
Non Convertible Promissory Note					$ 482,000					$ 482,000
Common stock shares issued (in Shares)					51,901,711					51,901,711	2,500		2,500
Common stock price per share (in Dollars per share)															$ 0.06
Aggregate amount								$ 2,264,784
Convertible notes													$ 836,414
Black-scholes valuation model													1,499,577
Convertible note holders											$ 238,182		238,182
Additional charge													920,392
Value of notes											964,000		964,000
Warrant cost													11
Holders amount													841,003
Interest expense											69,320	$ 43,793	129,057	$ 88,172
Amortization of debt discount											88,687	$ 0
Amortization of debt discount total													111,654	$ 263,200
Net proceeds										$ 1,800
Loss on conversion							$ 18,478
Net of unamortized debt discount											463,104		$ 463,104		$ 0
RepaymentOfNotesPayables										$ 62,700
Purchase of aggregate shares (in Shares)													66,335,391
Conversion price of per share (in Dollars per share)													$ 0.0115
Beneficially own of percentage													4.99%
Limitation exceeds of percentage													9.99%
Warrant [Member]
Convertible Notes Payable (Details) [Line Items]
Accrued interest											447,626		$ 447,626
Net of unamortized debt discount											269,172		269,172
Cavalry Fund I LP [Member]
Convertible Notes Payable (Details) [Line Items]
Interest rate percentage			20.00%		10.00%				20.00%	10.00%
Exercise price per share (in Dollars per share)							$ 0.0115		$ 0.15	$ 0.24
Warrant exercisable (in Shares)					2,486,957					2,486,957
Net proceeds										$ 500,500
Original issue discount										71,500
Senior secured convertible note					$ 572,000					$ 572,000
Initial conversion price per share (in Dollars per share)										$ 0.23
Purchase an additional shares (in Shares)									3,000,000
Principal amount							$ 25,000
Purchase of additional shares (in Shares)							2,173,913
Accrued interest											1,162,901		1,162,901
Mercer Street Global Opportunity Fund, LLC [Member]
Convertible Notes Payable (Details) [Line Items]
Interest rate percentage			20.00%						20.00%
Exercise price per share (in Dollars per share)									$ 0.15	$ 0.24
Warrant exercisable (in Shares)					2,486,957					2,486,957
Net proceeds										$ 500,500
Original issue discount										572,000
Senior secured convertible note					$ 71,500					$ 71,500
Purchase an additional shares (in Shares)									3,000,000
Accrued interest											1,188,192		1,188,192
Original issue discount rate										10.00%
Conversion price (in Dollars per share)					$ 0.23					$ 0.23
Quick Capital, LLC [Member]
Convertible Notes Payable (Details) [Line Items]
Exercise price per share (in Dollars per share)						$ 0.0115
Warrant exercisable (in Shares)						5,465,826
Net proceeds						$ 50,000
Original issue discount						62,857
Senior secured convertible note						$ 12,857
Accrued interest											18,655		18,655
Original issue discount rate						8.00%
Conversion price (in Dollars per share)						$ 0.0115
Net of unamortized debt discount											$ 44,340		$ 44,340
Diagonal Street Lending LLC [Member]
Convertible Notes Payable (Details) [Line Items]
Net proceeds		$ 100,000
Original issue discount		117,320
Senior secured convertible note		$ 17,320
Original issue discount rate		13.00%
Conversion price (in Dollars per share)											$ 15,406		$ 15,406
Net of unamortized debt discount											$ 90,782		$ 90,782
Variable conversion rate percentage		60.00%														60.00%
Minimum [Member]
Convertible Notes Payable (Details) [Line Items]
Conversion price, per share (in Dollars per share)											$ 0.15		$ 0.15
Minimum [Member] \| Cavalry Fund I LP [Member]
Convertible Notes Payable (Details) [Line Items]
Conversion price, per share (in Dollars per share)			$ 0.15						$ 0.15
Minimum [Member] \| Mercer Street Global Opportunity Fund, LLC [Member]
Convertible Notes Payable (Details) [Line Items]
Conversion price, per share (in Dollars per share)			0.15						0.15
Maximum [Member]
Convertible Notes Payable (Details) [Line Items]
Conversion price, per share (in Dollars per share)											$ 0.0115		$ 0.0115
Maximum [Member] \| Cavalry Fund I LP [Member]
Convertible Notes Payable (Details) [Line Items]
Conversion price, per share (in Dollars per share)			0.0115						0.0115
Maximum [Member] \| Mercer Street Global Opportunity Fund, LLC [Member]
Convertible Notes Payable (Details) [Line Items]
Conversion price, per share (in Dollars per share)			0.0115						$ 0.0115
Convertible Debt [Member] \| Diagonal Street Lending LLC [Member]
Convertible Notes Payable (Details) [Line Items]
Accrued interest											$ 4,396		$ 4,396
Net of unamortized debt discount											$ 58,810		$ 58,810
Cavalry and Mercer [Member]
Convertible Notes Payable (Details) [Line Items]
Interest rate percentage				20.00%
Exercise price per share (in Dollars per share)			$ 0.15												$ 0.04
Aggregate amount								$ 1,132,392
Net proceeds										$ 50,000
Original issue discount										$ 12,700
RepaymentOfNotesPayables					$ 572,000
Cavalry and Mercer [Member] \| Minimum [Member]
Convertible Notes Payable (Details) [Line Items]
Conversion price, per share (in Dollars per share)											$ 0.15		$ 0.15
Cavalry and Mercer [Member] \| Maximum [Member]
Convertible Notes Payable (Details) [Line Items]
Conversion price, per share (in Dollars per share)											$ 0.0115		$ 0.0115

Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable - USD ($)

6 Months Ended

Jun. 30, 2023

Dec. 31, 2022

Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable [Line Items]

Unamortized debt discount

$ (463,104)

$ 0

Convertible Notes Payable [Member]

Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable [Line Items]

Principal

3,089,545

Accrued Interest

210,735

Unamortized debt discount

(463,104)

Total convertible notes payable

$ 2,837,176

2,266,602

Cavalry Fund I LP [Member]

Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable [Line Items]

10.00%

December 30, 2023

$ 1,066,754

96,147

Unamortized debt discount

Total convertible notes payable

$ 1,162,901

1,133,301

Mercer Street Global Opportunity Fund, LLC [Member]

Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable [Line Items]

10.00%

December 30, 2023

$ 1,091,754

96,438

Unamortized debt discount

Total convertible notes payable

$ 1,188,192

1,133,301

Quick Capital, LLC [Member]

Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable [Line Items]

8.00%

December 20, 2023

$ 62,857

138

Unamortized debt discount

(44,340)

Total convertible notes payable

$ 18,655

1800 Diagonal Street Lending, LLC [Member]

Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable [Line Items]

Interest Rate

^[1]

13.00%

Maturity date

^[1]

May 10, 2024

Principal

^[1]

$ 105,480

Accrued Interest

^[1]

708

Unamortized debt discount

^[1]

(90,782)

Total convertible notes payable

^[1]

$ 15,406

1800 Diagonal Street Lending, LLC One [Member]

Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable [Line Items]

17.33%

March 13, 2024

$ 62,700

506

Unamortized debt discount

(58,810)

Total convertible notes payable

$ 4,396

2023 convertible notes [Member]

Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable [Line Items]

Interest Rate

8.00%

Maturity date

February 13, 2024 to June 21, 2024

Principal

$ 700,000

Accrued Interest

16,798

Unamortized debt discount

(269,172)

Total convertible notes payable

$ 447,626

[1]	These notes were repaid on August 3, 2023. See note 18.

Derivative Liability (Details) - USD ($)	3 Months Ended	6 Months Ended
Derivative Liability (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2023	Jun. 13, 2023	May 10, 2023
Derivative Liability (Details) [Line Items]
Rachet provision		$ 474,614
Convertible notes			$ 150,000	$ 360,491
Warrant [Member]
Derivative Liability (Details) [Line Items]
Derivative liability	$ 2,317,051	2,317,051
Black-Scholes [Member]
Derivative Liability (Details) [Line Items]
Derivative liability	$ 1,252,682	$ 311,932

Derivative Liability (Details) - Schedule of Assumptions Were Used in the Black-Scholes Valuation Model - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Expected dividend rate	0.00%	0.00%
Minimum [Member]
Conversion price (in Dollars per share)	$ 0.0048	$ 0.0115
Risk free interest rate	3.60%	0.79%
Expected life of derivative liability	9 months	1 month 15 days
Expected volatility of underlying stock	158.72%	120.49%
Maximum [Member]
Conversion price (in Dollars per share)	$ 0.0115	$ 0.15
Risk free interest rate	5.48%	4.73%
Expected life of derivative liability	50 months	59 months
Expected volatility of underlying stock	192.53%	258.30%

Derivative Liability (Details) - Schedule of Movement in Derivative Liability - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Opening balance	$ 2,550,642	$ 407,161
Derivative financial liability arising from convertible note and warrants	150,000	238,182
Derivative financial liability arising on note amendment included in loss on convertible notes		2,317,051
Fair value adjustment to derivative liability	311,932	(411,752)
Total	$ 3,012,574	$ 2,550,642

Stockholders’ Equity (Details) - USD ($)									1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
Stockholders’ Equity (Details) - USD ($)	Jun. 22, 2023	Jun. 21, 2023	May 19, 2023	Dec. 30, 2022	Sep. 13, 2022	Jul. 11, 2022	Oct. 22, 2021	Dec. 31, 2019	Aug. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Feb. 16, 2021
Stockholders’ Equity (Details) [Line Items]
Common stock authorized (in Shares)										750,000,000		750,000,000		750,000,000
Common stock par value (in Dollars per share)										$ 0.0001		$ 0.0001		$ 0.0001
Common stock issued (in Shares)										379,075,592		379,075,592		376,901,679
Common stock outstanding (in Shares)										379,075,592		379,075,592		376,901,679
Common stock conversion shares (in Shares)			2,173,913
Convertible debt			$ 25,000									$ 25,000
Expense										$ 0	$ 62,766	$ 0	125,532
Preferred stock, authorized (in Shares)										25,000,000		25,000,000		25,000,000
Preferred stock, par value (in Dollars per share)										$ 0.0001		$ 0.0001		$ 0.0001
Description of compensation service												(i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date.
Shares of common stock (in Shares)										2,500		2,500			51,901,711
Expiration date									Aug. 30, 2027
Purchased shares (in Shares)								2,250,000
Exercise price (in Dollars per share)					$ 0.04
Note amendment transaction description				the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred: ●The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of Common Stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above; ●The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt. ●An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.
Limitation exceeds percentage												9.99%
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears (in Dollars per share)	$ 0.015
Warrants outstanding an intrinsic value										$ 395,833	0	$ 395,833	0
Incentive stock options (in Shares)										198,926,452		198,926,452
Amount of immediate expense														$ 31,970
Options exercisable shares (in Shares)					200,000
Intrinsic value outstanding options										$ 0	0	$ 0	0
Option expense										$ 94,465	$ 94,462	$ 188,928	$ 188,928
Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock conversion shares (in Shares)										2,173,913
Shares of common stock (in Shares)									3,000,000
Exercise price (in Dollars per share)									$ 0.15
Exercise price (in Dollars per share)				$ 0.0115
Options exercisable shares (in Shares)					800,000
Warrant [Member]
Stockholders’ Equity (Details) [Line Items]
Purchased shares (in Shares)				30,000,000
Fair value of warrants				$ 348,938
Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock (in Shares)										800,000		800,000
Maximum [Member] \| Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock (in Shares)										100,000		100,000
Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Warrants beneficially percentage												4.99%
Chief Executive Officer [Member]
Stockholders’ Equity (Details) [Line Items]
Incentive stock options (in Shares)						15,000,000
Stock option exercise price (in Dollars per share)						$ 0.15
Amount of immediate expense														$ 823,854
Debt Conversion Notices [Member]
Stockholders’ Equity (Details) [Line Items]
Aggregate shares of common stock (in Shares)		66,335,391
Convertible debt amount		$ 0.0115
2021 Stock Incentive Plan [Member] \| Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock (in Shares)							53,000,000
2018 Stock Incentive Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Terminates period												10 years
2021 Stock Incentive Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Terminates period							10 years

Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Total restricted shares [Member]
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]
Total restricted shares, Outstanding at beginning (in Shares)	23,495,000	21,495,000
Total restricted shares, Granted and issued (in Shares)		2,000,000
Total restricted shares, Forfeited/Cancelled (in Shares)
Total restricted shares, Vested (in Shares)
Total restricted shares, Outstanding at ending (in Shares)	23,495,000	23,495,000
Weighted average fair market value per share [Member]
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]
Weighted average fair market value per share, Outstanding at beginning	$ 0.05	$ 0.049
Weighted average fair market value per share, Granted and issued		0.055
Weighted average fair market value per share, Forfeited/Cancelled
Weighted average fair market value per share, Vested
Weighted average fair market value per share, Outstanding at ending	$ 0.05	$ 0.05
Total unvested restricted shares [Member]
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]
Total unvested restricted shares, Outstanding at beginning (in Shares)	5,123,750	10,247,500
Total unvested restricted shares, Granted and issued (in Shares)
Total unvested restricted shares, Forfeited/Cancelled (in Shares)
Total unvested restricted shares, Vested (in Shares)	(5,123,750)	(5,123,750)
Total unvested restricted shares, Outstanding at ending (in Shares)		5,123,750
Unvested restricted Weighted average fair market value per share [Member]
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]
Weighted average fair market value per share, Outstanding at beginning	$ 0.049	$ 0.049
Weighted average fair market value per share, Granted and issued
Weighted average fair market value per share, Forfeited/Cancelled
Weighted average fair market value per share, Vested	(0.049)	(0.049)
Weighted average fair market value per share, Outstanding at ending	0.049	0.049
Total vested restricted shares [Member]
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]
Total vested restricted shares, Outstanding at beginning	18,371,250	11,247,500
Total vested restricted shares, Granted and issued		2,000,000
Total vested restricted shares, Forfeited/Cancelled
Total vested restricted shares, Vested	5,123,750	5,123,750
Total vested restricted shares, Outstanding at ending	23,495,000	18,371,250
Vested restricted Weighted average fair market value per share [Member]
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]
Weighted average fair market value per share, Outstanding at beginning	0.05	0.049
Weighted average fair market value per share, Granted and issued		0.055
Weighted average fair market value per share, Forfeited/Cancelled
Weighted average fair market value per share, Vested	0.049	0.049
Weighted average fair market value per share, Outstanding at ending	$ 0.05	$ 0.05

Stockholders’ Equity (Details) - Schedule of Restricted Stock Granted Issued and Exercisable	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Restricted stock granted and Vested, number granted \| shares	23,495,000
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) \| $ / shares	$ 0.05
Grant date Price 0.049 [Member]
Restricted stock granted and Vested, number granted \| shares	20,495,000
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) \| $ / shares	$ 0.049
Grant date Price 0.050 [Member]
Restricted stock granted and Vested, number granted \| shares	1,000,000
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) \| $ / shares	$ 0.05
Grant date Price 0.055 [Member]
Restricted stock granted and Vested, number granted \| shares	2,000,000
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) \| $ / shares	$ 0.055

Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued Black Scholes Valuation Model - Warrants [Member]	6 Months Ended
	Jun. 30, 2023 $ / shares
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued Black Scholes Valuation Model [Line Items]
Exercise price (in Dollars per share)	$ 0.0115
Expected life	5 years
Expected dividend rate	0.00%
Minimum [Member]
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued Black Scholes Valuation Model [Line Items]
Risk free interest rate	3.77%
Expected volatility of underlying stock	187.40%
Maximum [Member]
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued Black Scholes Valuation Model [Line Items]
Risk free interest rate	4.16%
Expected volatility of underlying stock	189.37%

Stockholders’ Equity (Details) - Schedule of Warrant Activity - Warrant [Member] - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Product Warranty Liability [Line Items]
Shares Underlying Warrants, Outstanding at beginning (in Shares)	155,591,061	37,304,105
Weighted average exercise price, Outstanding at ending	$ 0.03	$ 0.12
Shares Underlying Warrants, Outstanding at beginning (in Shares)	198,926,452	155,591,061
Weighted average exercise price, Outstanding at ending	$ 0.0259	$ 0.03
Shares Underlying Warrants, Granted (in Shares)	74,335,391	51,000,000
Exercise price per share, Granted	$ 0.0115
Weighted average exercise price, Granted	$ 0.0115	$ 0.01826
Shares Underlying Warrants, Forfeited (in Shares)	(1,000,000)
Exercise price per share, Forfeited	$ 0.05
Weighted average exercise price, Forfeited	$ 0.05
Shares Underlying Warrants, Cancelled on disposal of investment in Frictionless and Beyond Fintech (in Shares)	(30,000,000)
Exercise price per share, Cancelled on disposal of investment in Frictionless and Beyond Fintech (in Shares)	0.0115
Weighted average exercise price, Cancelled on disposal of investment in Frictionless and Beyond Fintech	$ 0.0115
Shares Underlying Warrants, Increase in warrants due to debt amendment full rachet trigger (in Shares)		72,260,870
Exercise price per share, Increase in warrants due to debt amendment full rachet trigger		$ 0.0115
Weighted average exercise price, Increase in warrants due to debt amendment full rachet trigger		$ 0.0115
Shares Underlying Warrants, Cancelled on debt amendment (in Shares)		(4,973,914)
Exercise price per share, Cancelled on debt amendment		$ 0.15
Weighted average exercise price, Cancelled on debt amendment		$ 0.15
Shares Underlying Warrants, Exercised (in Shares)
Exercise price per share, Exercised
Weighted average exercise price, Exercised
Minimum [Member]
Product Warranty Liability [Line Items]
Exercise price per share, Outstanding at ending	0.0115	0.05
Exercise price per share, Outstanding at ending	0.0115	0.0115
Exercise price per share, Granted		0.0115
Maximum [Member]
Product Warranty Liability [Line Items]
Exercise price per share, Outstanding at ending	0.1875	0.1875
Exercise price per share, Outstanding at ending	$ 0.1875	0.1875
Exercise price per share, Granted		$ 0.0345

Stockholders’ Equity (Details) - Schedule of Warrants Outstanding and Exercisable	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Warrants Outstanding, Number Outstanding	198,926,452
Warrants Outstanding, Weighted Average Remaining Contractual life in years	3 years 11 months 26 days
Warrants Outstanding, Weighted Average Exercise Price \| $ / shares	$ 0.0259
Warrants Exercisable, Number Exercisable	195,176,452
Warrants Exercisable ,Weighted Average Exercise Price \| $ / shares	$ 0.0259
Warrants Exercisable, Weighted Average Remaining Contractual life in years	3 years 11 months 26 days
Exercise Price 0.0115 [Member]
Warrants Outstanding, Exercise Price \| $ / shares	$ 0.0115
Warrants Outstanding, Number Outstanding	158,333,118
Warrants Outstanding, Weighted Average Remaining Contractual life in years	4 years 3 months 7 days
Warrants Exercisable, Number Exercisable	158,333,118
Warrants Exercisable, Weighted Average Remaining Contractual life in years	4 years 3 months 7 days
Exercise Price 0.0345 [Member]
Warrants Outstanding, Exercise Price \| $ / shares	$ 0.0345
Warrants Outstanding, Number Outstanding	15,000,000
Warrants Outstanding, Weighted Average Remaining Contractual life in years	2 years 7 days
Warrants Exercisable, Number Exercisable	11,250,000
Warrants Exercisable, Weighted Average Remaining Contractual life in years	2 years 7 days
Exercise Price 0.015 [Member]
Warrants Outstanding, Exercise Price \| $ / shares	$ 0.015
Warrants Outstanding, Number Outstanding	8,000,000
Warrants Outstanding, Weighted Average Remaining Contractual life in years	4 years 11 months 23 days
Warrants Exercisable, Number Exercisable	8,000,000
Warrants Exercisable, Weighted Average Remaining Contractual life in years	4 years 11 months 23 days
Exercise Price 0.15 [Member]
Warrants Outstanding, Exercise Price \| $ / shares	$ 0.15
Warrants Outstanding, Number Outstanding	15,166,667
Warrants Outstanding, Weighted Average Remaining Contractual life in years	2 years 8 months 19 days
Warrants Exercisable, Number Exercisable	15,166,667
Warrants Exercisable, Weighted Average Remaining Contractual life in years	2 years 8 months 19 days
Exercise Price 0.1875 [Member]
Warrants Outstanding, Exercise Price \| $ / shares	$ 0.1875
Warrants Outstanding, Number Outstanding	2,426,667
Warrants Outstanding, Weighted Average Remaining Contractual life in years	2 years 8 months 19 days
Warrants Exercisable, Number Exercisable	2,426,667
Warrants Exercisable, Weighted Average Remaining Contractual life in years	2 years 8 months 19 days

Stockholders’ Equity (Details) - Schedule of Option Activity - Stock Options [Member] - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Shares Underlying options, Outstanding at beginning (in Shares)	46,316,666	30,516,666
Weighted average exercise price, Outstanding at beginning	$ 0.15	$ 0.15
Shares Underlying options, Outstanding at ending (in Shares)	46,316,666	46,316,666
Weighted average exercise price, Outstanding at ending	$ 0.15	$ 0.15
Shares Underlying options, Granted (in Shares)		15,800,000
Exercise price per share, Granted
Weighted average exercise price, Granted		$ 0.14
Shares Underlying options, Forfeited/Cancelled (in Shares)
Exercise price per share, Forfeited/Cancelled
Weighted average exercise price, Forfeited/Cancelled
Shares Underlying options, Exercised (in Shares)
Exercise price per share, Exercised
Weighted average exercise price, Exercised
Minimum [Member]
Exercise price per share, Outstanding at beginning		0.15
Exercise price per share, Outstanding at ending	0.04	0.04
Exercise price per share, Granted		0.04
Maximum [Member]
Exercise price per share, Outstanding at beginning		0.4
Exercise price per share, Outstanding at ending	$ 0.4	0.4
Exercise price per share, Granted		$ 0.15

Stockholders’ Equity (Details) - Schedule of Options Outstanding and Exercisable	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Options Outstanding, Number Outstanding	46,316,666
Options Outstanding, Weighted Average Remaining Contractual life in years	8 years 5 months 8 days
Options Outstanding, Weighted Average Exercise Price \| $ / shares	$ 0.15
Options Exercisable, Number Exercisable	40,483,333
Options Exercisable ,Weighted Average Exercise Price \| $ / shares	$ 0.15
Options Exercisable, Weighted Average Remaining Contractual life in years	8 years 5 months 26 days
Exercise Price 0.04 [Member]
Options Outstanding, Exercise Price \| $ / shares	$ 0.04
Options Outstanding, Number Outstanding	800,000
Options Outstanding, Weighted Average Remaining Contractual life in years	9 years 2 months 15 days
Options Exercisable, Number Exercisable	800,000
Options Exercisable, Weighted Average Remaining Contractual life in years	9 years 2 months 15 days
Exercise Price 0.15 [Member]
Options Outstanding, Exercise Price \| $ / shares	$ 0.15
Options Outstanding, Number Outstanding	45,208,333
Options Outstanding, Weighted Average Remaining Contractual life in years	8 years 5 months 8 days
Options Exercisable, Number Exercisable	39,375,000
Options Exercisable, Weighted Average Remaining Contractual life in years	8 years 5 months 23 days
Exercise Price 0.24 [Member]
Options Outstanding, Exercise Price \| $ / shares	$ 0.24
Options Outstanding, Number Outstanding	208,333
Options Outstanding, Weighted Average Remaining Contractual life in years	7 years 7 months 24 days
Options Exercisable, Number Exercisable	208,333
Options Exercisable, Weighted Average Remaining Contractual life in years	7 years 7 months 24 days
Exercise Price 0.40 [Member]
Options Outstanding, Exercise Price \| $ / shares	$ 0.4
Options Outstanding, Number Outstanding	100,000
Options Outstanding, Weighted Average Remaining Contractual life in years	5 years 6 months
Options Exercisable, Number Exercisable	100,000
Options Exercisable, Weighted Average Remaining Contractual life in years	5 years 6 months

Net Loss Per Share (Details) - Schedule of Dilutive Shares - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Anti-dilutive shares	545,726,432	79,800,582	545,726,432	79,800,582
Convertible debt [Member]
Anti-dilutive shares	300,483,314	11,979,811	300,483,314	11,979,811
Stock options [Member]
Anti-dilutive shares	46,316,666	30,516,666	46,316,666	30,516,666
Warrants to purchase shares of common stock [Member]
Anti-dilutive shares	198.926452	37,304,104	198.926452	37,304,104

Related Party Transactions (Details) - USD ($)			3 Months Ended		6 Months Ended		12 Months Ended
Related Party Transactions (Details) - USD ($)	Sep. 13, 2022	Jul. 11, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Jun. 21, 2023
Mr. Fuller [Member]
Related Party Transactions (Textual)
Shares of common stock (in Shares)	200,000
Exercise price (in Dollars per share)	$ 0.04
Option expense			$ 0	$ 0	$ 0	$ 0
William Corbett [Member]
Related Party Transactions (Textual)
Shares of common stock (in Shares)		15,000,000
Exercise price (in Dollars per share)		$ 0.15
Option expense					133,174		$ 66,587
Working capital expenses								$ 50,000
Clifford Henry [Member]
Related Party Transactions (Textual)
Shares of common stock (in Shares)	200,000
Exercise price (in Dollars per share)	$ 0.04
Financial and capital markets advice					3,500
Common stock, value	$ 7,993
Mr. Henry [Member]
Related Party Transactions (Textual)
Option expense			0	0	0	0
Madisson Corbett [Member]
Related Party Transactions (Textual)
Shares of common stock (in Shares)	200,000
Exercise price (in Dollars per share)	$ 0.04
Common stock, value	$ 7,993
Ms. Corbett [Member]
Related Party Transactions (Textual)
Option expense			0	0	0	0
David Rios [Member]
Related Party Transactions (Textual)
Shares of common stock (in Shares)	200,000
Exercise price (in Dollars per share)	$ 0.04
Common stock, value	$ 7,993
Mr. Rios [Member]
Related Party Transactions (Textual)
Option expense			0	0	0	0
Mr. Rosenblum [Member]
Related Party Transactions (Textual)
Shares of common stock (in Shares)		2,000,000
Option expense			$ 27,879	$ 27,879	$ 55,758	$ 55,758
Common stock, value		$ 110,000

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)			1 Months Ended
	Aug. 04, 2023	Aug. 03, 2023	Aug. 04, 2023
Subsequent Events (Details) [Line Items]
Gross proceeds		$ 160,000	$ 576,666
Aggregate shares (in Shares)	50,144,870		50,144,870
Exercise price per share (in Dollars per share)	$ 0.0115		$ 0.0115
Subsequent event, description	On August 4, 2023, the Company made an IPSI Capital Contribution of $300,000 to IPSIPay Express, thereby completing its initial Trance contribution (see note 7). With the funding of its initial $500,000 capital contribution to IPSIPay Express, the Company received an 11.11% interest equity interest in IPSIPay Express. Such equity interest will increase to 33.33% upon the funding of next two $500,000 Tranches.
Principal amount		$ 168,180